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Abstract:	  
The	  goal	  of	  this	  work	  is	  to	  understand	  how	  cells	  form	  and	  maintain	  tubular	  shapes.	  The	  
protein	  EXC-­‐5	  is	  necessary	  for	  a	  small	  tubular	  structure	  in	  Caenorhabditis	  elegans	  to	  
maintain	  its	  shape.	  C.	  elegans	  is	  a	  small,	  easily	  manipulable,	  genetically	  tractable,	  and	  
transparent	  nematode	  with	  a	  unicellular	  excretory	  canal	  system.	  The	  C.	  elegans	  excretory	  
canal	  cell	  is	  a	  long	  “H”-­‐shaped	  tubular	  structure	  that	  serves	  as	  the	  osmoregulatory	  organ	  
for	  the	  animal.	  EXC-­‐5	  is	  a	  guanine	  nucleotide	  exchange	  factor	  (GEF).	  GEF	  proteins	  work	  by	  
binding	  to	  GDP-­‐bound	  small	  GTPases	  and	  facilitating	  the	  exchange	  of	  GDP	  with	  GTP,	  thus	  
activating	  the	  GTPase.	  The	  activated	  GTPases	  are	  effectors	  themselves	  and	  interact	  with	  
numerous	  other	  proteins	  to	  direct	  various	  cellular	  processes.	  	  
In	  this	  dissertation	  I	  discuss	  the	  various	  methods	  by	  which	  I	  examined	  how	  EXC-­‐5	  
functions	  in	  order	  to	  maintain	  the	  tubular	  structure	  of	  the	  excretory	  canal.	  I	  describe	  an	  
EMS	  non-­‐complementation	  screen	  to	  identify	  new	  alleles	  of	  EXC-­‐5,	  an	  EMS	  screen	  to	  
identify	  genetic	  enhancers	  of	  EXC-­‐5,	  methods	  to	  create	  an	  excretory	  canal-­‐specific	  RNAi	  
strain	  of	  C.	  elegans,	  the	  genetic	  interactions	  between	  exc-­5,	  cdc-­42,	  mig-­2,	  ced-­10	  and	  other	  
genes,	  the	  organization	  of	  subcellular	  organelles	  within	  the	  canal	  cell	  and	  in	  exc-­5	  mutants,	  
the	  generation	  of	  intein	  containing	  proteins	  to	  create	  conditional	  alleles,	  and	  the	  generation	  
of	  antibodies	  that	  bind	  to	  EXC-­‐5.	  	  
The	  data	  from	  these	  studies	  lead	  to	  a	  model	  of	  tubular	  maintenance	  where	  the	  sorting	  of	  
material	  to	  the	  apical	  surface	  is	  only	  required	  at	  certain	  points	  along	  the	  canal	  where	  it	  is	  
undergoing	  significant	  restructuring	  because	  of	  growth	  or	  physical	  damage.	  When	  exc-­5	  is	  
mutant,	  materials	  are	  not	  efficiently	  sorted	  to	  the	  apical	  surface	  where	  they	  are	  needed	  to	  
maintain	  the	  apical	  surface.	  Failure	  of	  the	  actin	  network	  under	  osmotic	  pressure	  from	  fluid	  
within	  the	  lumen	  causes	  cysts	  to	  form	  in	  the	  canal	  cell.	  When	  EXC-­‐5	  is	  overexpressed,	  
sorting	  to	  the	  apical	  surface	  is	  enhanced	  at	  the	  expense	  of	  sorting	  to	  the	  basal	  surface.	  This	  
leads	  to	  an	  inability	  of	  the	  basal	  surface	  to	  adhere	  to	  the	  basement	  membrane	  and	  grow	  
out,	  causing	  a	  convoluted	  tubule	  phenotype.	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Chapter	  1:	  Introduction	  
	  
Forward/Scope	  of	  Research	  
The	  nature	  of	  life	  is	  complex	  and	  messy.	  It	  is	  truly	  remarkable	  that	  life	  exists	  and	  a	  
challenge	  to	  be	  able	  to	  understand	  it.	  While	  day-­‐to-­‐day	  experimentation	  may	  temporarily	  
subvert	  the	  naïve	  wonder	  that	  I	  felt	  as	  an	  adolescent	  and	  the	  general	  curiosity	  about	  how	  
life	  exists	  and	  how	  things	  work,	  those	  feelings	  have	  never	  truly	  gone	  away.	  I	  would	  like	  to	  
take	  just	  a	  moment	  to	  address	  you	  and	  ask	  that	  you	  take	  a	  moment	  to	  reflect	  upon	  the	  
beauty,	  wonder,	  and	  complexity	  of	  the	  natural	  world.	  
The	  natural	  world	  is	  a	  big	  place,	  planet-­‐sized	  for	  some,	  universal	  to	  others.	  The	  diversity	  
and	  scope	  of	  trying	  to	  study	  all	  of	  it	  is	  staggering,	  yet	  our	  species	  has	  undertaken	  the	  role.	  
Although	  there	  seems	  to	  be	  an	  infinite	  number	  of	  aspects	  to	  studying	  life	  on	  this	  planet,	  the	  
most	  appealing	  to	  me	  has	  always	  been	  those	  processes	  that	  occur	  at	  a	  genetic	  and	  cellular	  
level.	  It	  is	  from	  a	  seemingly	  simple	  combination	  of	  a	  few	  nucleic	  acids	  that	  life	  arose	  and	  
formed	  cells.	  Those	  cells,	  under	  directions	  from	  the	  nucleic	  acids	  contained	  within,	  have	  
become	  the	  fundamental	  unit	  of	  life	  on	  this	  planet.	  
The	  scope	  of	  my	  research	  has	  focused	  on	  examining	  how	  cells	  are	  able	  to	  form	  and	  
maintain	  tubes.	  This	  process	  is	  essential	  in	  order	  for	  large	  multicellular	  organisms	  to	  exist.	  
(As	  a	  large	  multicellular	  organism	  with	  many	  complex	  tubular	  organ	  systems,	  I	  can	  attest	  to	  
this	  life-­‐dependent	  importance.)	  Without	  transportation	  systems	  to	  allow	  all	  cells	  to	  obtain	  
the	  nutrients	  they	  need	  and	  get	  rid	  of	  waste	  products,	  life	  would	  remain	  a	  strictly	  
microscopic	  pursuit.	  In	  this	  dissertation	  I	  examine	  one	  model	  of	  tube	  formation	  and	  
maintenance,	  the	  Caenorhabditis	  elegans	  excretory	  canal	  cell	  and	  the	  gene	  exc-­5.	  
	  
Tubular	  Structures	  
Cellular	  tubes	  are	  formed	  by	  polarized	  epithelial	  tissue.	  While	  skin	  may	  be	  the	  first	  thing	  
that	  springs	  to	  mind	  at	  the	  mention	  of	  epithelial	  tissue,	  epithelia	  do	  more	  than	  just	  
separate,	  contain,	  or	  protect	  other	  tissues	  from	  their	  surroundings.	  A	  working	  definition	  of	  
epithelia	  might	  be	  any	  cells	  or	  tissues	  that	  are	  designed	  to	  interface	  with	  the	  outside	  
environment.	  The	  function	  of	  epithelium	  is	  diverse	  and	  includes	  sensation,	  diffusion,	  
secretion,	  adsorption,	  and	  excretion.	  In	  order	  for	  many	  epithelia	  to	  perform	  these	  latter	  
tasks,	  the	  epithelial	  cells	  that	  make	  up	  the	  tissue	  must	  work	  together	  to	  form	  tubular	  
structures.	  
The	  ways	  in	  which	  cells	  form	  tubes	  varies	  and	  much	  is	  already	  known	  about	  the	  underlying	  
morphological	  processes.	  There	  are	  five	  mechanisms	  by	  which	  tubes	  can	  form:	  wrapping,	  
budding,	  cavitation,	  cord	  hollowing,	  and	  cell	  hollowing	  1.	  Different	  tubes	  use	  different	  
mechanisms	  to	  form	  and	  those	  mechanisms	  are	  correlated	  to	  their	  size.	  The	  largest	  tubes	  
are	  generally	  made	  by	  wrapping,	  cavitation,	  or	  cord	  hollowing.	  Smaller	  tubes,	  some	  
consisting	  of	  only	  a	  single	  cell,	  use	  budding	  and	  cell	  hollowing.	  While	  the	  way	  in	  which	  
these	  cells	  form	  tubes	  may	  differ,	  there	  is	  an	  underlying	  biology	  that	  they	  all	  share.	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As	  polarized	  cells,	  epithelia	  have	  an	  apical	  and	  a	  basal	  or	  basolateral	  surface	  (Fig.	  1.1).	  In	  a	  
single-­‐celled	  layer,	  these	  cells	  are	  firmly	  attached	  to	  each	  other	  through	  tight	  junctions	  and	  
adherens	  junctions	  that	  mark	  the	  boundary	  between	  the	  apical	  and	  basal/basolateral	  
surfaces.	  Beside	  their	  mechanical	  role	  to	  bind	  the	  two	  interfacing	  cells	  together	  through	  
claudin	  and	  occludins	  for	  tight	  junctions	  or	  cadherins	  and	  catenins	  for	  linking	  actin	  
together	  in	  adherens	  junctions,	  these	  junctions	  have	  also	  been	  shown	  to	  be	  an	  important	  
site	  of	  polarization.	  Tight	  junctions	  in	  particular	  are	  associated	  with	  the	  PAR	  proteins,	  
PTEN,	  and	  CDC42	  in	  order	  to	  maintain	  the	  boundary	  between	  the	  apical	  and	  basolateral	  
surfaces	  2,3.	  The	  basolateral	  surface	  of	  a	  cell	  contacts	  its	  neighboring	  epithelial	  cell	  and	  each	  
one	  is	  anchored	  at	  the	  basal	  surface	  to	  a	  basement	  membrane	  through	  integrins.	  All	  of	  this	  
remains	  true	  when	  these	  cells	  form	  a	  tubular	  shape.	  In	  a	  tubular	  structure,	  the	  apical	  
surfaces	  of	  the	  cells	  form	  a	  continuous	  surface	  that	  creates	  an	  enclosed	  space	  called	  a	  
lumen	  where	  fluids	  are	  free	  to	  flow	  past	  the	  cells.	  The	  basal	  surface	  of	  the	  cells	  similarly	  
forms	  a	  continuous	  outer	  surface	  that	  is	  anchored	  to	  and	  surrounded	  by	  a	  basement	  
membrane	  (Fig.	  1.1B).	  
Not	  all	  of	  the	  underlying	  cellular	  mechanisms	  by	  which	  these	  cells	  form	  a	  tube	  are	  entirely	  
clear,	  but	  much	  is	  known	  about	  the	  processes	  involved.	  Perhaps	  most	  important	  to	  lumen	  
formation	  is	  cell	  polarization.	  It	  is	  clear	  that	  CDC42,	  PAR	  proteins,	  aPKC,	  and	  PTEN	  function	  
together	  to	  alter	  the	  phospholipid	  composition	  of	  the	  apical	  and	  basolateral	  surfaces,	  
enriching	  the	  apical	  membrane	  with	  PIP2	  3,4,	  while	  PIP3	  is	  enriched	  in	  basal	  and	  basolateral	  
membranes	  5.	  	  The	  segregation	  of	  these	  phosphoinositides	  is	  fundamental	  to	  apical	  and	  
basal	  membrane	  identities	  and	  is	  closely	  linked	  to	  intracellular	  transport	  and	  proper	  
protein	  and	  vesicle	  targeting	  through	  the	  interactions	  between	  these	  phosphoinositides,	  
the	  Rho-­‐family	  of	  GTPases	  (especially	  CDC42),	  and	  the	  PAR	  complexes	  2,4.	  	  
Morphogenic	  processes	  are	  perhaps	  the	  second	  most	  important	  part	  of	  tube	  formation.	  The	  
cellular	  movements	  and	  cell	  shape	  changes	  that	  cells	  must	  undergo	  in	  order	  to	  organize	  
themselves	  into	  a	  functional	  tube	  require	  rearrangements	  of	  cells’	  cytoskeletons,	  the	  
extracellular	  matrix,	  and	  a	  luminal	  matrix	  6-­‐9.	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Figure	  1.1	  -­-­	  Polarized	  Epithelia	  Form	  Tubes	  
(A)	  A	  diagram	  
illustrating	  a	  single-­‐	  
celled	  layer	  of	  
polarized	  mammalian	  
epithelial	  cells.	  Apical	  
surfaces	  are	  lined	  in	  
red	  while	  basal	  and	  
basolateral	  surfaces	  
are	  lined	  in	  blue.	  	  
(B)	  A	  diagram	  
illustrating	  a	  cross-­‐
section	  of	  a	  mammalian	  
multicellular	  epithelial	  
tube.	  	  
(C)	  A	  diagram	  illustrating	  
a	  cross	  section	  of	  the	  
unicellular	  C.	  elegans	  
excretory	  canal	  cell.	  	  
(D)	  A	  3D	  representation	  
of	  the	  excretory	  canal	  
cell.	  The	  arrow	  indicates	  
movement	  of	  fluid	  





1.	  The	  apical	  surface	  of	  a	  polarized	  epithelial	  cell	  contacts	  the	  external	  environment	  and	  is	  enriched	  in	  
phosphatidylinositol	  4,5-­‐bisphosphate	  (PIP2).	  
2.	  The	  basal	  surface	  of	  a	  polarized	  epithelial	  cell	  contacts	  the	  basement	  membrane	  and	  is	  enriched	  in	  
phosphatidylinositol	  3,4,5	  triphosphate	  (PIP3).	  
3.	  Basolateral	  surface	  of	  an	  epithelial	  cell	  contacts	  neighboring	  epithelial	  cells	  and	  the	  basement	  membrane.	  It	  
is	  enriched	  in	  phosphatidylinositol	  3,4,5	  triphosphate	  (PIP3).	  
4.	  The	  basement	  membrane	  is	  a	  thin	  layer	  of	  fibrous	  proteins	  that	  help	  anchor	  the	  epithelium	  to	  the	  
underlying	  tissue.	  	  
5.	  Tight	  junctions	  physically	  anchor	  two	  cells	  together	  using	  claudin	  and	  occludins	  in	  vertebrates.	  Tight	  
junctions	  also	  serve	  as	  centers	  for	  polarization	  through	  their	  association	  with	  PAR	  proteins,	  PTEN,	  and	  CDC-­‐
42	  2,3	  and	  enrichment	  of	  the	  apical	  membrane	  with	  PIP2.	  These	  junctions	  form	  the	  boundary	  between	  the	  
apical	  and	  basolateral	  surface	  of	  the	  cell.	  	  
6.	  Adherens	  junctions	  physically	  anchor	  cells	  together	  using	  cadherins	  and	  catenins	  and	  link	  to	  the	  actin	  
cytoskeleton.	  These	  junctions	  are	  typically	  basal	  to	  tight	  junctions	  in	  vertebrates	  and	  may	  recruit	  PI3K	  to	  
enrich	  PIP3	  on	  the	  basolateral	  surface	  3.	  
7.	  Integrins	  anchor	  the	  basal	  surface	  of	  epithelial	  cells	  to	  the	  basement	  membrane.	  
8.	  Cell	  Nucleus.	  
9.	  Extracellular	  Matrix	  (ECM).	  
10.	  Lumen	  of	  the	  tubule	  where	  fluid	  flows	  through	  the	  organ.	  
11.	  Canaliculi	  are	  small	  tubular	  invaginations	  that	  connect	  to	  the	  lumen	  and	  extend	  into	  the	  cytoplasm	  of	  the	  
canal	  cell.	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While	  the	  initial	  formation	  of	  tubes	  from	  the	  cellular	  milieu	  is	  fascinating,	  it	  represents	  only	  
a	  small	  portion	  of	  the	  biology	  of	  these	  structures.	  The	  majority	  of	  the	  lifetime	  of	  these	  
tubular	  systems	  is	  spent	  carrying	  out	  their	  biological	  function	  -­‐	  transporting	  fluids.	  How	  do	  
these	  tubes	  maintain	  their	  shape	  while	  under	  constant	  pressure?	  How	  do	  they	  stay	  in	  
working	  condition	  in	  such	  a	  dynamic	  and	  often	  harsh	  environment?	  The	  cells	  that	  form	  
these	  tubes	  are	  dynamic	  and	  maintain	  sensitivity	  to	  the	  fluids	  that	  flow	  through	  them	  10-­‐13.	  
These	  cells	  must	  also	  be	  able	  to	  regenerate	  themselves,	  remain	  flexible	  and	  robust	  while	  
being	  bent	  and	  moved,	  and	  be	  able	  to	  repair	  damage	  when	  it	  occurs.	  Cells	  are	  able	  to	  do	  all	  
of	  these	  things	  (and	  more!)	  through	  regulation	  and	  formation	  of	  cytoskeleton	  components,	  
cell	  signaling,	  and	  intracellular	  transport.	  
	  
Polarized	  Membrane	  Trafficking	  
Cells	  are	  able	  to	  move	  membrane	  proteins,	  add	  or	  subtract	  membrane	  surface,	  and	  interact	  
with	  their	  environment	  through	  the	  exchange	  of	  materials	  by	  means	  of	  membrane	  
trafficking.	  The	  recycling	  and	  targeting	  of	  materials	  occurs	  through	  vesicular	  movement	  to	  
and	  from	  many	  different	  membrane	  compartments	  or	  the	  plasma	  membrane	  via	  actin	  
formation	  and	  microtubule	  transport.	  These	  compartments	  are	  primarily	  sub-­‐regions	  and	  
components	  of	  a	  large	  and	  dynamic	  tubulo-­‐vesicular	  network	  whose	  parts	  are	  identified	  
more	  by	  the	  proteins	  they	  contain	  than	  their	  gross	  morphology	  14,15.	  
This	  complex	  system	  of	  membranous	  compartments	  allows	  material	  to	  be	  taken	  into	  the	  
cell	  at	  the	  plasma	  membrane	  through	  endocytosis	  and	  sent	  to	  specific	  destinations	  in	  the	  
cell	  through	  sorting.	  During	  sorting,	  material	  may	  be	  sent	  back	  to	  the	  plasma	  membrane	  
and	  recycled	  while	  other	  cargo	  may	  be	  broken	  down	  and	  metabolized	  in	  lysosomes.	  Sorting	  
also	  directs	  material	  that	  has	  been	  synthesized	  within	  the	  cell	  to	  be	  incorporated	  into	  the	  
proper	  membrane	  or	  to	  be	  secreted	  by	  transport	  to	  the	  plasma	  membrane	  and	  exocytosis.	  
These	  processes	  become	  more	  complicated	  in	  polarized	  epithelial	  cells.	  As	  mentioned	  
previously,	  polarized	  cells	  have	  an	  apical	  and	  a	  basal	  surface	  that	  differ	  in	  composition,	  
have	  different	  functions,	  and	  require	  different	  components	  to	  be	  delivered	  to	  each	  surface.	  
The	  organization	  of	  the	  organelles	  and	  the	  control	  of	  the	  progression	  from	  one	  
compartment	  to	  the	  next	  are	  largely	  directed	  by	  RABs,	  small	  G-­‐proteins	  of	  the	  Ras	  
superfamily	  16.	  The	  cytoskeleton	  (actin,	  microtubules,	  and	  associated	  motors)	  as	  well	  as	  the	  
Rho	  and	  Rac	  GTPases	  also	  play	  distinct	  roles	  in	  the	  movement	  and	  progression	  of	  material	  
through	  the	  trafficking	  pathways	  17-­‐19.	  A	  general	  model	  of	  polarized	  membrane	  trafficking	  
is	  provided	  in	  Figure	  1.2,	  and	  summarized	  below.	  
Material	  is	  endocytosed	  from	  the	  plasma	  membrane	  at	  either	  the	  apical	  or	  basolateral	  
surface.	  This	  process	  can	  be	  clathrin-­‐dependent	  or	  clathrin-­‐independent.	  In	  clathrin-­‐
dependent	  endocytosis	  (CDE),	  the	  clathrin	  coat	  forms	  around	  the	  plasma	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Figure	  1.2	  -­-­	  A	  General	  Model	  of	  Polarized	  Intracellular	  Transport	  
	  
Endocytosis	  occurs	  through	  either	  clathrin-­‐dependent	  endocytosis	  (CDE)	  or	  clathrin-­‐
independent	  endocytosis	  (CIE).	  Early	  endocytic	  vesicles	  are	  enriched	  in	  RAB-­‐5	  and	  fuse	  
together	  to	  form	  early	  endosomes	  through	  the	  aid	  of	  EEA-­‐1.	  Material	  from	  either	  the	  basal	  
or	  apical	  early	  endosomes	  can	  mature	  into	  late	  endosomes	  and	  eventually	  be	  degraded	  in	  
the	  lysosome.	  Alternatively,	  material	  can	  either	  be	  ‘rapidly	  recycled’	  to	  the	  plasma	  
membrane	  through	  RAB-­‐4,	  RAB-­‐35	  (RME-­‐5),	  and	  RME-­‐4;	  or	  ‘slow-­‐recycled’	  to	  the	  
endocytic	  recycling	  compartment	  (ERC)	  through	  RAB-­‐11.	  Material	  in	  the	  ERC	  can	  then	  be	  
sorted	  back	  to	  the	  plasma	  membrane	  or	  to	  the	  Golgi	  via	  several	  routes,	  each	  using	  different	  
proteins.	  CDC-­‐42,	  RAB-­‐11,	  RME-­‐1,	  and	  the	  exocyst	  are	  involved	  in	  the	  transport	  of	  material	  
from	  the	  ERC	  to	  the	  plasma	  membrane.
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membrane	  and	  helps	  create	  a	  membrane	  invagination.	  This	  invagination	  is	  then	  severed	  
from	  the	  membrane	  in	  order	  to	  produce	  an	  endocytic	  vesicle,	  also	  known	  as	  a	  primary	  
vesicle.	  The	  endocytic	  vesicle	  loses	  this	  clathrin	  coat	  as	  it	  is	  transported	  to	  a	  membranous	  
organellar	  compartment	  termed	  the	  early	  endosome.	  	  
Clathrin-­‐independent	  endocytosis	  (CIE)	  can	  be	  achieved	  through	  several	  different	  
pathways.	  One	  method	  involves	  a	  caveolin	  coat	  and	  dynamin	  to	  make	  a	  vesicle	  from	  the	  
plasma	  membrane.	  Another	  involves	  CDC42,	  ARF1,	  and	  actin	  in	  a	  dynamin-­‐independent	  
process.	  Yet	  another	  clathrin-­‐	  and	  dynamin-­‐independent	  process	  uses	  the	  ARF6	  GTPase.	  
Interestingly,	  cargo	  of	  ARF6-­‐associated	  endocytosis	  has	  been	  shown	  to	  include	  βH-­‐spectrin	  
and	  cell-­‐extracellular	  matrix-­‐interacting	  proteins.	  Regardless	  of	  the	  method	  of	  
internalization,	  clathrin-­‐independent	  endocytosis	  results	  in	  endocytic	  vesicles	  that	  are	  then	  
transported	  to	  the	  early	  endosome	  15.	  	  
The	  early	  endosome	  is	  defined	  as	  the	  membrane	  compartment	  that	  receives	  material	  from	  
primary	  vesicles	  derived	  from	  both	  clathrin-­‐dependent	  and	  clathrin-­‐independent	  
endocytosis	  and	  is	  first	  characterized	  by	  the	  presence	  of	  RAB-­‐5.	  RAB-­‐5	  is	  a	  small	  GTPase	  
that	  binds	  to	  the	  PI3P	  present	  on	  early	  endocytic	  membranes	  and	  is	  necessary	  for	  the	  
fusion	  of	  endocytic	  vesicles	  together	  to	  form	  the	  early	  endosome	  16.	  In	  order	  for	  this	  fusion	  
to	  occur,	  RAB-­‐5	  binds	  to	  EEA-­‐1	  (early	  endosomal	  antigen	  1,	  which	  itself	  contains	  a	  PI3P	  
binding	  FYVE	  domain	  and	  is	  recruited	  to	  endocytic	  membranes)	  along	  with	  other	  adaptor	  
proteins	  to	  form	  a	  fusion	  complex	  20,21.	  It	  is	  thought	  that	  EEA-­‐1	  provides	  a	  tether	  to	  connect	  
RAB-­‐5	  proteins	  on	  other	  vesicles	  in	  order	  to	  facilitate	  their	  fusion	  into	  the	  early	  endosome.	  
The	  early	  endosome	  serves	  as	  the	  first	  cargo-­‐sorting	  organelle	  and	  is	  a	  tubular-­‐vesicular	  
network.	  In	  polarized	  cells,	  there	  exists	  both	  a	  basolateral	  early	  endosome	  and	  an	  apical	  
early	  endosome	  22.	  Material	  in	  the	  early	  endosomes	  has	  three	  general	  ways	  of	  being	  sorted	  
23.	  	  
The	  default	  pathway	  for	  material	  that	  has	  not	  been	  selected	  to	  exit	  the	  early	  endosome	  for	  
recycling	  is	  degradation.	  As	  the	  early	  endosome	  (also	  termed	  the	  sorting	  endosome)	  
matures,	  it	  turns	  into	  a	  more	  acidic	  and	  spherical	  compartment	  termed	  the	  late	  endosome	  
23	  and	  is	  characterized	  by	  the	  presence	  of	  RAB-­‐7	  24.	  RAB-­‐7	  has	  several	  functions	  and	  is	  
essential	  in	  several	  trafficking	  events	  including	  the	  movement	  of	  late	  endosomal	  material	  
into	  multi-­‐vesicular	  bodies	  and	  lysosomes	  25,26	  where	  the	  cargo	  will	  be	  degraded	  and	  
metabolized.	  Interestingly,	  RAB-­‐7	  has	  been	  shown	  to	  directly	  interact	  with	  Rac	  27	  and	  when	  
over-­‐active,	  RAB-­‐7	  has	  been	  shown	  to	  cause	  Charcot-­‐Marie-­‐Tooth	  disease	  type	  2B	  (CMT2B)	  
28.	  
The	  second	  method	  of	  early	  endosome	  exit	  is	  sometimes	  termed	  ‘rapid	  recycling’.	  Rapid	  
recycling	  occurs	  when	  material	  is	  directly	  taken	  from	  the	  early	  endosome	  and	  replaced	  on	  
the	  plasma	  membrane	  from	  whence	  it	  came.	  	  Although	  the	  precise	  function	  of	  rapid	  
recycling	  is	  unclear,	  RAB-­‐4,	  RAB-­‐35	  (RME-­‐5),	  and	  RME-­‐4,	  all	  seem	  to	  be	  necessary	  for	  the	  
process	  15.	  
The	  third	  method	  of	  early	  endosome	  sorting	  is	  sometimes	  termed	  ‘slow	  recycling’.	  For	  
apical	  early	  endosomes,	  this	  involves	  moving	  material	  into	  a	  compartment	  called	  the	  apical	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recycling	  endosome	  (ARE)	  22	  or	  the	  endocytic	  recycling	  compartment	  (ERC)	  15,	  or	  the	  
recycling	  endosome.	  Material	  in	  the	  ERC	  can	  then	  be	  sorted	  back	  to	  the	  plasma	  membrane	  
15,22.	  It	  should	  be	  noted	  that	  there	  is	  debate	  as	  to	  whether	  the	  ARE	  is	  a	  distinct	  
compartment	  separate	  from	  the	  CRE,	  or	  whether	  they	  are	  both	  subdomains	  of	  a	  larger	  
recycling	  complex	  29,30.	  
Both	  the	  ERC	  and	  recycling	  endosomes	  are	  enriched	  for	  RAB-­‐11.	  Slow-­‐recycling	  material	  
from	  the	  basal	  early	  endosomes	  also	  moves	  into	  the	  recycling	  endosome,	  joining	  with	  slow	  
recycling	  material	  from	  the	  apical	  surface	  22.	  It	  is	  in	  this	  compartment	  that	  the	  apical	  and	  
basal	  endocytic	  transport	  routes	  converge	  and	  allow	  material	  from	  either	  of	  the	  polarized	  
surfaces	  to	  be	  recycled	  back	  to	  the	  plasma	  membrane	  or	  to	  another	  membrane	  
compartment.	  In	  C.	  elegans,	  movement	  from	  the	  recycling	  endosome	  to	  the	  plasma	  surface	  
or	  back	  to	  the	  Golgi	  requires	  RME-­‐1/EHD1	  31,32.	  Although	  the	  specific	  proteins	  required	  for	  
any	  particular	  cargo	  to	  be	  sorted	  out	  of	  the	  recycling	  endosome	  and	  into	  sub-­‐domains	  of	  
the	  plasma	  membrane	  will	  vary,	  CDC-­‐42,	  Rac,	  ARF6,	  RAB-­‐22,	  RAB-­‐11,	  and	  members	  of	  the	  
exocyst	  complex	  are	  involved	  in	  the	  process	  15,33,34.	  
	  
The	  Rho	  Family	  of	  GTPases	  
The	  Rho	  family	  of	  GTPases	  (Rho-­‐GTPases)	  is	  a	  sub-­‐family	  of	  the	  Ras	  superfamily	  of	  small	  
GTPases.	  Like	  all	  small	  GTPases,	  these	  Rho	  family	  members	  are	  activated	  when	  bound	  to	  
GTP	  (Fig.	  1.3).	  As	  their	  name	  implies,	  they	  have	  a	  GTPase	  activity	  that	  will	  eventually	  cleave	  
the	  terminal	  phosphate	  of	  their	  GTP-­‐bound	  substrate,	  turning	  it	  into	  GDP	  and	  thereby	  
inactivating	  the	  small	  GTPase.	  There	  are	  three	  proteins	  associated	  with	  the	  activation	  and	  
inactivation	  of	  GTPases:	  Guanine	  nucleotide	  exchange	  factors	  (GEFs)	  help	  activate	  these	  
proteins	  by	  facilitating	  the	  release	  of	  the	  inactive	  GDP-­‐bound	  molecule,	  and	  the	  binding	  of	  
an	  activating	  GTP	  molecule;	  GTPase	  -­‐activating	  proteins	  (GAPs)	  stimulate	  the	  GTPase	  
activity	  inherent	  in	  the	  GTPase,	  causing	  inactivation	  of	  the	  protein	  as	  it	  cleaves	  GTP	  into	  
GDP;	  Guanine	  nucleotide	  dissociation	  inhibitors	  (GDIs)	  slow	  the	  release	  of	  the	  inactive	  GDP	  
molecule	  from	  the	  GTPases,	  causing	  the	  GTPase	  to	  remain	  in	  its	  inactive	  form	  for	  longer	  
periods.	  
The	  most-­‐studied	  members	  of	  the	  Rho-­‐GTPases	  include	  Rho,	  Rac,	  and	  CDC-­‐42.	  All	  three	  
proteins	  are	  well	  known	  for	  their	  involvement	  with	  modulating	  the	  actin	  cytoskeleton.	  
They	  are	  involved	  in	  a	  vast	  array	  or	  cellular	  processes,	  most	  of	  which	  require	  movement	  or	  
changes	  in	  cell	  shape.	  These	  include	  cell	  migration,	  cell	  death,	  cell	  polarization,	  and	  
tubulogenesis.	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Figure	  1.3	  –	  Activation	  of	  RhoGTPases	  	  
	  
RhoGTPases	  are	  activated	  when	  bound	  to	  GTP.	  Guanine	  nucleotide	  exchange	  factors	  (GEFs)	  
bind	  to	  the	  inactivated	  GTPase	  and	  facilitate	  the	  release	  of	  GDP	  and	  the	  binding	  of	  GTP	  in	  
order	  to	  activate	  the	  protein.	  Activated	  GTPases	  will	  eventually	  inactivate	  themselves	  
through	  their	  own	  GTPase	  activity	  by	  removing	  the	  terminal	  phosphate	  on	  GTP	  and	  turning	  
it	  into	  GDP.	  GTPase	  activating	  proteins	  (GAPs)	  can	  catalyze	  this	  activity	  and	  enhance	  the	  
inactivation	  of	  the	  GTPase.
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Rho-­‐GTPases	  have	  also	  been	  shown	  to	  be	  involved	  in	  intracellular	  trafficking.	  CDC-­‐42	  in	  
particular	  is	  well	  known	  for	  its	  role	  in	  the	  polarization	  of	  cells	  35	  and	  its	  involvement	  in	  
membrane	  trafficking	  36.	  CDC-­‐42	  has	  recently	  emerged	  as	  a	  link	  between	  cell	  polarization,	  
which	  is	  essential	  in	  lumen	  formation,	  and	  intracellular	  transport	  34,37.	  CDC-­‐42	  activity	  is	  
required	  for	  vesicle	  trafficking	  in	  polarized	  cells.	  When	  CDC-­‐42	  activity	  is	  altered	  or	  
reduced,	  sorting	  and	  recycling	  to	  the	  apical	  and	  basolateral	  surfaces	  is	  disrupted	  38	  and	  
sometimes	  causes	  mis-­‐targeting	  of	  basolateral	  cargo	  to	  the	  apical	  surface	  39,40.	  In	  addition,	  
endocytosis	  is	  also	  disrupted	  in	  cdc-­42	  mutants.	  Endocytosis	  from	  either	  the	  apical	  or	  the	  
basal	  surface	  (or	  both)	  is	  impaired	  and	  can	  cause	  apical	  membrane	  proteins	  to	  accumulate	  
in	  sorting	  endosomes	  41.	  CDC-­‐42	  has	  also	  been	  shown	  to	  interact	  with	  the	  exocyst	  in	  
regulating	  vesicle	  trafficking	  42.	  
The	  specifics	  of	  how	  CDC-­‐42	  and	  the	  other	  Rho	  GTPases	  influence	  trafficking	  are	  not	  well	  
known.	  Considering	  the	  functions	  of	  these	  proteins,	  it	  is	  likely	  that	  the	  effects	  are	  mediated	  
through	  modification	  or	  rearrangement	  of	  the	  actin	  cytoskeleton.	  
	  
Your	  friend:	  Caenorhabditis	  elegans	  
The	  small,	  free-­‐living,	  temperate	  soil	  nematode	  Caenorhabditis	  elegans	  can	  be	  found	  
ubiquitously	  on	  earth.	  As	  an	  adult,	  it	  can	  grow	  to	  approximately	  1mm	  long.	  While	  relatively	  
simple,	  C.	  elegans	  contains	  most	  of	  the	  major	  tissue	  types	  found	  in	  much	  larger	  organisms.	  
These	  tiny	  animals	  have	  a	  host	  of	  inherent	  properties	  that	  make	  them	  excellent	  organisms	  
to	  use	  to	  study	  genetics	  as	  well	  as	  developmental	  and	  cellular	  biology	  43.	  
The	  nematodes	  are	  hermaphroditic,	  which	  allows	  the	  maintenance	  of	  genetic	  backgrounds	  
without	  the	  need	  for	  mating.	  Male	  animals	  do	  exist,	  and	  arise	  spontaneously	  at	  a	  very	  low	  
frequency.	  Using	  males,	  it	  is	  also	  possible	  to	  set	  up	  genetic	  crosses	  to	  introduce	  and	  
combine	  different	  genes	  or	  mutations	  as	  well	  as	  any	  transgenic	  integrated	  constructs.	  
C.	  elegans	  matures	  rapidly	  and	  is	  prolific.	  From	  the	  time	  it	  is	  laid	  as	  an	  egg,	  until	  the	  time	  it	  
lays	  its	  own	  eggs	  is	  a	  little	  over	  2	  days	  (approximately	  50	  hours	  at	  25°).	  Each	  
hermaphrodite	  is	  capable	  of	  laying	  300-­‐400	  eggs	  44.	  In	  a	  relatively	  short	  amount	  of	  time,	  
you	  can	  alter	  the	  genotypes	  of	  the	  animals	  and	  have	  a	  large	  population	  of	  animals	  for	  
phenotypic	  analysis.	  
The	  lifecycle	  of	  C.	  elegans	  consists	  of	  6	  stages	  44.	  The	  animals	  begin	  life	  as	  eggs	  inside	  of	  
their	  mother	  and	  are	  generally	  laid	  within	  2-­‐4	  hours	  of	  fertilization	  (growth	  times	  are	  given	  
at	  25°).	  After	  8	  hours	  of	  embryonic	  development,	  the	  animal	  hatches	  from	  the	  egg	  in	  its	  
first	  larval	  stage,	  termed	  L1.	  Twelve	  hours	  later,	  the	  animal	  goes	  through	  another	  molting	  
process	  and	  emerges	  in	  its	  second	  larval	  stage,	  L2.	  After	  seven	  hours,	  the	  L2	  animals	  molt,	  
and	  emerge	  in	  their	  third	  larval	  stage,	  L3.	  After	  another	  seven	  hours,	  the	  L3	  animals	  molt	  
and	  emerge	  in	  their	  fourth	  larval	  stage,	  L4.	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Figure	  1.4	  –	  Caenorhabditis	  elegans	  	  
	  
(A)	  A	  DIC	  micrograph	  of	  a	  live	  L4	  animal	  at	  200x	  magnification.	  As	  adults	  these	  animals	  
reach	  about	  1mm	  in	  length.	  Their	  transparency	  makes	  it	  easy	  to	  identify	  cells	  and	  organs	  
within	  the	  animal.	  Most	  of	  the	  body	  cavity	  is	  filled	  with	  the	  intestine	  and	  gonad.	  The	  
anterior	  of	  the	  animal	  is	  to	  the	  left;	  the	  posterior	  of	  the	  animal	  is	  to	  the	  right;	  dorsal	  is	  up	  
and	  ventral	  is	  down.	  	  
(B)	  A	  micrograph	  taken	  of	  animals	  growing	  on	  an	  NGM	  plate	  with	  a	  lawn	  of	  E.	  coli	  BK16.	  C.	  
elegans	  has	  six	  primary	  life	  stages:	  egg,	  L1,	  L2,	  L3,	  L4,	  and	  adult.
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During	  the	  L4	  stage,	  the	  animal	  reaches	  the	  end	  of	  gonadogenesis	  and	  spermatogenesis.	  
Nine	  hours	  after	  becoming	  an	  L4,	  the	  animal	  undergoes	  its	  final	  molt	  into	  an	  adult	  and	  
begins	  to	  lay	  eggs.	  In	  our	  work,	  we	  have	  largely	  focused	  on	  L4	  and	  young	  adult	  animals.	  
Older	  adults	  begin	  to	  accumulate	  eggs	  that	  fill	  the	  body	  cavity	  and	  disrupt	  the	  morphology	  
of	  many	  of	  the	  organs	  in	  the	  animal,	  often	  causing	  breakdown	  of	  the	  affected	  tissues.	  
Animals	  younger	  than	  the	  L4	  stage	  are	  quite	  small	  and	  underdeveloped,	  which	  makes	  the	  
canal	  cell	  difficult	  to	  see.	  Due	  to	  the	  large	  number	  of	  animals,	  as	  well	  as	  their	  ability	  to	  
survive	  adverse	  conditions,	  it	  is	  possible	  to	  freeze	  the	  animals	  and	  store	  them	  in	  liquid	  
nitrogen	  or	  low-­‐temperature	  freezers	  (-­‐80°C)	  for	  years.	  This	  greatly	  reduces	  the	  amount	  of	  
work	  required	  to	  maintain	  genetic	  strains	  and	  facilitates	  storage	  of	  a	  huge	  library	  of	  
different	  mutations	  and	  transgenic	  animals.	  
In	  addition	  to	  the	  already	  mentioned	  aspects	  of	  C.	  elegans	  biology,	  the	  nematodes	  are	  
transparent.	  This	  property	  allows	  for	  easy	  observation	  of	  whole,	  living	  animals	  under	  the	  
microscope	  (Fig.	  1.4A).	  Every	  cell	  of	  the	  animal	  is	  observable	  at	  any	  time	  point	  in	  
development.	  Because	  of	  this,	  and	  one	  more	  unique	  property	  –	  the	  invariant	  cell	  lineage	  of	  
the	  somatic	  tissues	  of	  the	  animal,	  the	  cell	  lineage	  for	  every	  one	  of	  the	  959	  cells	  (1031	  in	  the	  
male)	  has	  been	  mapped	  out	  45.	  This	  eutelic	  nature	  provides	  a	  powerful	  tool	  to	  look	  at	  the	  
development	  of	  the	  animal	  as	  well	  as	  the	  cellular	  biology	  underlying	  it.	  
	  
C.	  elegans	  Excretory	  Canal	  Cell	  
Of	  all	  the	  cells	  in	  C.	  elegans,	  one	  stands	  out	  as	  particularly	  useful	  for	  examining	  tubule	  
formation	  and	  maintenance,	  the	  excretory	  canal	  cell.	  The	  excretory	  canal	  cell	  is	  a	  large	  and	  
highly	  organized	  unicellular	  tubule.	  It	  has	  a	  single	  basal	  surface,	  and	  a	  circular	  apical	  
surface	  that	  forms	  the	  lumen	  of	  the	  tube	  (Fig.	  1.1C).	  Invaginations	  that	  form	  from	  the	  
luminal	  surface	  and	  extend	  into	  the	  cytoplasm	  of	  the	  canal	  cell	  are	  called	  canaliculi.	  These	  
form	  even	  smaller	  tubulo-­‐vesicular	  structures.	  The	  excretory	  canal	  cell	  provides	  both	  a	  
sensitive	  and	  relatively	  simple	  single-­‐celled	  model	  of	  the	  mechanisms	  required	  for	  tubule	  
formation	  and	  maintenance.	  	  
The	  excretory	  canal	  cell	  is	  only	  part	  of	  the	  excretory	  system	  of	  C.	  elegans,	  though	  it	  is	  the	  
largest.	  	  The	  entire	  excretory	  system	  is	  composed	  of	  the	  canal	  cell,	  two	  fused	  gland	  cells,	  
and	  a	  duct	  cell	  that	  connects	  the	  canal	  cell	  to	  the	  pore	  cell.	  The	  pore	  cell	  connects	  the	  
excretory	  duct	  to	  the	  outside	  environment	  (Fig.	  1.5).	  The	  excretory	  system	  serves	  as	  an	  
osmoregulatory	  organ	  and	  is	  vital	  to	  the	  survival	  of	  the	  animals.	  Laser	  ablation	  of	  the	  canal	  
cell	  leads	  to	  death	  within	  a	  few	  hours	  46.	  
	   20	  
Figure	  1.5	  –	  The	  Excretory	  System	  of	  C.	  elegans	  
	  
The	  excretory	  system	  functions	  as	  the	  osmoregulatory	  organ	  of	  C.	  elegans	  and	  is	  essential	  
for	  its	  survival.	  The	  cells	  that	  make	  up	  the	  excretory	  system	  are	  primarily	  located	  ventrally	  
to	  the	  terminal	  bulb	  of	  the	  pharynx	  (green).	  The	  excretory	  canal	  cell	  (red)	  collects	  fluid	  
from	  the	  body	  of	  the	  animal	  and	  connects	  to	  the	  duct	  cell	  (speckled	  brown).	  The	  duct	  cell	  
creates	  a	  passage	  between	  the	  excretory	  canal	  cell	  and	  the	  pore	  cell	  (yellow).	  The	  pore	  cell	  
then	  empties	  into	  the	  outside	  environment.	  The	  excretory	  gland	  cells	  (blue)	  are	  connected	  
to	  the	  duct	  and	  pore	  and	  secrete	  materials	  into	  the	  lumen.	  Image	  reprinted	  with	  permission	  
from	  WormAtlas	  47.
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The	  canal	  cell	  originates	  at	  the	  end	  of	  gastrulation	  as	  a	  spherical	  non-­‐polarized	  cell	  ventral	  
to	  the	  posterior	  bulb	  of	  the	  developing	  pharynx.	  As	  the	  cell	  grows,	  it	  starts	  to	  extend	  two	  
processes	  dorsolaterally,	  one	  to	  the	  left	  of	  the	  animal	  and	  one	  to	  the	  right	  (Fig.	  1.6).	  At	  the	  
same	  time	  as	  the	  cell	  is	  growing	  out,	  vacuoles	  accumulate	  and	  fuse	  to	  form	  a	  large	  hollow	  
structure	  within	  the	  cell.	  This	  structure	  then	  becomes	  apically	  polarized	  and	  begins	  to	  form	  
a	  luminal	  structure	  within	  the	  cell	  that	  extends	  with	  the	  growing	  processes.	  Once	  the	  left	  
and	  right	  processes	  reach	  the	  midline	  of	  the	  animal,	  they	  bifurcate	  to	  the	  anterior	  and	  
posterior	  of	  the	  animal.	  When	  the	  animal	  hatches,	  the	  canal	  cell	  has	  only	  extended	  halfway	  
along	  the	  posterior	  length	  of	  the	  animal.	  The	  cell	  continues	  to	  grow	  rapidly	  through	  the	  L1	  
stage	  until	  it	  reaches	  the	  posterior	  end	  of	  the	  animal.	  Since	  the	  canal	  cell	  maintains	  its	  
length	  relative	  to	  the	  animal,	  the	  canal	  cell	  must	  continue	  to	  grow	  in	  proportion	  with	  the	  
animal	  through	  the	  larval	  stages	  and	  into	  adulthood.	  
Excretory	  cell	  growth	  results	  in	  a	  large	  “H”-­‐shaped	  structure	  that	  is	  composed	  of	  one	  cell	  
and	  a	  continuous	  lumen.	  The	  nucleus	  remains	  at	  the	  cell	  body,	  largely	  unmoved	  from	  its	  
place	  of	  origin.	  Morphologically,	  there	  are	  two	  long	  canals	  on	  either	  side	  of	  the	  animal	  that	  
extend	  from	  the	  head	  of	  the	  animal	  to	  the	  anus	  (Fig.	  1.7).	  These	  are	  connected	  through	  the	  
cell	  body	  of	  the	  canal	  cell	  and	  then	  fused	  to	  the	  duct	  cell,	  where	  the	  collected	  contents	  of	  the	  
canals	  can	  be	  emptied	  through	  the	  pore	  cell	  and	  into	  the	  environment.
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Figure	  1.6	  –	  Development	  of	  the	  Excretory	  Canal	  Cell	  
	  
(A)	  The	  excretory	  canal	  cell	  originates	  as	  a	  spherical	  non-­‐polarized	  cell	  at	  the	  end	  of	  
gastrulation.	  (B)	  As	  the	  cell	  grows,	  it	  extends	  two	  processes	  dorsolaterally.	  During	  this	  time	  
the	  cell	  also	  accumulates	  vacuoles	  that	  fuse	  together	  to	  form	  large	  hollow	  structures	  within	  
the	  cell.	  (C)	  The	  hollow	  structures	  fuse	  and	  become	  apically	  polarized.	  The	  compartment	  
begins	  to	  take	  on	  a	  luminal	  structure	  and	  extends	  with	  the	  growing	  processes	  on	  either	  
side	  of	  the	  canal.	  (D)	  When	  the	  growing	  processes	  reach	  the	  midline	  of	  the	  animal,	  they	  
bifurcate	  and	  extend	  both	  anteriorly	  and	  posteriorly.	  (E)	  These	  processes	  continue	  to	  grow	  
and	  extend	  to	  the	  head	  and	  tail	  of	  the	  animal	  and	  form	  two	  long	  canals	  on	  both	  the	  left	  and	  
right	  side	  that	  are	  connected	  through	  the	  excretory	  canal	  cell	  body.	  Image	  reprinted	  from	  
WormAtlas.org	  with	  permission	  47.	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Figure	  1.7	  –	  The	  C.	  elegans	  Excretory	  Canal	  Cell	  
	  
The	  excretory	  canal	  cell	  forms	  a	  large	  “H”-­‐shaped	  structure	  that	  is	  composed	  of	  one	  cell	  and	  
a	  continuous	  lumen	  (white).	  The	  luminal/apical	  surface	  of	  the	  canal	  is	  in	  red.	  The	  basal	  
surface	  of	  the	  canal	  is	  in	  blue.	  The	  cytoplasm	  of	  the	  canal	  cell	  is	  in	  light	  blue.	  The	  relative	  
position	  of	  the	  pharynx	  is	  shaded	  in	  dark	  grey.	  Morphologically,	  there	  are	  two	  long	  canals	  
on	  either	  side	  of	  the	  animal	  that	  extend	  from	  the	  head	  of	  the	  animal	  to	  the	  anus.	  These	  are	  
connected	  through	  the	  cell	  body	  of	  the	  canal	  cell	  and	  then	  fused	  to	  the	  duct	  cell,	  where	  the	  
collected	  contents	  of	  the	  canals	  can	  be	  emptied	  through	  the	  pore	  cell	  and	  into	  the	  
environment.	  Adapted	  from	  Buechner	  2002.	  
1.	  The	  nucleus	  of	  the	  excretory	  canal	  cell	  remains	  at	  the	  cell	  body,	  largely	  unmoved	  from	  its	  
place	  of	  origin.	  	  
2.	  The	  anterior	  canals	  extend	  towards	  the	  mouth	  of	  the	  animal	  and	  are	  shorter	  and	  have	  a	  
smaller	  diameter	  than	  the	  posterior	  canals.	  	  
3.	  The	  posterior	  canals	  extend	  towards	  the	  tail	  of	  the	  animal.	  Their	  diameter	  is	  largest	  near	  
the	  cell	  body	  but	  gradually	  decreases	  towards	  the	  tail.	  On	  average,	  the	  approximate	  
diameter	  of	  the	  canal	  is	  5µm.	  
4.	  The	  canal	  duct	  cell	  connects	  the	  excretory	  canal	  cell	  to	  the	  pore	  cell.	  
5.	  The	  excretory	  pore	  cell	  opens	  to	  the	  environment	  and	  allows	  the	  contents	  of	  the	  
excretory	  system	  to	  be	  released	  from	  the	  animal.	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exc	  Mutations	  
In	  a	  wild-­‐type	  animal,	  the	  diameter	  of	  the	  canals	  remains	  relatively	  constant.	  The	  anterior	  
canals	  (anterior	  to	  the	  excretory	  canal	  cell	  body)	  are	  both	  shorter	  and	  have	  a	  narrower	  
diameter	  than	  do	  the	  posterior	  canals	  (posterior	  to	  the	  excretory	  canal	  cell	  body).	  The	  
posterior	  canals	  reach	  their	  largest	  diameter	  right	  at	  the	  excretory	  canal	  cell	  body	  then	  
gradually	  taper	  in	  diameter	  as	  they	  reach	  the	  tail	  of	  the	  animal	  (Fig.	  1.7).	  
In	  a	  collection	  of	  mutations,	  first	  identified	  in	  the	  Edward	  Hedgecock	  laboratory	  48	  and	  
termed	  exc	  mutants	  (for	  excretory	  canal	  cell	  abnormal),	  this	  consistent	  canal	  cell	  
morphology	  is	  disrupted.	  While	  the	  severity	  and	  specific	  phenotype	  of	  these	  mutations	  
vary,	  they	  all	  share	  the	  common	  characteristic	  of	  disrupting	  the	  continuous	  lumen	  diameter	  
of	  the	  canal	  and	  forming	  enlarged,	  fluid-­‐filled	  cysts.	  
Many	  of	  the	  exc	  genes	  have	  been	  cloned	  and	  their	  encoded	  proteins	  characterized.	  	  EXC-­‐4	  is	  
a	  chloride	  channel	  49,	  EXC-­‐7	  is	  an	  RNA	  transport	  protein	  50	  and	  EXC-­‐9	  is	  a	  LIM-­‐domain-­‐
containing	  CRIP	  homologue	  51.	  Recent	  work	  by	  Kelly	  Grussendorf	  has	  indicated	  that	  EXC-­‐1	  
is	  homologous	  to	  a	  mammalian	  class	  of	  interferon-­‐inducible	  GTPases	  of	  the	  Ras	  family.	  
Other	  genes	  producing	  an	  Exc	  phenotype	  include	  sma-­1,	  a	  βH-­‐spectrin	  52,	  let-­653,	  a	  secreted	  
mucin	  53,	  let-­4	  48,	  lpr-­1,	  a	  lipocalin	  that	  causes	  defects	  in	  the	  duct	  cell	  54,	  	  and	  erm-­‐1,	  an	  ezrin,	  
radixin,	  moesin	  homologue	  55.	  
By	  identifying	  and	  characterizing	  the	  mutations	  that	  disrupt	  the	  morphology	  and	  
maintenance	  of	  the	  canal,	  we	  can	  gain	  a	  better	  understanding	  of	  the	  mechanisms	  involved	  
in	  the	  processes	  of	  normal	  tubule	  formation	  and	  maintenance.	  
	  
EXC-­5:	  Past	  and	  Present	  
Exc-­5	  encodes	  a	  guanine	  nucleotide	  exchange	  factor	  (GEF)	  for	  CDC-­‐42	  56,57.	  Although	  EXC-­‐5	  
has	  previously	  been	  identified	  as	  the	  homologue	  of	  FGD1,	  more	  members	  of	  the	  FGD	  family	  
have	  been	  discovered.	  Through	  studies	  based	  on	  homology,	  we	  have	  identified	  EXC-­‐5	  as	  
sharing	  similarities	  with	  the	  entire	  mammalian	  FGD	  family	  (Fig.	  1.8).	  This	  family	  is	  named	  
for	  the	  human	  disease	  associated	  with	  mutations	  in	  FGD1,	  FacioGenital	  Dysplasia	  58.	  In	  this	  
disease,	  also	  known	  as	  Aarskog-­‐Scott	  syndrome,	  there	  are	  mild	  morphological	  defects	  of	  
the	  face	  (widely	  spaced	  eyes,	  anteverted	  nostrils,	  broad	  upper	  lip)	  and	  scrotum.	  Mutations	  
in	  another	  member	  of	  this	  family,	  FGD4,	  cause	  the	  human	  muscular	  dystrophy	  Charcot-
Marie-Tooth disease type 4H (CMT4H) 59. CMT4H is a progressive demyelinating neuropathy 
that leads to pain as well as loss of movement and sensation in the distal limbs 60.
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Figure	  1.8	  –	  EXC-­5	  Belongs	  to	  the	  FGD	  Family	  of	  Proteins	  
	  
Although previously characterized as being the equivalent of FGD1 in humans, EXC-5 shares 
similarity to the entire family of FGD proteins. While nematodes and insects seem to have only 
one member of the family, vertebrates have several members including FGD1, FGD2, FGD3, 
and FGD4. These proteins have been implicated in several human diseases including 
Faciogenital Dysplasia and Charcot-Marie-Tooth disease type 4H. The FGD proteins are part of 
a larger family of Dbl guanine nucleotide exchange factors (GEFs). These GEFs contain a Dbl 
homology (DH) domain in tandem with a Pleckstrin homology (PH) domain. DNA polymerase 
Type II from Halobacterium salinarium was used as an outgroup. Sequences were aligned using 
ClustalW’s PHYLIP algorithm. Distances between groups are proportional to their similarity.
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EXC-­‐5,	  like	  other	  FGD	  family	  members,	  is	  a	  member	  of	  the	  Dbl	  (diffuse	  B-­‐cell	  lymphoma)	  
family	  of	  GEFs.	  It	  contains	  a	  Dbl	  Homology	  domain	  (DH)	  in	  tandem	  with	  a	  Pleckstrin	  
Homology	  domain	  (PH),	  common	  to	  the	  Dbl	  family	  of	  GEFs.	  The	  DH	  domain	  contains	  the	  
GEF	  activity	  of	  these	  proteins	  as	  well	  as	  the	  Rho-­‐GTPase	  binding	  site.	  Interestingly,	  some	  of	  
these	  proteins	  may	  bind	  more	  than	  one	  GTPase	  but	  have	  GEF	  activity	  for	  only	  one	  specific	  
GTPase	  61.	  Like	  the	  other	  members	  of	  the	  FGD	  family	  of	  proteins	  (which	  has	  had	  its	  official	  
name	  changed	  to	  mean	  FYVE,	  RhoGEF,	  and	  PH	  domain-­‐containing	  protein),	  EXC-­‐5	  also	  
contains	  a	  FYVE	  domain,	  as	  well	  as	  a	  second	  PH	  domain	  (Fig.	  1.9B).	  While	  the	  DH	  domain	  
interacts	  with	  Rho-­‐GTPases,	  the	  PH	  domains	  have	  been	  shown	  to	  interact	  with	  
phosphatidylinositol	  4,5-­‐bisphosphate	  (PIP2)	  62,	  which	  is	  enriched	  on	  plasma	  membranes.	  
The	  FYVE	  domain	  is	  a	  Zinc-­‐finger	  domain	  that	  has	  been	  shown	  to	  associate	  with	  
phosphatidylinositol	  3-­‐phosphate	  (PI3P)	  63,64,	  a	  phospholipid	  that	  is	  enriched	  on	  
endosomal	  membranes.	  
exc-­5	  is	  located	  on	  chromosome	  IV	  in	  C.	  elegans.	  There	  are	  two	  reported	  splice	  forms	  of	  the	  
gene,	  a	  longer	  form	  consisting	  of	  16	  exons	  57	  and	  a	  shorter	  form	  that	  contains	  15	  exons	  56	  
(Fig.	  1.9).	  The	  shorter	  form	  excludes	  exon	  14	  and	  removes	  a	  small,	  slightly	  less	  conserved	  
N-­‐terminal	  portion	  of	  the	  second	  PH	  domain.	  exc-­5	  cDNA	  we	  have	  isolated	  does	  not	  contain	  
exon	  14,	  and	  therefore	  we	  suggest	  that	  this	  shorter	  transcript	  is	  the	  more	  predominant	  
form.	  This	  is	  in	  agreement	  with	  previous	  studies	  that	  reported	  the	  shorter	  isoform	  exists	  at	  
about	  a	  20-­‐fold	  excess	  over	  the	  longer	  isoform	  56.	  It	  remains	  unclear	  what	  the	  functional	  
difference	  is,	  if	  any,	  between	  these	  two	  transcripts.	  Regardless,	  I	  will	  refer	  to	  EXC-­‐5	  as	  
containing	  16	  exons	  and	  being	  844	  amino	  acids	  long	  (and	  not	  826	  as	  the	  shorter	  isoform	  
encodes)	  as	  this	  represents	  the	  most	  inclusive	  form	  of	  the	  gene.	  exc-­5	  is	  expressed	  in	  the	  
excretory	  canal	  and	  in	  several	  other	  tissues	  including	  the	  pharynx,	  rectal	  epithelial	  cells,	  
and	  several	  head	  and	  tail	  neurons	  57.	  	  Although	  exc-­5	  is	  expressed	  in	  other	  tissues,	  there	  
does	  not	  appear	  to	  be	  any	  obvious	  defects	  in	  exc-­5	  mutants	  in	  cells	  other	  than	  the	  excretory	  
canal.	  
In	  C.	  elegans,	  loss-­‐of-­‐function	  mutations	  in	  exc-­5	  cause	  large	  fluid-­‐filled	  cysts	  to	  form	  
approximately	  halfway	  through	  the	  animal	  (Fig.	  1.10,	  Table	  6.2)	  48,57.	  These	  cysts	  form	  
early	  in	  development,	  shortly	  before	  or	  after	  hatching,	  and	  grow	  larger	  as	  the	  animal	  ages	  
(Fig.	  6.10).	  Generally,	  these	  cysts	  appear	  at	  the	  canal	  termini,	  but	  that	  does	  not	  preclude	  
other	  cysts	  from	  forming	  at	  discrete	  points	  along	  the	  length	  of	  the	  canal.	  The	  lumen	  of	  the	  
canal	  before	  and	  after	  these	  cysts	  retains	  its	  structure,	  which	  indicates	  that	  cyst	  formation	  
occurs	  at	  discrete	  points	  along	  the	  canal.	  	  Previous	  electron	  microscopy	  work	  has	  shown	  
that	  the	  apical	  structure	  surrounding	  the	  lumen	  has	  broken	  down	  at	  the	  places	  where	  these	  
cysts	  have	  formed	  57.	  Our	  current	  model	  for	  the	  formation	  of	  these	  cysts	  is	  that	  there	  is	  a	  
weak	  point	  in	  the	  apical	  cytoskeleton.	  Due	  to	  the	  osmotic	  stress	  that	  the	  canal	  cell	  is	  under,	  
this	  weak	  point	  fails	  under	  osmotic	  pressure	  and	  causes	  the	  canal	  cell	  to	  lose	  its	  structural	  
integrity.	  As	  the	  animal	  grows	  older,	  the	  osmotic	  pressure	  continues	  to	  enlarge	  and	  deform	  
the	  canal	  to	  form	  the	  large	  fluid-­‐filled	  cysts	  characteristic	  of	  the	  Exc-­‐5	  phenotype.	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Figure	  1.9	  –	  Genetic	  and	  Protein	  Architecture	  of	  EXC-­5	  
	  
exc-­5	  is	  located	  on	  chromosome	  IV	  in	  C.	  elegans	  and	  is	  5766bp	  long	  (2535bp	  of	  coding	  
sequence).	  (A)	  exc-­5	  has	  16	  exons	  (blue).	  Exons	  8	  and	  9	  contain	  the	  DH	  domain	  sequence;	  
exons	  10	  and	  11	  contain	  the	  first	  PH	  domain	  sequence;	  exons	  12	  and	  13	  contain	  the	  FYVE	  
domain	  sequence;	  exons	  14,15,	  and	  16	  contain	  the	  second	  PH	  domain	  sequence.	  exc-­5	  has	  a	  
shorter	  isoform	  that	  does	  not	  include	  exon	  14	  (dark	  blue).	  This	  shorter	  isoform	  is	  2481bp	  
and	  does	  not	  include	  some	  sequence	  of	  the	  second	  PH	  domain.	  Purple	  arrows	  indicate	  the	  
segments	  and	  their	  lengths	  that	  were	  used	  to	  amplify	  the	  coding	  region	  of	  exc-­5	  for	  Chapter	  
2.	  (B)	  EXC-­‐5	  is	  844	  aa	  long	  (826	  aa	  for	  the	  shorter	  isoform).	  The	  DH	  domain	  extends	  from	  
amino	  acids	  301-­‐479,	  the	  first	  PH	  domain	  extends	  from	  510-­‐613,	  the	  FYVE	  domain	  631-­‐
693,	  and	  the	  second	  PH	  domain	  736-­‐829.	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Figure	  1.10	  –	  exc-­5	  Mutants	  Develop	  Cysts	  or	  Convoluted	  Tubules	  
(A)	  A	  DIC	  micrograph	  of	  an	  L4	  BK36	  animal	  at	  200x	  magnification.	  The	  pharynx	  is	  a	  
muscular	  structure	  that	  contains	  two	  bulbous	  structures.	  The	  excretory	  canal	  cell	  body	  
(asterisk)	  lies	  ventrally	  to	  the	  posterior	  bulb.	  No	  cysts	  are	  obvious	  along	  the	  length	  of	  the	  
animal.	  (B)	  BK36	  animals	  are	  phenotypically	  wild-­‐type	  but	  contain	  an	  integrated	  transgene	  
(qpIs11)	  that	  expresses	  a	  canal-­‐specific	  GFP	  maker.	  This	  construct	  uses	  the	  promoter	  for	  
vha-­1,	  part	  of	  a	  vacuolar	  ATPase	  expressed	  only	  in	  the	  canal	  and	  the	  head	  mesodermal	  cell	  
(arrowhead).	  The	  left	  canal	  is	  visible	  in	  the	  plane	  of	  focus.	  The	  anterior	  canals	  are	  thinner	  
and	  shorter	  than	  the	  posterior	  canals	  and	  almost	  reach	  the	  buccal	  opening	  of	  the	  animal.	  
The	  cell	  body	  is	  the	  brightest	  part	  of	  the	  excretory	  cell	  and	  contains	  the	  nucleus.	  The	  
posterior	  canal’s	  largest	  diameter	  is	  next	  to	  the	  cell	  body	  and	  gradually	  thins	  as	  it	  progress	  
to	  the	  end	  of	  the	  canal	  near	  the	  anus	  of	  the	  worm.	  There	  are	  no	  cysts	  present	  and	  the	  
diameter	  of	  the	  canal	  remains	  uniformly	  thin	  and	  continuous.	  (C)	  A	  DIC	  micrograph	  of	  an	  
L4	  BK30	  animal	  at	  200x	  magnification	  that	  is	  homozygous	  for	  the	  exc-­5	  (rh232)	  null	  allele.	  
A	  large	  cyst	  is	  visible	  in	  the	  center	  of	  the	  animal.	  (D)	  BK30	  animals	  contain	  the	  qpIs11	  
insertion	  in	  addition	  to	  the	  rh232	  allele.	  Typical	  for	  the	  exc-­5	  null	  phenotype,	  the	  canal	  
extends	  only	  halfway	  through	  the	  animal	  and	  ends	  with	  a	  large	  cyst.	  
	   29	  
Figure	  1.10	  E-­F	  –	  EXC-­5	  Mutants	  Develop	  Cysts	  or	  Convoluted	  Tubules	  
(E)	  A	  DIC	  micrograph	  of	  an	  
adult	  animal	  overexpressing	  a	  
genomic	  copy	  of	  exc-­5	  linked	  to	  
gfp	  at	  400x	  magnification.	  The	  
canal	  cell	  has	  not	  extended	  
along	  the	  length	  of	  the	  animal.	  
The	  lumen	  structure	  remains	  
intact	  but	  is	  confined	  to	  a	  
smaller	  space	  and	  coils	  within	  
the	  cell	  body.	  The	  lumen	  passes	  
in	  and	  out	  of	  the	  plane	  of	  focus,	  
but	  cross	  sections	  of	  it	  appear	  
as	  small	  holes	  (asterisks).	  	  
(F)	  EXC-­‐5	  is	  expressed	  in	  the	  
entire	  canal	  cell	  but	  is	  most	  
strongly	  associated	  with	  the	  
luminal	  surface	  (asterisks).	  The	  
white	  circle	  outlines	  the	  cell	  
body.	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Interestingly,	  this	  phenotype	  is	  similar	  to	  the	  defect	  seen	  in	  patients	  with	  CMT4H.	  In	  these	  
individuals,	  the	  Schwann	  cells	  develop	  properly	  to	  wrap	  around	  the	  neurons	  and	  insulate	  
them	  with	  a	  tubular	  myelin	  sheath.	  As	  the	  patients	  age,	  discrete	  points	  of	  failure	  occur	  
along	  the	  insulating	  tubule	  in	  the	  Schwann	  cells	  and	  cause	  progressive	  degeneration	  of	  the	  
nervous	  system	  65.	  	  
In	  addition	  to	  the	  cystic	  phenotype	  seen	  in	  animals	  having	  no	  EXC-­‐5	  activity,	  there	  is	  also	  a	  
phenotype	  associated	  with	  overexpression	  of	  EXC-­‐5.	  In	  animals	  overexpressing	  EXC-­‐5,	  the	  
canal	  fails	  to	  extend	  along	  the	  length	  of	  the	  animal	  (Fig.	  8).	  The	  canal	  cell	  becomes	  
spherically	  shaped	  due	  to	  the	  apparent	  inability	  of	  the	  basal	  surface	  to	  adhere	  to	  the	  
hypodermis	  and	  extend.	  The	  apical	  surface,	  however,	  appears	  unaffected	  except	  for	  the	  fact	  
that	  is	  trapped	  within	  the	  confines	  of	  the	  un-­‐extended	  basal	  surface	  and	  therefore	  becomes	  
convoluted	  as	  it	  forms	  51,57.	  We	  have	  termed	  this	  phenotype	  a	  convoluted	  tubule	  phenotype.	  
This	  phenotype	  is	  similar	  to	  those	  seen	  in	  mosaic	  animals	  that	  are	  mutant	  in	  basolateral	  
proteins	  such	  as	  β-­‐integrin	  and	  laminin	  66,67.	  	  
Although	  exc-­5	  has	  been	  cloned	  and	  its	  phenotype	  has	  been	  characterized	  previously,	  the	  
underlying	  mechanisms	  that	  determine	  where	  and	  why	  cysts	  form	  in	  an	  exc-­5	  mutant	  and	  
why	  overexpression	  of	  EXC-­‐5	  causes	  a	  convoluted	  tubule	  phenotype	  remain	  unclear.	  In	  this	  
dissertation,	  I	  present	  a	  series	  of	  experiments	  the	  aim	  of	  which	  is	  to	  examine	  how	  EXC-­‐5	  
works	  within	  the	  C.	  elegans	  excretory	  canal	  cell	  in	  order	  to	  maintain	  its	  tubular	  shape.	  In	  
Chapter	  Two,	  I	  describe	  my	  attempts	  to	  identify	  novel	  temperature-­‐sensitive	  alleles	  of	  EXC-­‐
5	  as	  a	  means	  of	  determining	  when	  during	  the	  excretory	  canal’s	  growth	  EXC-­‐5	  activity	  is	  
required.	  In	  Chapter	  Three,	  I	  describe	  the	  isolation	  of	  two	  genetic	  enhancers	  of	  EXC-­‐5	  
activity	  as	  a	  means	  to	  determine	  what	  cellular	  pathways	  EXC-­‐5	  might	  be	  working	  in.	  In	  
Chapter	  Four,	  I	  describe	  my	  attempts	  to	  create	  an	  excretory	  canal-­‐specific	  RNAi	  strain	  as	  a	  
tool	  to	  look	  at	  knockdown	  of	  gene	  function	  only	  in	  the	  excretory	  canal	  without	  disrupting	  
other	  tissues.	  In	  Chapter	  Five,	  I	  describe	  the	  genetic	  interactions	  that	  EXC-­‐5	  has	  with	  some	  
of	  the	  RhoGTPases	  as	  well	  as	  other	  EXC	  proteins.	  Next,	  in	  Chapter	  Six,	  I	  describe	  the	  
disruption	  of	  trafficking	  within	  the	  excretory	  canal	  cell	  when	  EXC-­‐5	  activity	  is	  lost	  or	  
gained.	  In	  Chapter	  Seven,	  I	  describe	  the	  construction	  of	  a	  conditional	  allele	  of	  EXC-­‐9	  and	  
EXC-­‐5	  using	  inteins.	  In	  Chapter	  Eight,	  I	  describe	  the	  work	  that	  has	  been	  done	  to	  isolate	  
antibodies	  specific	  to	  EXC-­‐5.	  In	  the	  last	  chapter,	  Chapter	  Nine,	  I	  summarize	  the	  
observations	  made	  from	  this	  work	  and	  present	  a	  new	  model	  for	  EXC-­‐5	  function	  within	  the	  
excretory	  canal	  cell.	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Chapter	  2:	  Identification	  of	  Novel	  Temperature-­Sensitive	  	  
Alleles	  of	  EXC-­5	  
	  
Abstract	  
Previously	  isolated	  alleles	  of	  exc-­5	  (rh232,	  n2672,	  tm412,	  ok271,	  and	  rh275)	  are	  all	  null	  
mutations.	  In	  order	  to	  ascertain	  the	  developmental	  requirements	  of	  EXC-­‐5	  during	  the	  
growth	  of	  the	  excretory	  canal	  cell,	  we	  devised	  an	  EMS	  non-­‐complementation	  screen	  to	  
identify	  new	  temperature-­‐sensitive	  alleles	  of	  EXC-­‐5.	  Through	  this	  screen	  we	  produced	  
forty-­‐three	  isolates.	  Two	  new	  alleles,	  qp39	  and	  qp21,	  have	  premature	  stop	  codons	  in	  the	  
last	  PH	  domain	  of	  exc-­5	  and	  have	  null	  phenotypes.	  Three	  isolates,	  qp35,	  qp37,	  and	  qp56,	  all	  
had	  hypomorphic	  canal	  phenotypes	  but	  did	  not	  contain	  any	  mutations	  within	  the	  coding	  
regions	  of	  exc-­5.	  One	  isolate,	  qp49,	  did	  show	  temperature-­‐sensitive	  effects	  but	  when	  
sequenced	  still	  contained	  the	  original	  rh232	  deletion.	  This	  indicates	  that	  we	  have	  isolated	  
an	  extragenic	  temperature-­‐sensitive	  mutation	  in	  a	  suppressor	  of	  EXC-­‐5.	  Although	  a	  
temperature-­‐sensitive	  allele	  of	  exc-­5	  was	  not	  isolated,	  I	  discuss	  the	  insight	  these	  new	  
strains	  have	  provided	  on	  our	  view	  of	  EXC-­‐5	  activity.	  
Rationale	  
“When	  during	  development	  is	  EXC-­‐5	  required?”	  
Only	  animals	  homozygous	  for	  the	  mutant	  exc-­5	  allele	  rh232,	  and	  therefore	  lacking	  any	  EXC-­‐
5	  activity	  since	  their	  conception,	  show	  a	  cystic	  phenotype.	  Is	  EXC-­‐5	  activity	  only	  required	  
during	  the	  early	  larval	  stages	  (the	  point	  at	  which	  cysts	  initially	  form)?	  Is	  it	  required	  for	  the	  
entire	  life	  of	  the	  animal,	  constantly	  providing	  an	  essential	  activity	  to	  maintain	  the	  canal	  
shape?	  Is	  it	  possible	  to	  reduce	  or	  even	  reverse	  or	  repair	  the	  cysts	  in	  the	  canal	  by	  supplying	  
EXC-­‐5	  activity	  after	  cysts	  have	  formed?	  To	  answer	  these	  questions	  we	  needed	  a	  conditional	  
allele	  of	  exc-­5,	  one	  that	  we	  could	  turn	  on	  and	  off	  during	  different	  times	  as	  the	  canal	  cell	  
develops	  and	  grows.	  The	  most	  efficient	  type	  of	  allele	  for	  this	  purpose	  is	  a	  temperature-­‐
sensitive	  (TS)	  allele.	  
The	  rh232	  allele	  is	  a	  null	  allele	  consisting	  of	  a	  large	  EMS-­‐induced	  deletion	  that	  removes	  the	  
first	  twelve	  exons	  of	  exc-­5	  as	  well	  as	  fourteen	  kilobases	  of	  upstream	  sequence.	  The	  other	  
mutant	  alleles	  of	  exc-­5	  available	  from	  the	  Caenorhabditis	  Genetics	  Center	  (n2672,	  tm412,	  
ok271,	  and	  rh275)	  are	  similarly	  null	  mutations.	  We	  had	  to	  make	  our	  own	  TS	  allele	  and	  we	  
attempted	  to	  do	  so	  using	  an	  ethyl	  methanesulfonate	  (EMS)	  non-­‐complementation	  screen	  
(Fig.	  2.1).	  By	  using	  this	  scheme,	  we	  isolated	  several	  new	  alleles	  of	  exc-­5	  by	  their	  inability	  to	  
complement	  the	  rh232	  null	  allele.	  Alleles	  that	  we	  recovered	  were	  screened	  to	  verify	  them	  
as	  new	  alleles	  and	  tested	  for	  temperature	  sensitivity.	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Materials	  and	  Methods	  
Strains	  Used	  
In	  order	  to	  have	  a	  genetic	  marker	  for	  the	  rh232	  deletion	  and	  avoid	  re-­‐isolating	  the	  same	  
mutant	  allele,	  I	  created	  a	  recombinant	  chromosome	  that	  included	  the	  exc-­5	  (rh232)	  
mutation	  and	  the	  unc-­44	  (e362)	  mutation	  approximately	  1.1cM	  away.	  This	  was	  done	  by	  
mating	  male	  animals	  that	  were	  heterozygous	  for	  the	  rh232	  mutation	  with	  hermaphrodites	  
that	  were	  homozygous	  for	  the	  e362	  mutation	  (CB362).	  Progeny	  from	  this	  mating	  were	  
allowed	  to	  self-­‐fertilize.	  At	  this	  step,	  there	  is	  a	  small	  possibility	  for	  a	  recombination	  to	  
occur,	  and	  any	  progeny	  showing	  an	  Exc-­‐5	  phenotype	  were	  kept,	  and	  allowed	  to	  self-­‐
fertilize	  again.	  Progeny	  from	  these	  animals	  were	  isolated	  that	  appeared	  both	  Exc	  and	  Unc,	  
as	  these	  animals	  had	  become	  homozygous	  for	  an	  rh232	  e362	  recombinant	  chromosome	  
(BK50).	  BK50	  hermaphrodites	  were	  then	  mated	  with	  male	  animals	  containing	  a	  GFP	  
transgene	  (BK44)	  on	  chromosome	  I	  (qpIs11	  [unc-­‐119;Pvha-­‐1::gfp])	  that	  labels	  the	  canal.	  
Animals	  that	  were	  homozygous	  for	  rh232,	  e362,	  and	  qpIs11were	  re-­‐isolated	  (BK51)	  and	  
used	  in	  the	  EMS	  non-­‐complementation	  screen.	  
EMS	  Non-­‐Complementation	  Screen	  
BK44	  animals	  were	  collected	  into	  2ml	  of	  M9	  buffer.	  Animals	  were	  then	  added	  to	  an	  
additional	  2ml	  of	  M9	  buffer	  with	  20µl	  of	  ethyl	  methanesulfonate	  (EMS)	  dissolved.	  Animals	  
were	  left	  to	  agitate	  in	  a	  rotary	  shaker	  for	  four	  hours,	  and	  then	  washed	  to	  remove	  the	  EMS	  
solution.	  Mutagenized	  BK44	  L4	  males	  were	  isolated	  and	  mated	  to	  BK51	  hermaphrodites	  in	  
a	  ratio	  of	  4:2	  at	  a	  temperature	  of	  25°C.	  	  
Progeny	  from	  these	  matings	  were	  screened	  for	  animals	  showing	  the	  Exc	  phenotype.	  These	  
animals	  are	  presumed	  to	  contain	  a	  mutant	  allele	  from	  the	  mutagenized	  father,	  as	  their	  copy	  
of	  exc-­5	  fails	  to	  complement	  the	  rh232	  deletion	  provided	  by	  the	  mother.	  In	  order	  to	  isolate	  
homozygous	  strains	  for	  these	  new	  alleles,	  Exc	  animals	  were	  allowed	  to	  self-­‐fertilize.	  Any	  
animals	  that	  produced	  Unc	  progeny	  were	  discarded	  as	  the	  presence	  of	  the	  unc-­44	  gene	  
indicated	  that	  the	  rh232	  mutation	  was	  still	  present	  in	  the	  genome.	  Animals	  breeding	  true	  
for	  the	  Exc	  phenotype	  at	  25°	  were	  considered	  new	  alleles	  of	  exc-­5.	  
Temperature-­‐Sensitive	  Screening	  of	  New	  Alleles	  
In	  order	  to	  test	  whether	  these	  new	  alleles	  were	  temperature-­‐sensitive,	  animals	  were	  grown	  
at	  25°	  and	  15°C	  by	  one	  of	  two	  methods.	  The	  first	  took	  forty	  animals	  homozygous	  for	  each	  of	  
the	  new	  alleles	  and	  placed	  them	  on	  separate	  plates.	  Twenty	  plates	  were	  grown	  at	  25°	  and	  
twenty	  at	  15°C.	  Alternatively,	  homozygous	  animals	  were	  chunked	  onto	  two	  plates	  to	  be	  
grown	  at	  25°,	  and	  two	  plates	  to	  be	  grown	  at	  15°.	  The	  worms	  were	  compared	  approximately	  
three	  days	  later.	  Alleles	  that	  were	  cystic	  at	  25°	  but	  not	  at	  15°	  were	  considered	  
temperature-­‐sensitive.	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Figure	  2.1	  –	  EMS	  Non-­Complementation	  Scheme	  
	  
BK44	  animals	  contain	  wild-­‐type	  alleles	  of	  both	  exc-­5	  and	  unc-­44.	  These	  animals	  are	  
mutagenized	  and	  then	  mated	  to	  BK50	  animals	  that	  are	  homozygous	  for	  the	  rh232	  and	  e362	  
mutant	  alleles.	  The	  majority	  of	  the	  mutagenized	  chromosomes	  will	  not	  contain	  a	  mutation	  
in	  exc-­5	  and	  will	  complement	  the	  mutant	  rh232	  allele	  with	  a	  wild-­‐type	  version,	  producing	  a	  
wild-­‐type	  phenotype.	  On	  rare	  occasions	  a	  new	  mutation	  will	  have	  been	  induced	  in	  exc-­5.	  
These	  mutations	  will	  no	  longer	  be	  able	  to	  complement	  the	  rh232	  allele	  and	  will	  produce	  
animals	  with	  an	  EXC	  phenotype.	  Since	  the	  rh232	  allele	  is	  linked	  to	  the	  e362	  allele,	  we	  can	  
isolate	  the	  new	  allele	  from	  rh232	  by	  identifying	  animals	  that	  look	  Exc	  but	  no	  longer	  
produce	  Unc	  progeny.
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Characterizing	  the	  Cystic	  Phenotype	  between	  Animals	  
In	  conjunction	  with	  Dr.	  Xiangyan	  Tong,	  I	  developed	  a	  scoring	  method	  to	  characterize	  the	  
cystic	  phenotype	  of	  exc-­5	  and	  exc-­9	  mutants	  (Fig.	  2.2)	  51.	  Using	  this	  scale,	  the	  canal	  is	  given	  
a	  length	  between	  zero	  and	  four.	  Canals	  that	  do	  not	  extend	  are	  scored	  as	  having	  a	  length	  of	  
0,	  whereas	  canals	  that	  are	  full-­‐length	  are	  scored	  as	  a	  4.	  Canals	  that	  end	  halfway	  through	  the	  
animal	  are	  scored	  as	  a	  2.	  
In	  addition	  to	  canal	  length,	  I	  also	  defined	  cysts	  into	  three	  sizes:	  small,	  medium,	  and	  large.	  
Cysts	  that	  are	  larger	  than	  half	  the	  body	  diameter	  of	  the	  worm	  are	  considered	  large,	  cysts	  
that	  were	  less	  than	  half	  the	  diameter	  of	  the	  animal,	  but	  larger	  than	  ¼	  the	  diameter	  of	  the	  
animal	  were	  considered	  medium,	  and	  cysts	  smaller	  than	  ¼	  of	  the	  diameter	  were	  
considered	  small.	  
Sequencing	  the	  rh232	  Deletion	  
In	  order	  to	  create	  a	  quick	  molecular	  screen	  to	  determine	  if	  the	  new	  alleles	  were	  in	  fact	  new	  
alleles	  and	  not	  re-­‐isolates	  of	  rh232,	  the	  ends	  of	  the	  rh232	  deletion	  first	  needed	  to	  be	  
identified.	  By	  designing	  primers	  to	  small	  (~1kb)	  exon-­‐rich	  regions	  of	  exc-­5	  (Fig.	  1.9),	  I	  was	  
able	  to	  identify	  the	  exons	  that	  were	  present	  in	  the	  rh232	  deletion.	  I	  then	  used	  this	  point	  as	  
an	  anchor	  to	  design	  a	  reverse	  primer.	  I	  then	  designed	  a	  series	  of	  primers	  in	  5kb	  increments	  
upstream	  of	  the	  deletion	  point	  in	  exc-­5.	  Presence	  of	  a	  PCR	  (polymerase	  chain	  reaction)	  
product	  indicated	  the	  existence	  of	  upstream	  sequence	  where	  the	  forward	  primer	  was	  
designed.	  I	  then	  made	  a	  series	  of	  primers	  that	  were	  designed	  closer	  and	  closer	  to	  the	  break	  
point.	  	  The	  final	  result	  was	  a	  PCR	  product	  	  ~500bp	  in	  length	  using	  a	  forward	  primer	  14.5kb	  
upstream	  of	  the	  exc-­5	  start	  codon	  (5’-­‐CCGAATACTTTTACTCGTTAGC-­‐3’)	  and	  a	  reverse	  
primer	  located	  near	  the	  end	  of	  exon	  13	  (5’-­‐GCGAAGGTGCTAGAATTAGGTC-­‐3’).	  This	  product	  
was	  then	  sequenced	  to	  determine	  the	  precise	  endpoints	  of	  the	  rh2332	  deletion.	  
The	  rh232	  allele	  was	  found	  to	  be	  missing	  18,866	  bp	  of	  sequence.	  This	  removes	  the	  first	  
twelve	  exons	  of	  exc-­5	  as	  well	  as	  the	  first	  three	  base	  pairs	  of	  exon	  13.	  In	  addition	  to	  almost	  
total	  deletion	  of	  the	  gene,	  rh232	  also	  removes	  14kb	  of	  upstream	  sequence,	  removing	  any	  
upstream	  genetic	  elements	  that	  would	  ordinarily	  regulate	  the	  transcription	  of	  exc-­5.	  The	  
sequence	  of	  the	  21bp	  on	  either	  side	  of	  the	  deletion	  is	  as	  follows:	  
TTATTTTATTTAACGTTATA-­‐-­‐-­‐18866bp	  Deletion	  -­‐-­‐-­‐	  CCTATCACGGGGTCGAAATG.	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Sequencing	  New	  Alleles	  
The	  series	  of	  new	  alleles	  was	  first	  screened	  using	  a	  set	  of	  three	  primers	  in	  a	  Multiplex-­‐PCR	  
reaction	  (Fig.	  2.3).	  Two	  of	  these	  were	  the	  primers	  that	  bridged	  the	  ~19kb	  deletion	  in	  exc-­5;	  
a	  forward	  primer	  15kb	  upstream	  of	  the	  exc-­5	  start	  codon	  (5’-­‐TGCGCGAAACTGAGATGAATG-­‐
3’)	  and	  a	  reverse	  primer	  at	  the	  end	  of	  exon	  16	  (5’-­‐GAGGGATGAGATGAGATGAACGTAT-­‐3’).	  
The	  third	  was	  a	  forward	  primer	  near	  the	  beginning	  of	  exon	  9	  (5’-­‐
CTCGACTTCTTGCCAATGTGT-­‐3’).	  Any	  strains	  that	  contained	  the	  deletion	  would	  produce	  an	  
~1.5kb	  size	  band	  in	  a	  PCR	  reaction,	  whereas	  those	  strains	  that	  had	  a	  novel	  non-­‐deletion	  
allele	  would	  not	  be	  able	  to	  amplify	  a	  ~19kb	  product,	  and	  instead	  amplify	  using	  the	  exon	  9	  
primer	  site	  that	  is	  not	  present	  in	  the	  deletion,	  and	  produce	  a	  product	  ~2kb	  in	  size.	  Those	  
strains	  that	  produced	  a	  ~2kb	  band	  and	  therefore	  did	  not	  contain	  rh232	  were	  amplified	  in	  
six	  pieces	  using	  the	  primers	  designed	  to	  the	  six	  exon	  segments	  of	  exc-­5	  and	  sent	  to	  a	  
sequencing	  facility	  at	  Idaho	  State	  University.	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Figure	  2.2	  –	  Measuring	  Canals	  and	  Cysts	  
	  
(A)	  A	  diagram	  representing	  a	  wild-­‐type	  canal	  in	  an	  animal.	  Canal	  length	  is	  measured	  
relative	  to	  the	  cell	  body,	  the	  vulva,	  and	  the	  anus	  of	  the	  animal.	  Canals	  that	  do	  not	  extend	  
and	  remain	  at	  the	  cell	  body	  are	  scored	  as	  0.	  Canals	  that	  extend	  halfway	  to	  the	  vulva	  are	  
scored	  as	  2.	  Canals	  that	  extend	  full-­‐length	  to	  the	  anus	  of	  the	  animal	  are	  scored	  as	  4.	  	  
(B)	  A	  diagram	  representing	  the	  body	  cavity	  of	  the	  worm.	  Cysts	  are	  defined	  as	  large	  if	  their	  
diameter	  is	  larger	  than	  half	  the	  diameter	  of	  the	  animal.	  Medium	  cysts	  are	  defined	  as	  ¼	  to	  ½	  
the	  diameter	  of	  the	  animal.	  Small	  cysts	  are	  defined	  as	  ones	  that	  are	  ¼	  or	  less	  of	  the	  
diameter	  of	  the	  animal.	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Figure	  2.3	  –	  Multiplex-­PCR	  Screen	  to	  Confirm	  New	  Alleles	  
	  
(A)	  A	  diagram	  of	  the	  genetic	  structure	  of	  exc-­5	  and	  the	  rh232	  deletion.	  Areas	  in	  red	  are	  
missing	  in	  the	  rh232	  allele.	  P1	  represents	  the	  primer-­‐binding	  site	  upstream	  of	  the	  deletion.	  
P2	  represents	  the	  primer-­‐binding	  site	  that	  will	  be	  present	  in	  non-­‐deletion	  alleles	  and	  
missing	  in	  the	  rh232	  deletion.	  P3	  represents	  the	  reverse	  primer-­‐binding	  site	  for	  the	  
reaction.	  (B)	  The	  PCR	  reaction	  will	  proceed	  using	  the	  P1	  and	  P3	  primers	  and	  amplify	  a	  
1.5kb	  product	  in	  animals	  containing	  the	  rh232	  deletion.	  (C)	  Animals	  that	  do	  not	  contain	  the	  
deletion	  won’t	  produce	  a	  19kb	  product	  using	  the	  P1	  and	  P3	  primers.	  Instead,	  the	  smaller	  
2kb	  product	  using	  the	  P2	  and	  P3	  primers	  will	  be	  amplified.
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Results	  
Twenty-­‐seven	  rounds	  of	  mutagenesis	  resulted	  in	  an	  estimated	  50,855	  genomes	  screened	  
and	  produced	  forty-­‐three	  isolates.	  	  Of	  these,	  six	  had	  properties	  of	  interest	  but	  none	  of	  them	  
were	  novel	  TS	  alleles	  of	  EXC-­‐5.	  
Two	  of	  the	  isolates	  were	  novel	  mutations	  in	  exc-­5,	  but	  did	  not	  show	  any	  temperature-­‐
sensitive	  effects.	  Both	  alleles,	  qp39	  and	  qp21,	  contained	  premature	  stop	  codons	  in	  the	  last	  
PH	  domain,	  encoded	  by	  exons	  14-­‐16.	  qp39	  has	  a	  C	  	  T	  transition	  in	  exon	  15	  that	  changes	  
amino	  acid	  756	  from	  an	  arginine	  to	  a	  stop	  (CGA	  	  TGA).	  qp21	  also	  contains	  a	  CT	  
transition	  in	  exon	  16,	  changing	  amino	  acid	  815	  from	  a	  glutamine	  	  into	  a	  stop	  codon	  (CAA	  
TAA).	  The	  last	  PH	  domain	  consists	  of	  amino	  acids	  743-­‐830.	  Therefore,	  qp39	  excludes	  
almost	  the	  entire	  second	  PH	  domain	  whereas	  qp21	  only	  removes	  the	  last	  15	  amino	  acids	  
(Fig.	  2.4).	  Both	  of	  these	  strains	  had	  a	  null	  phenotype	  and	  looked	  similar	  to	  the	  rh232	  allele.	  
Three	  of	  the	  isolates	  had	  hypomorphic	  phenotypes:	  qp35,	  qp37,	  and	  qp56.	  These	  animals	  
had	  much	  less	  severe	  phenotypes	  and	  frequently	  did	  not	  look	  mutant	  at	  all.	  When	  mutant,	  
these	  animals	  had	  shortened,	  slightly	  malformed	  canals	  (Fig.	  2.5).	  Sequencing	  of	  these	  
animals,	  however,	  showed	  no	  mutations	  in	  the	  coding	  regions	  of	  exc-­5.	  The	  frequency	  of	  
slightly	  mutant	  canal	  phenotypes	  was	  not	  altered	  by	  temperature	  in	  these	  mutants.	  
The	  last	  isolate,	  qp49,	  showed	  temperature-­‐sensitive	  effects,	  but	  did	  not	  show	  an	  absence	  
of	  cysts	  at	  the	  lower	  temperature	  (Table	  2.1).	  rh232	  showed	  little	  variation	  when	  moved	  
between	  15°	  and	  20°.	  19%	  of	  the	  animals	  had	  canals	  that	  formed	  large	  cysts	  at	  either	  
temperature	  in	  the	  posterior	  canals,	  and	  roughly	  20%	  had	  cysts	  in	  the	  anterior	  canals	  at	  
both	  temperatures.	  In	  contrast,	  qp49	  was	  free	  of	  anterior	  canal	  cysts	  at	  15°.	  Additionally,	  
when	  qp49	  was	  moved	  to	  25°,	  the	  number	  of	  canals	  that	  had	  large	  cysts	  rose	  to	  38%,	  nearly	  
double	  that	  of	  rh232.	  Sequencing	  of	  qp49,	  however,	  showed	  that	  it	  contained	  the	  original	  
rh232	  deletion.	  
	  Table	  2.1	  –	  Temperature	  Sensitive	  effects	  of	  rh232	  and	  qp49	  
rh232	   qp49	  	  
15°	   25°	   15°	   25°	  
%	  Canals	  with	  Large	  Cystsa	   19%	   19%	   17%	   38%	  
Total	  #	  of	  Cystsb	   5	   9	   6	   5	  
%	  Anterior	  Canals	  with	  Cystsc	   21%	   17%	   0%	   12%	  
nd	   88	   69	   46	   87	  
The	  exc-­5	  null	  allele	  rh232	  shows	  little	  difference	  in	  phenotype	  between	  15°	  
and	  25°.	  In	  contrast,	  at	  15°	  qp49	  shows	  a	  slight	  decrease	  in	  the	  	  number	  of	  
canals	  with	  large	  cysts.	  More	  significantly,	  it	  shows	  complete	  suppression	  of	  
cyst	  formation	  in	  the	  anterior	  canals	  (green).	  At	  25°	  this	  suppression	  is	  
eliminated.	  In	  addition,	  at	  25°	  the	  number	  of	  canals	  with	  large	  cysts	  	  in	  qp49	  
doubles	  over	  that	  of	  rh232	  (red).	  aThe	  percentage	  of	  canals	  that	  contained	  
large	  cysts	  at	  a	  given	  temperature.	  bAverage	  total	  number	  of	  cysts	  counted	  
per	  canal.	  cPercentage	  of	  anterior	  canals	  that	  contained	  cysts.	  dNumber	  of	  
canals	  examined.	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Figure	  2.4	  –	  New	  Null	  Alleles	  of	  exc-­5	  
	  
(A)	  Genetic	  structure	  of	  exc-­5	  showing	  the	  locations	  of	  the	  qp39	  and	  qp21	  mutations.	  qp39	  
has	  a	  C	  	  T	  transition	  in	  exon	  15	  that	  changes	  amino	  acid	  756	  from	  an	  arginine	  to	  a	  stop	  
(CGA	  	  TGA).	  qp21	  also	  contains	  a	  CT	  transition	  in	  exon	  16,	  changing	  amino	  acid	  815	  
from	  a	  glutamine	  into	  a	  stop	  codon	  (CAA	  TAA).	  (B)	  Both	  mutations	  disrupt	  the	  last	  PH	  
domain	  of	  EXC-­‐5.	  Both	  of	  these	  alleles	  have	  phenotypes	  similar	  to	  that	  of	  rh232.	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Figure	  2.5	  –	  Hypomorphs	  Show	  Minor	  Canal	  Defects	  	  
	  
A	  micrograph	  taken	  under	  fluorescence	  of	  an	  L4	  qp35	  animal	  at	  200x	  magnification.	  
Hypomorphic	  phenotypes	  are	  all	  similar	  to	  the	  animal	  depicted	  here.	  Canals	  extend	  two-­‐
thirds	  of	  the	  way	  to	  the	  tail	  and	  do	  not	  have	  visible	  cysts.	  Instead,	  the	  canals	  often	  end	  in	  
slightly	  malformed	  protrusions	  (arrows).	  Inset	  is	  of	  the	  same	  animal	  at	  higher	  
magnification.	  Sequencing	  of	  the	  exons	  of	  alleles	  qp35,	  qp37,	  and	  qp56	  did	  not	  show	  any	  
mutations	  present.	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Discussion	  
Although	  no	  new	  temperature-­‐sensitive	  alleles	  of	  exc-­5	  were	  found,	  six	  strains	  were	  
isolated	  that	  provide	  some	  information,	  and	  the	  rh232	  deletion	  was	  successfully	  identified.	  
Two	  of	  the	  isolates,	  qp39	  and	  qp21,	  were	  novel	  alleles	  of	  exc-­5.	  Both	  contained	  C-­‐>T	  
transitions	  within	  the	  last	  PH	  domain	  of	  the	  gene.	  This	  type	  of	  point	  mutation	  is	  common	  
for	  EMS-­‐induced	  mutations	  68.	  Interestingly,	  although	  these	  nonsense	  mutations	  only	  
remove	  a	  small	  portion	  of	  the	  gene,	  the	  phenotypes	  of	  these	  animals	  were	  as	  severe	  as	  was	  
the	  rh232	  deletion.	  This	  indicates	  that	  the	  last	  PH	  domain	  of	  EXC-­‐5	  is	  essential	  for	  function	  
within	  the	  excretory	  canal.	  Mutations	  in	  the	  lipid-­‐binding	  site	  of	  the	  first	  PH	  domain	  of	  
FGD1	  have	  been	  shown	  to	  cause	  disease	  effects	  69.	  If	  destroying	  the	  function	  of	  the	  last	  PH	  
domain	  in	  EXC-­‐5	  causes	  a	  null	  phenotype,	  this	  would	  indicate	  that	  the	  DH/PH	  tandem	  
domains	  are	  not	  the	  only	  essential	  domains	  in	  EXC-­‐5,	  and	  that	  the	  activity	  of	  EXC-­‐5	  does	  
not	  lie	  solely	  in	  its	  ability	  to	  function	  as	  a	  GEF.	  The	  related	  Vav	  family	  of	  proteins	  has	  been	  
shown	  to	  have	  effects	  independent	  of	  its	  GEF	  activity	  70,71.	  It	  is	  also	  possible	  that	  the	  second	  
PH	  domain	  in	  EXC-­‐5	  is	  important	  for	  determining	  the	  location	  of	  the	  protein	  within	  the	  
excretory	  cell,	  and	  without	  it	  EXC-­‐5	  is	  unable	  to	  reach	  the	  correct	  membrane	  surfaces	  to	  
activate/interact	  with	  its	  binding	  partners	  to	  maintain	  the	  canal	  shape.	  Future	  experiments	  
would	  include	  creating	  a	  GFP-­‐labeled	  version	  of	  EXC-­‐5	  that	  removed	  the	  terminal	  PH	  
domain	  and	  then	  check	  its	  subcellular	  location	  as	  compared	  with	  that	  of	  WT	  EXC-­‐5.	  A	  
difference	  in	  location	  would	  indicate	  that	  EXC-­‐5	  is	  located	  improperly	  without	  the	  last	  PH	  
domain.	  Additional	  experiments	  could	  be	  done	  to	  determine	  the	  roles	  of	  the	  other	  domains	  
of	  EXC-­‐5	  by	  creating	  several	  different	  forms	  of	  the	  protein,	  selectively	  removing	  the	  
different	  domains	  and	  observing	  whether	  these	  proteins	  retained	  their	  activity	  by	  
preventing	  cysts	  to	  form	  within	  the	  canal.	  Previous	  studies	  of	  this	  kind	  have	  been	  done	  
with	  FGD1;	  these	  experiments,	  however,	  have	  indicated	  that	  the	  N-­‐terminal	  proline-­‐rich	  
domain	  in	  FGD1	  is	  largely	  responsible	  for	  its	  location	  in	  the	  plasma	  membrane	  and	  Golgi	  
complex	  72	  and	  that	  FGD1’s	  Src	  homology	  (SH3)	  domain	  is	  responsibly	  for	  its	  interaction	  
with	  cortactin	  and	  Arp2/3	  73.	  Interestingly,	  EXC-­‐5	  does	  not	  contain	  these	  domains.	  
Alternatively,	  the	  transcript	  from	  qp39	  and	  qp21	  could	  be	  degraded	  through	  nonsense-­‐
mediated	  decay	  74.	  I	  suggest	  that	  this	  is	  unlikely	  due	  to	  the	  proximity	  of	  the	  new	  premature	  
stop	  codons	  to	  the	  native	  ones.	  No	  experiments	  were	  done	  to	  ascertain	  the	  presence	  or	  
absence	  of	  an	  exc-­5	  mRNA	  or	  EXC-­‐5	  protein	  in	  these	  strains	  to	  verify	  this	  assumption,	  so	  
the	  possibility	  remains	  that	  the	  mRNA	  is	  being	  degraded	  and	  no	  EXC-­‐5	  protein	  is	  being	  
produced.	  The	  presence	  of	  a	  persistent	  exc-­5	  mRNA	  in	  these	  strains	  could	  be	  checked	  using	  
either	  RT-­‐PCR	  (Reverse	  Transcriptase	  PCR)	  or	  a	  5’	  RACE-­‐PCR	  (Rapid	  Amplification	  of	  cDNA	  
Ends).	  Determining	  whether	  or	  not	  the	  protein	  is	  present	  in	  these	  animals	  could	  be	  
checked	  by	  using	  an	  antibody	  specific	  for	  EXC-­‐5.	  
Screening	  through	  an	  estimated	  51,000	  genomes	  did	  not	  produce	  a	  TS	  allele	  that	  was	  
suitable	  for	  our	  purposes.	  Ideally,	  we	  would	  have	  recovered	  an	  allele	  that	  had	  a	  100%	  
penetrant	  cystic	  phenotype	  at	  25°	  and	  0%	  (no	  cysts	  at	  all)	  at	  15°,	  and	  then	  used	  this	  to	  look	  
at	  the	  effects	  of	  removing	  or	  adding	  EXC-­‐5	  activity	  at	  different	  developmental	  time	  points	  
during	  the	  growth	  of	  the	  animal	  and	  the	  excretory	  canal.	  The	  nature	  of	  the	  protein	  and	  
phenotype	  may	  have	  made	  finding	  a	  TS	  allele	  improbable.	  The	  phenotype	  of	  an	  exc-­5	  null	  
mutant	  is	  stochastic.	  Although	  there	  is	  a	  100%	  chance	  that	  it	  will	  form	  cysts,	  where	  and	  
	   42	  
how	  many	  cysts	  form	  is	  not	  predictable	  for	  any	  one	  animal.	  If	  there	  was	  a	  subtle	  TS	  effect,	  it	  
may	  have	  gone	  unnoticed	  in	  the	  variation	  between	  animals	  at	  the	  two	  different	  
temperatures.	  The	  value	  of	  such	  a	  subtle	  TS	  allele	  for	  our	  purposes	  would	  be	  low.	  	  
In	  addition,	  EXC-­‐5	  activity	  is	  not	  required	  to	  maintain	  the	  entire	  length	  of	  the	  canal.	  On	  a	  
cellular	  level,	  this	  indicates	  that	  EXC-­‐5	  is	  only	  essential	  at	  certain	  points	  along	  the	  canal	  
(where	  the	  cysts	  form)	  and	  not	  along	  other	  parts	  of	  the	  canal	  (which	  maintain	  their	  normal	  
lumen	  diameter).	  The	  points	  along	  the	  canal	  that	  do	  fail,	  fail	  catastrophically	  and	  create	  
large	  cysts.	  	  Our	  screen	  was	  sensitive	  enough	  to	  identify	  three	  hypomorphic	  alleles,	  which	  
indicates	  that	  we	  were	  able	  to	  isolate	  alleles	  that	  had	  reduced	  activity.	  These	  strains	  also	  
indicate	  that	  even	  a	  small	  amount	  of	  EXC-­‐5	  activity	  is	  enough	  to	  eliminate	  the	  cystic	  
phenotype.	  As	  heterozygotes,	  they	  were	  unable	  to	  fully	  complement	  the	  rh232	  allele.	  When	  
homozygous,	  they	  had	  enough	  activity	  to	  only	  allow	  minor	  defects	  in	  the	  canal	  to	  form.	  To	  
generate	  a	  TS	  allele,	  a	  mutation	  that	  completely	  eliminated	  all	  EXC-­‐5	  activity	  at	  25°	  would	  
have	  to	  be	  induced.	  At	  the	  same	  time,	  this	  mutation	  would	  have	  to	  restore	  activity	  at	  15°.	  It	  
is	  feasible	  that	  such	  an	  EMS-­‐induced	  mutation	  may	  not	  be	  possible	  for	  EXC-­‐5.	  We	  have	  
pursued	  other	  methods	  to	  generate	  TS	  alleles	  of	  EXC-­‐5	  in	  a	  more	  directed	  approach	  by	  
engineering	  conditional	  alleles	  using	  inteins	  (see	  Chapter	  7).	  
Our	  screen	  does	  indicate	  that	  it	  is	  possible	  to	  identify	  temperature-­‐sensitive	  alleles	  of	  other	  
genes	  that	  work	  with	  EXC-­‐5.	  qp49	  was	  TS	  for	  its	  cystic	  phenotype	  even	  though	  it	  still	  
contained	  the	  rh232	  deletion,	  which	  indicates	  that	  qp49	  is	  a	  TS	  mutation	  in	  a	  gene	  other	  
than	  exc-­5.	  At	  15°,	  qp49	  acts	  as	  a	  mild	  suppressor	  of	  EXC-­‐5,	  eliminating	  the	  formation	  of	  
cysts	  in	  the	  anterior	  canals	  and	  slightly	  reducing	  the	  number	  of	  canals	  with	  large	  cysts.	  At	  
25°,	  qp49	  no	  longer	  suppressed	  the	  formation	  of	  cysts	  in	  the	  anterior	  canals.	  Interestingly,	  
at	  25°	  qp49	  also	  increased	  the	  number	  of	  canals	  with	  large	  cysts	  to	  nearly	  double	  that	  from	  
rh232,	  which	  indicates	  that	  at	  higher	  temperatures	  qp49	  exacerbates	  the	  Exc-­‐5	  mutant	  
phenotype.	  Currently	  there	  is	  no	  mapping	  data	  for	  this	  allele.	  Identifying	  what	  gene	  is	  being	  
affected	  could	  be	  very	  interesting	  and	  future	  work	  will	  require	  qp49	  to	  be	  mapped.	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Chapter	  3:	  Identification	  of	  Genetic	  Enhancers	  of	  exc-­5	  
	  
Abstract	  
In	  order	  to	  identify	  more	  proteins	  that	  interact	  with	  EXC-­‐5,	  we	  set	  up	  an	  EMS	  screen	  to	  
identify	  mutations	  that	  suppressed	  the	  Exc-­‐5	  gain-­‐of-­‐function	  phenotype.	  We	  isolated	  two	  
strains,	  BK188	  and	  BK190,	  which	  contain	  mutations	  that	  act	  as	  enhancers	  of	  EXC-­‐5	  activity.	  
Both	  mutations	  are	  recessive	  and	  do	  not	  show	  linkage	  to	  chromosomes	  I	  or	  X.	  Additional	  
mapping	  information	  for	  BK188	  shows	  that	  it	  is	  not	  linked	  to	  the	  middle	  of	  chromosomes	  
II,	  III,	  IV,	  or	  V.	  
Rationale	  
“What	  other	  gene	  products	  interact	  with	  EXC-­‐5?”	  
Several	  proteins	  have	  been	  shown	  to	  interact	  with	  FGD	  family	  members.	  CDC-­‐42	  and	  Rac	  
have	  both	  been	  implicated	  in	  interactions	  with	  FGD	  proteins	  either	  directly	  or	  indirectly	  75-­‐
78.	  We	  wanted	  to	  broaden	  our	  search	  over	  the	  entire	  C.	  elegans	  genome	  to	  look	  for	  novel	  
proteins	  that	  might	  interact	  with	  EXC-­‐5.	  By	  identifying	  novel	  genes	  that	  interact	  with	  exc-­5,	  
we	  can	  gain	  insight	  into	  the	  pathways	  involved	  in	  regulating	  and	  maintaining	  the	  tubular	  
shape	  of	  the	  excretory	  canal.	  The	  isolation	  of	  qp49	  suggested	  that	  suppressors	  of	  exc-­5	  
function	  exist.	  We	  were	  interested	  in	  also	  identifying	  enhancers	  of	  exc-­5.	  
In	  order	  to	  do	  this,	  we	  took	  advantage	  of	  the	  gain-­‐of-­‐function	  phenotype	  of	  exc-­5	  and	  set	  up	  
an	  EMS	  suppressor	  screen	  to	  identify	  genes	  whose	  products	  normally	  contribute	  
(enhancers)	  to	  EXC-­‐5	  function.	  Animals	  overexpressing	  EXC-­‐5	  show	  shortened	  and	  
sometimes	  convoluted	  canals	  (Fig.	  1.10).	  By	  mutagenizing	  animals	  that	  stably	  
overexpressed	  EXC-­‐5,	  we	  can	  screen	  for	  animals	  that	  appear	  suppressed;	  animals	  that	  have	  
normal	  length	  canals.	  These	  animals	  will	  have	  had	  a	  mutation	  in	  a	  gene	  that	  normally	  
contributes	  to	  EXC-­‐5’s	  function,	  and	  helps	  shorten	  the	  canal	  cell.	  Once	  mutated,	  the	  gene	  
will	  alleviate	  the	  mutant	  gain-­‐of-­‐function	  phenotype	  of	  EXC-­‐5	  overexpression.	  By	  using	  this	  
type	  of	  EMS	  suppressor	  screen,	  we	  isolated	  two	  	  genetic	  enhancers	  of	  exc-­5.	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Materials	  and	  Methods	  
Strains	  Used	  
In	  order	  to	  carry	  out	  this	  screen	  we	  first	  needed	  to	  build	  a	  strain	  that	  stably	  overexpressed	  
EXC-­‐5.	  This	  becomes	  particularly	  difficult	  as	  the	  overexpression	  of	  EXC-­‐5	  is	  deleterious,	  
and	  at	  very	  high	  levels	  lethal;	  therefore	  transgenic	  arrays	  of	  EXC-­‐5	  are	  lost	  from	  the	  
population	  at	  high	  rates.	  	  
A	  plasmid	  containing	  a	  genomic	  copy	  of	  exc-­5	  under	  its	  own	  promoter	  and	  fused	  N-­‐
terminally	  to	  GFP	  (7.2kb	  of	  upstream	  sequence	  from	  exc-­5	  and	  5.3kb	  of	  exc-­5	  coding	  region	  
placed	  into	  pPD95.75	  (gift	  from	  A.	  Fire)	  in	  front	  of	  the	  gfp	  gene	  and	  an	  unc-­54	  3’	  UTR)	  (gift	  
from	  K.	  Matsumoto)	  was	  used	  to	  introduce	  excess	  copies	  of	  exc-­5	  into	  wild-­‐type	  (N2)	  
animals.	  After	  many	  injections	  of	  the	  plasmid	  at	  various	  concentrations,	  I	  was	  ultimately	  
successful	  in	  producing	  a	  worm	  strain	  containing	  an	  unstable	  array	  at	  a	  very	  low	  
transmission	  rate	  (0.6-­‐1%	  of	  animals	  would	  inherit	  the	  array,	  n=300)	  by	  injecting	  exc-­
5::gfp	  at	  15ng/µl	  in	  combination	  with	  purified	  N2	  genomic	  DNA	  at	  a	  concentration	  of	  
25ng/µl.	  The	  inclusion	  of	  the	  N2	  DNA	  was	  designed	  to	  provide	  additional	  carrier	  DNA	  so	  
that	  the	  transgenic	  array	  built	  by	  the	  animal	  would	  incorporate	  random	  wild-­‐type	  DNA	  and	  
prevent	  incorporation	  of	  a	  lethal,	  highly	  repetitive,	  high-­‐copy-­‐number	  array	  of	  only	  exc-­
5::gfp	  DNA.	  
The	  low-­‐transmission	  array	  was	  then	  integrated	  into	  the	  chromosome	  by	  use	  of	  4,5’,8-­‐
trimethylpsoralen	  (TMP)	  79.	  Nematodes	  were	  washed	  off	  plates	  with	  M9	  buffer,	  pelleted,	  
and	  resuspended	  in	  a	  minimal	  volume.	  	  TMP	  was	  added	  to	  a	  final	  concentration	  of	  30µg/ml.	  	  	  
Animals	  were	  soaked	  in	  the	  TMP	  solution	  for	  15	  minutes	  in	  the	  dark	  and	  washed	  twice	  in	  
M9	  buffer.	  	  Nematodes	  were	  then	  plated	  and	  irradiated	  by	  use	  of	  a	  Spectrolinker™	  
(Spectronics	  Corporation,	  New	  York)	  set	  to	  350µJ	  at	  360nm.	  	  F2	  progeny	  from	  the	  
irradiated	  animals	  were	  isolated	  and	  screened	  for	  integrants.	  	  Plates	  containing	  all	  
fluorescent	  transgenic	  progeny	  were	  identified	  as	  having	  the	  transgene	  homozygously	  
integrated.	  The	  resultant	  strain	  (BK157)	  has	  the	  exc-­5::gfp	  array,	  qpIs78,	  integrated	  on	  the	  
X	  chromosome.	  The	  strain	  was	  then	  outcrossed	  five	  times.	  .	  The	  GFP	  expression	  was	  so	  low	  
in	  this	  strain	  that	  it	  was	  not	  suitable	  for	  screening	  through	  a	  fluorescent	  dissecting	  scope.	  
To	  enhance	  canal	  visibility,	  I	  crossed	  the	  bright	  canal	  marker	  integrant	  qpIs11	  ([unc-­
119;Pvha-­1::gfp]	  on	  I)	  into	  the	  outcrossed	  BK157	  strain	  to	  create	  BK178.	  This	  strain	  was	  
then	  used	  in	  the	  EMS	  suppressor	  screen.	  
EMS	  Suppressor	  Screen	  
Animals	  were	  mutagenized	  similarly	  to	  the	  manner	  described	  in	  Chapter	  1.	  BK178	  animals	  
were	  collected	  into	  2mL	  of	  M9	  buffer.	  Animals	  were	  then	  added	  to	  an	  additional	  2mL	  of	  M9	  
buffer	  containing	  20µl	  of	  ethyl-­‐methanesulfonate	  (EMS)(for	  a	  final	  1%	  EMS	  solution).	  
Animals	  were	  left	  to	  agitate	  in	  a	  rotary	  shaker	  for	  four	  hours,	  and	  then	  washed	  to	  remove	  
the	  EMS	  solution.	  Mutagenized	  BK178	  young	  adult	  hermaphrodites	  were	  moved	  to	  new	  
plates	  and	  allowed	  to	  self-­‐fertilize.	  The	  F1	  progeny	  were	  allowed	  to	  self-­‐fertilize	  in	  order	  to	  
isolate	  animals	  that	  may	  need	  to	  be	  homozygous	  for	  a	  suppression	  effect,	  and	  the	  F2	  
generation	  was	  screened	  for	  animals	  that	  showed	  full-­‐length	  canals.	  Animals	  with	  full-­‐
length	  canals	  were	  picked	  to	  separate	  plates	  and	  allowed	  to	  self-­‐fertilize.	  Animals	  that	  bred	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true	  for	  the	  suppressed	  phenotype	  were	  considered	  to	  have	  new	  mutations	  that	  
suppressed	  exc-­5	  gain-­‐of-­‐function.	  
Mapping	  the	  Genetic	  Locus	  of	  the	  Suppressors	  
In	  order	  to	  identify	  where	  the	  suppressors	  are	  located,	  test-­‐crosses	  were	  done	  between	  
BK188	  or	  BK189	  heterozygous	  males	  and	  a	  series	  of	  different	  hermaphrodites	  containing	  
the	  following	  mutations	  linked	  to	  each	  of	  the	  six	  chromosomes	  of	  C.	  elegans	  respectively:	  
dpy-­5(e61)	  I;	  dpy-­10(e128)	  unc-­4(e120)	  II;	  dpy-­17(e164)	  unc-­32(e189)	  III;	  dpy-­20(e1282)	  
unc-­22(e66)	  IV;	  dpy-­11(e224)	  unc-­42(e270),	  dpy-­11(e224)	  unc-­76(e911),	  and	  unc-­51(e369)	  
V;	  and	  dpy-­6	  (e14)	  unc-­3(e151)	  X.	  
Matings	  that	  did	  not	  result	  in	  the	  expected	  frequency	  of	  animals	  containing	  both	  the	  
marker	  gene(s)	  and	  the	  suppression	  phenotype	  were	  considered	  to	  have	  the	  suppressor	  
mutations	  linked	  to	  the	  chromosome	  associated	  with	  the	  marker	  gene(s).	  	  	  
Scoring	  of	  strains	  was	  carried	  out	  as	  in	  Chapter	  2,	  with	  a	  length	  equal	  to	  0	  indicating	  no	  
canal	  extension	  and	  a	  length	  of	  4	  indicating	  complete	  canal	  extension.	  
	  
Results	  
Four	  rounds	  of	  mutagenesis	  resulted	  in	  an	  estimated	  2,000	  genomes	  screened	  and	  the	  
isolation	  of	  two	  suppressor	  strains,	  BK188	  and	  BK190.	  	  
The	  parent	  strain,	  BK178,	  has	  an	  average	  canal	  length	  of	  1.8,	  although	  the	  range	  of	  canal	  
lengths	  can	  vary	  between	  0.5	  and	  3.5	  (n=66).	  The	  two	  suppressor	  strains	  were	  identified	  
through	  two	  selection	  criteria:	  First,	  individual	  animals	  that	  had	  full-­‐length	  canals;	  and	  
second,	  the	  progeny	  of	  these	  animals	  showed	  the	  same	  lengthening	  effect.	  Although	  not	  
every	  animal	  in	  the	  second	  stage	  of	  selection	  had	  a	  full-­‐length	  canal,	  the	  effect	  on	  the	  
population	  of	  animals	  had	  to	  be	  observable.	  For	  both	  BK188	  and	  BK190,	  approximately	  
75%	  of	  the	  animals	  have	  full-­‐length	  canals.	  
Both	  suppressors	  are	  recessive	  and	  do	  not	  appear	  to	  be	  on	  chromosomes	  I	  or	  X.	  In	  addition,	  
BK188	  did	  not	  show	  linkage	  to	  the	  center	  of	  chromosomes	  II,	  III,	  IV,	  or	  V.	  Unfortunately,	  it	  
also	  did	  not	  show	  linkage	  to	  the	  center	  or	  right	  side	  of	  chromosome	  V.	  BK190	  was	  isolated	  
with	  the	  assistance	  of	  Tekalign	  Burka	  and	  remains	  to	  be	  tested	  for	  chromosomes	  II,	  III,	  IV,	  
and	  V.	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Discussion	  
Although	  there	  have	  been	  several	  attempts	  to	  map	  these	  suppressors,	  we	  have	  currently	  
not	  identified	  the	  genetic	  locus	  for	  the	  suppression	  effect.	  There	  are	  several	  reasons	  this	  
has	  been	  difficult.	  The	  first	  is	  that	  these	  suppressors	  are	  only	  identifiable	  through	  their	  
population	  effect.	  Individual	  animals	  may	  not	  always	  show	  a	  full-­‐length	  canal.	  The	  second	  
is	  that	  the	  suppressors	  are	  recessive,	  so	  only	  animals	  homozygous	  for	  the	  mutation	  will	  
show	  the	  suppression	  phenotype.	  Thirdly,	  the	  suppression	  phenotype	  can	  only	  be	  seen	  
with	  qpIs78.	  The	  inclusion	  of	  qpIs11	  in	  these	  strains	  was	  necessary	  to	  be	  able	  to	  screen	  the	  
animals	  under	  the	  dissecting	  scope.	  The	  intensity	  of	  this	  canal	  marker,	  however,	  masks	  the	  
GFP	  expression	  from	  qpIs78,	  and	  therefore	  animals	  must	  be	  known	  to	  contain	  qpIs78	  
through	  the	  generation	  of	  animals	  with	  shortened	  canals	  and	  not	  through	  fluorescence.	  
When	  creating	  the	  testcrosses	  in	  order	  to	  determine	  linkage,	  at	  least	  three	  different	  genetic	  
elements	  (qpIs78,	  the	  suppressor	  locus,	  and	  the	  tester	  gene	  or	  genes)	  need	  to	  be	  
homozygous	  in	  order	  to	  determine	  if	  the	  suppressor	  is	  linked	  to	  the	  chromosome.	  We	  are	  
confident	  that	  the	  suppressors	  are	  not	  on	  chromosome	  I	  or	  X,	  as	  they	  show	  no	  linkage	  to	  
either	  qpIs78	  or	  to	  qpIs11.	  Therefore,	  they	  cannot	  be	  mutations	  in	  exc-­1,	  which	  has	  been	  
shown	  to	  interact	  with	  exc-­5	  (Chapter	  5).	  While	  it	  is	  possible	  that	  the	  BK188	  mutation	  is	  on	  
the	  ends	  of	  chromosomes	  I,	  II,	  III,	  IV,	  or	  the	  left	  end	  of	  V,	  the	  initial	  crosses	  did	  not	  show	  it	  
to	  be	  linked	  to	  any	  of	  the	  chromosomes.	  	  
These	  suppressors	  do	  not	  appear	  to	  affect	  qpIs11	  fluorescence,	  and	  therefore	  are	  unlikely	  
to	  be	  nonspecific	  suppressors	  of	  transgene	  activity.	  It	  is	  possible	  that	  these	  suppressors	  are	  
mutations	  that	  affect	  the	  expression	  of	  the	  exc-­5::gfp	  transgene	  through	  either	  
transcriptional	  or	  translational	  effects.	  Although	  these	  kinds	  of	  mutations	  would	  not	  be	  
ideal	  in	  determining	  what	  proteins	  are	  interacting	  with	  the	  EXC-­‐5	  protein	  itself,	  they	  would	  
still	  provide	  insight	  as	  to	  how	  exc-­5	  is	  being	  regulated	  within	  the	  excretory	  canal	  cell.	  
Future	  work	  on	  this	  project	  requires	  these	  suppressors	  to	  be	  identified.	  We	  have	  shown	  
that	  it	  is	  possible	  to	  isolate	  new	  strains	  that	  suppress	  the	  gain-­‐of-­‐function	  phenotype	  of	  
EXC-­‐5.	  Identifying	  what	  these	  mutations	  are	  could	  provide	  new	  insight	  into	  the	  molecular	  
pathways	  in	  which	  EXC-­‐5	  works	  to	  maintain	  tubular	  shape.
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Chapter	  4:	  Creating	  a	  Canal-­Specific	  RNAi	  System	  
	  
Abstract	  
Loss-­‐of-­‐function	  mutations	  in	  several	  of	  the	  genes	  thought	  to	  be	  involved	  in	  the	  growth	  and	  
maintenance	  of	  the	  excretory	  canal	  are	  lethal	  when	  mutated	  in	  the	  entire	  animal.	  In	  order	  
to	  manipulate	  these	  genes	  and	  others	  in	  a	  cell-­‐specific	  manner,	  we	  require	  a	  technique	  that	  
allows	  us	  to	  manipulate	  gene	  function	  only	  in	  the	  excretory	  canal	  cell.	  In	  this	  chapter	  I	  
describe	  two	  attempts,	  one	  using	  RNAi	  hair-­‐pins	  and	  one	  using	  cell-­‐specific	  expression	  of	  
RDE-­‐1,	  	  as	  well	  as	  current	  methods	  being	  implemented	  to	  create	  an	  excretory	  canal	  cell-­‐
specific	  RNAi	  technique.	  
Rationale	  
“What	  other	  gene	  products	  interact	  with	  EXC-­‐5?”	  
Many	  of	  the	  genes	  that	  may	  or	  may	  not	  interact	  with	  EXC-­‐5,	  in	  particular	  the	  RhoGTPases	  
and	  CDC-­‐42,	  are	  lethal	  when	  completely	  knocked	  out.	  Some	  mutations	  of	  these	  genes	  do	  
exist,	  but	  are	  not	  null	  phenotypes.	  For	  instance,	  the	  cdc-­42	  allele	  gk388	  must	  be	  maintained	  
as	  a	  heterozygote.	  Animals	  that	  are	  homozygous	  for	  this	  allele	  are	  viable,	  but	  are	  sterile.	  
The	  fact	  that	  animals	  homozygous	  for	  a	  presumably	  null	  allele	  of	  cdc-­42	  are	  viable	  at	  all	  
indicates	  that	  there	  is	  a	  maternal	  effect	  and,	  while	  genetically	  these	  animals	  may	  be	  null	  for	  
cdc-­42,	  cellularly	  they	  are	  not.	  The	  excretory	  canals	  in	  these	  animals	  do	  not	  appear	  to	  have	  
major	  defects	  (see	  Chapter	  5).	  
To	  date,	  most	  of	  the	  exc	  genes	  identified	  have	  been	  expressed	  primarily	  in	  the	  canal	  cell.	  
This	  indicates	  that	  single-­‐cell	  tubulogenesis	  and	  tubule	  maintenance	  are	  largely	  cell	  
autonomous	  processes.	  Another	  possible	  explanation	  is	  that	  more	  generally	  expressed	  
genes	  that	  would	  cause	  cysts	  to	  form	  in	  the	  canal	  also	  cause	  defects	  in	  other	  tissues	  and	  are	  
lethal	  when	  mutated.	  In	  addition	  to	  testing	  particular	  genes	  of	  interest,	  a	  canal-­‐specific	  
method	  to	  knockout	  genes	  would	  allow	  the	  implementation	  of	  high-­‐throughput	  genomic	  
screens	  to	  identify	  genes	  that	  are	  involved	  in	  tubulogenesis,	  but	  would	  otherwise	  not	  be	  
found	  through	  more	  traditional	  genetic	  screens.	  
In	  order	  to	  manipulate	  theses	  genes	  in	  a	  cell-­‐specific	  manner	  and	  not	  affect	  the	  general	  
development	  or	  morphology	  of	  the	  animal,	  we	  needed	  a	  way	  to	  disrupt	  these	  genes	  only	  in	  
the	  excretory	  canal.	  We	  decided	  to	  use	  the	  robust	  RNAi	  (RNA	  interference)	  system	  within	  C.	  
elegans	  80	  as	  a	  means	  to	  selectively	  knock	  down	  genes	  within	  the	  excretory	  canal	  cell	  while	  
not	  perturbing	  other	  tissues	  within	  the	  animal.	  We	  have	  approached	  this	  technical	  hurdle	  
in	  several	  ways.	  
The	  first	  attempt	  relies	  on	  the	  transcription	  of	  a	  construct	  only	  in	  the	  canal	  cell.	  The	  
transcript	  is	  designed	  to	  bind	  back	  on	  itself	  to	  form	  a	  dsRNA	  hairpin.	  The	  second	  method	  is	  
based	  on	  the	  rde-­1	  (RNAi-­‐defective)	  mutant.	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Materials	  and	  Methods	  
1.	  Creating	  Excretory-­‐Canal-­‐Expressed	  RNAi	  Hairpins	  
By	  designing	  a	  DNA	  construct	  that	  has	  a	  canal-­‐specific	  promoter,	  ~600bp	  of	  a	  cDNA	  of	  
interest	  (forward	  fragment),	  followed	  by	  a	  ~300bp	  fragment	  containing	  the	  same	  ending	  
sequence	  of	  the	  same	  cDNA	  in	  a	  reverse	  orientation	  (reverse	  fragment),	  we	  intended	  to	  
create	  a	  transgene	  that	  would	  transcribe	  an	  mRNA	  that	  would	  fold	  back	  on	  itself	  and	  
produce	  ~300bp	  of	  dsRNA	  sequence	  to	  trigger	  the	  RNAi	  mechanism	  within	  the	  excretory	  
canal	  cell.	  To	  prevent	  the	  RNAi	  effect	  from	  spreading	  out	  of	  the	  canal	  cell,	  these	  constructs	  
were	  to	  be	  injected	  into	  animals	  mutant	  for	  sid-­1,	  which	  encodes	  a	  dsRNA	  transporter	  
required	  for	  systemic	  RNAi	  in	  C.	  elegans.	  
The	  construct	  was	  assembled	  in	  a	  pCR-­‐XL-­‐TOPO®	  (Invitrogen™	  Corporation,	  California)	  
vector.	  The	  promoter	  used	  to	  drive	  the	  expression	  of	  the	  hairpins	  was	  a	  1528bp	  fragment	  
upstream	  of	  the	  vha-­1	  gene	  and	  was	  inserted	  using	  the	  TA	  site	  of	  the	  vector.	  cDNA	  
fragments	  were	  cloned	  from	  mRNA	  prepared	  from	  wild-­‐type	  (N2)	  animals.	  Primers	  were	  
designed	  to	  amplify	  both	  a	  ~600bp	  and	  ~300bp	  reverse	  fragment	  from	  exc-­5,	  cdc-­42,	  mig-­
2,	  rho-­1,	  rac-­2,	  chw-­1,	  and	  crp-­1.	  exc-­5	  and	  cdc-­42	  fragments	  were	  successfully	  amplified	  
and	  used	  in	  subsequent	  cloning	  reactions	  as	  a	  control	  and	  test	  case,	  respectively.	  The	  
~600bp	  forward	  fragments	  were	  inserted	  at	  the	  XbaI	  site	  while	  the	  ~300bp	  reverse	  
fragments	  was	  inserted	  into	  the	  vector	  at	  the	  ApaI	  site.	  
Although	  creating	  constructs	  of	  cdc-­42	  and	  exc-­5	  that	  contained	  the	  canal-­‐specific	  Pvha-­‐1	  
promoter	  and	  the	  ~600bp	  forward	  fragment	  of	  each	  gene	  was	  made,	  cloning	  the	  smaller	  
~300bp	  inverted	  sequence	  into	  the	  construct	  was	  unsuccessful.	  Despite	  many	  attempts	  in	  
several	  bacterial	  strains,	  we	  were	  unable	  to	  retrieve	  sequences	  that	  had	  the	  sequence	  in	  an	  
inverted	  orientation.	  Clones	  were	  recovered	  that	  contained	  the	  second	  sequence	  in	  the	  
forward	  orientation,	  but	  not	  the	  reverse.	  No	  functional	  constructs	  were	  created.	  
Failure	  to	  create	  the	  canal-­‐expressed	  RNAi	  hairpin	  constructs	  was	  likely	  due	  to	  the	  length	  
of	  the	  sequence	  to	  be	  inserted	  in	  an	  inverse	  orientation.	  An	  inverted	  repeat	  of	  this	  size	  was	  
not	  accommodated	  by	  the	  bacteria	  and	  was	  heavily	  selected	  against,	  producing	  DNA	  
constructs	  that	  only	  contained	  the	  reversed	  fragment	  in	  the	  forward	  orientation.	  Future	  
work	  on	  this	  project	  would	  require	  reducing	  the	  sizes	  of	  the	  gene-­‐specific	  elements	  and	  
designing	  a	  more	  forced	  orientation	  cloning	  strategy.	  
	  
2.	  Creating	  an	  RNAi-­‐competent	  canal	  cell	  in	  an	  animal	  deficient	  in	  RNAi	  
rde-­1	  mutant	  animals	  are	  defective	  in	  RNAi	  even	  though	  they	  are	  able	  to	  produce	  siRNAs	  
(short	  interfering	  RNAs)	  from	  a	  dsRNA	  (double-­‐stranded	  RNA)	  injected	  trigger	  81,82.	  This	  
indicates	  that	  the	  animals	  are	  not	  defective	  in	  their	  systemic	  response	  to	  injected	  dsRNA,	  
but	  rather	  in	  a	  later	  process	  after	  siRNAs	  have	  been	  formed.	  We	  hypothesized	  that	  
introducing	  rde-­1	  back	  into	  the	  canal	  cell	  in	  an	  rde-­1	  mutant	  background	  would	  restore	  the	  
RNAi	  effect	  in	  the	  canal	  cell	  without	  disrupting	  other	  tissues	  of	  the	  animal.	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A	  plasmid	  containing	  the	  promoter	  for	  vha-­1	  and	  gfp	  (pCV01,	  gift	  from	  gift of T. Oka and M. 
Futai)	  was	  used	  as	  the	  backbone	  for	  canal	  expression	  of	  RDE-­‐1.	  A	  genomic	  copy	  of	  rde-­1	  
was	  amplified	  and	  inserted	  in-­‐frame	  upstream	  of	  gfp	  as	  a	  SacI-­‐AgeI	  ~3.5kb	  fragment.	  This	  
plasmid	  was	  then	  used	  for	  injection	  into	  rde-­1(ne219)	  animals.	  
High	  levels	  of	  RDE-­‐1	  expression	  (caused	  by	  injections	  of	  25ng/µl	  or	  higher	  of	  the	  construct)	  
were	  deleterious	  to	  canal	  morphology.	  Injection	  of	  lower	  concentrations	  of	  the	  construct	  
made	  GFP	  fluorescence	  almost	  undetectable.	  In	  order	  to	  identify	  transgenic	  progeny,	  a	  
second	  plasmid	  containing	  the	  promoter	  for	  CO3F11.1	  fused	  to	  GFP	  was	  used	  as	  a	  co-­‐
injection	  marker.	  This	  marker	  labels	  some	  of	  the	  head	  neurons,	  and	  does	  not	  interfere	  with	  
RDE-­‐1’s	  expression	  in	  the	  canal.	  Injection	  of	  the	  Pvha-­1::rde-­1::gfp	  construct	  at	  5ng/µl	  and	  
the	  PC03F11.1::GFP	  construct	  at	  100ng/µl	  resulted	  in	  a	  strain	  containing	  a	  stable	  high-­‐
transmission	  (~90%)	  array	  	  (BK142,	  qpEx67).	  Integration	  of	  this	  array	  through	  TMP	  
(similarly	  as	  described	  in	  Chapter	  3)	  resulted	  in	  four	  integrants:	  BK143,	  BK144,	  BK145,	  
and	  BK146.	  BK143	  was	  determined	  to	  have	  qpEx67	  integrated	  on	  chromosome	  II	  and	  used	  
for	  further	  testing.	  
Testing	  BK143	  for	  RNAi	  Sensitivity	  
The	  gene	  sma-­1	  encodes	  βH-­‐spectrin	  and	  is	  necessary	  for	  proper	  elongation	  of	  C.	  elegans	  as	  
well	  as	  the	  morphogenesis	  of	  the	  excretory	  canal	  cell	  and	  pharynx	  52.	  When	  mutated,	  sma-­1	  
creates	  defects	  in	  both	  the	  body	  of	  the	  animal	  (short	  and	  dumpy	  body	  type	  with	  a	  blunted	  
nose)	  as	  well	  as	  the	  excretory	  canal	  (shortened	  length,	  enlarged	  lumen,	  and	  occasional	  
cysts).	  Therefore,	  this	  gene	  makes	  an	  excellent	  test	  for	  a	  canal-­‐specific	  RNAi	  strain.	  If	  the	  
strain	  works,	  RNAi	  for	  sma-­1	  will	  cause	  defects	  in	  the	  canal	  but	  not	  in	  the	  body	  morphology	  
of	  the	  animal.	  	  
sma-­1	  dsRNA	  was	  produced	  by	  first	  PCR-­‐amplifying	  a	  genomic	  copy	  of	  sma-­1	  through	  use	  
of	  primers	  that	  contain	  a	  T7	  transcription	  site	  on	  both	  ends.	  This	  PCR	  product	  was	  then	  
used	  as	  a	  template	  for	  an	  in	  vitro	  transcription	  reaction	  by	  use	  of	  the	  MEGAscript®	  T7	  kit	  
(Ambion®	  Incorporated,	  Texas).	  The	  resultant	  dsRNA	  was	  then	  injected	  into	  BK143	  
animals	  in	  addition	  to	  a	  co-­‐injection	  marker,	  the	  dominant	  rol-­6	  (su1006)	  allele	  that	  causes	  
the	  animals	  to	  have	  a	  twisted	  body	  morphology	  83.	  Transgenic	  animals	  that	  showed	  a	  rol-­6	  
phenotype	  were	  examined	  for	  their	  canal	  morphology.	  Wild-­‐type	  animals	  (N2)	  were	  also	  
injected	  with	  the	  sma-­1	  dsRNA	  and	  rol-­6	  marker	  as	  a	  control.	  
Results	  
Surprisingly,	  RDE-­‐1	  had	  a	  strong	  deleterious	  affect	  on	  the	  canal	  cell.	  High	  concentrations	  
(injection	  of	  25ng/µl	  or	  greater)	  RDE-­‐1	  caused	  extremely	  shortened	  canals	  and	  a	  punctate	  
expression	  pattern	  of	  GFP	  (Fig.	  4.1).	  Even	  at	  lower	  concentrations	  (10ng/µl),some	  punctate	  
expression	  and	  luminal	  defects	  near	  the	  end	  of	  the	  canal	  were	  observed.	  At	  lower	  
concentrations	  (5ng/µl)	  most	  of	  the	  canals	  appeared	  normal	  and	  the	  punctate	  expression	  
of	  RDE-­‐1::GFP	  was	  eliminated,	  producing	  a	  continuous	  cytoplasmic	  expression	  pattern.	  
Injection	  of	  the	  sma-­1	  dsRNA	  caused	  a	  robust	  sma-­1	  phenotype	  in	  N2	  animals	  (Fig.	  4.2A).	  	  
Injection	  of	  the	  same	  sma-­1	  dsRNA	  into	  the	  BK143	  strain	  showed	  no	  RNAi	  effects	  in	  either	  
the	  body	  or	  the	  canal	  cells	  of	  the	  animals	  (Fig.	  4.2B,C).	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Figure	  4.1	  –	  Overexpression	  of	  RDE-­1	  Causes	  Canal	  Defects	  
	  
Expression	  of	  RDE-­‐1	  at	  high	  levels	  disrupts	  excretory	  canal	  morphology.	  	  (A)	  Progeny	  of	  
animals	  injected	  with	  the	  Pvha-­1::rde-­1::gfp	  construct	  at	  50ng/µl	  display	  excretory	  canals	  
that	  have	  failed	  to	  extend.	  Unlike	  the	  convoluted	  tubule	  phenotype,	  these	  canals	  display	  
defects	  at	  the	  luminal	  surface	  as	  well	  as	  the	  basal	  surface.	  RDE-­‐1::GFP	  collects	  in	  large	  
aggregates	  in	  the	  cell.	  (B)	  In	  the	  subsequent	  F2	  generation	  the	  rde-­1::gfp	  array	  shows	  
reduced	  deleterious	  effects.	  The	  canals	  extend	  further	  but	  still	  do	  not	  reach	  the	  vulva.	  	  
Expression	  of	  RDE-­‐1::GFP	  is	  still	  highly	  punctate	  and	  is	  not	  distributed	  evenly	  in	  the	  canal.	  
Canal	  morphology	  is	  still	  highly	  disrupted.	  (C)	  In	  the	  F3	  generation,	  the	  array	  exhibits	  even	  
less	  deleterious	  effects.	  Although	  short	  and	  still	  containing	  RDE-­‐1::GFP	  puncta,	  	  the	  canal	  
begins	  to	  take	  on	  normal	  morphology.	  The	  reduction	  of	  the	  RDE-­‐1	  overexpression	  
phenotype	  over	  multiple	  generations	  indicated	  that	  a	  lower	  amount	  of	  RDE-­‐1	  would	  be	  
non-­‐detrimental	  to	  the	  canal.	  (D)	  Injection	  of	  the	  Pvha-­1::rde-­1::gfp	  construct	  at	  10ng/µl	  
(along	  with	  the	  	  PC03F11.1::gfp	  construct	  at	  100ng/µl	  as	  an	  injection	  marker)	  has	  little	  effect	  
on	  canal	  morphology.	  Although	  some	  animals	  still	  have	  RDE-­‐1::GFP	  puncta,	  diffuse	  
expression	  can	  be	  seen	  in	  the	  canal.	  (E)	  In	  other	  animals,	  canal	  morphology	  is	  wild-­‐type	  
and	  expression	  of	  RDE-­‐1::GFP	  is	  continuous	  throughout	  the	  canal.	  	  (F)	  RDE-­‐1	  expression	  is	  
enriched	  at	  the	  luminal	  surface	  of	  the	  canal	  (arrow)	  and	  not	  the	  basal	  surface	  (arrowhead)	  
when	  overexpressed.	  All	  images	  are	  fluorescent	  micrographs	  taken	  of	  L4	  animals,	  except	  D.	  
The	  animal	  pictured	  in	  D	  is	  a	  young	  adult.	  Magnification	  is	  as	  labeled.
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Figure	  4.2	  –	  RNAi	  of	  sma-­1	  is	  Ineffective	  on	  Animals	  Expressing	  RDE-­1	  in	  the	  Canal	  
	  
(A)	  Injection	  of	  dsRNA	  of	  
sma-­1	  into	  a	  wild-­‐type	  
(N2)	  background	  causes	  a	  
characteristic	  body	  defect	  
(open	  arrowhead)	  in	  the	  
head	  of	  the	  animal	  to	  
produce	  a	  short	  blunt	  
nose.	  sma-­1	  RNAi	  also	  
causes	  short	  excretory	  
canals	  with	  larger	  than	  
normal	  lumen	  diameter	  
(solid	  arrowhead).	  	  
(B)	  In	  BK143,	  animals	  
express	  RDE-­‐1	  only	  in	  the	  
canal.	  sma-­1	  RNAi,	  
however,	  has	  no	  effect	  on	  
canal	  morphology	  (solid	  
arrowhead).	  	  
(C)	  In	  addition	  to	  no	  canal	  
defects,	  (solid	  
arrowheads)	  BK143	  
animals	  also	  do	  not	  display	  
the	  sma-­1	  head	  defect	  
(open	  arrowhead).	  All	  
images	  are	  of	  L4	  animals	  
at	  400x	  magnification.	  All	  
animals	  were	  co-­‐injected	  
with	  rol-­6	  as	  an	  injection	  
marker.	  This	  causes	  the	  
animals	  to	  twist	  along	  the	  
body	  axis	  which	  is	  most	  evident	  in	  animals	  pictured	  in	  B	  and	  C.	  In	  addition,	  BK143	  animals	  
contain	  the	  PC03F11.1::gfp	  construct	  that	  is	  expressed	  in	  head	  neurons	  (B,C).
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Discussion	  
RDE-­‐1	  is	  an	  Argonaute	  protein	  that	  is	  required	  to	  process	  siRNAs.	  It	  has	  an	  RNase	  H	  activity	  
that	  separates	  the	  siRNA	  duplex	  so	  that	  the	  resultant	  single-­‐stranded	  siRNAs	  can	  be	  used	  
for	  mRNA	  targeting	  84.	  It	  is	  interesting	  that	  the	  canal	  cell	  is	  sensitive	  to	  overexpression	  of	  
this	  protein.	  Parts	  of	  the	  RNAi	  mechanism,	  specifically	  those	  that	  are	  involved	  in	  miRNA	  
(micro	  RNA)	  processing	  and	  include	  the	  Argonaute	  proteins,	  are	  involved	  in	  the	  normal	  
developmental	  regulation	  of	  eukaryotes	  85,86.	  Phenotypic	  defects	  have	  normally	  been	  
associated	  with	  loss-­‐of-­‐function	  mutations	  in	  these	  proteins	  and	  their	  inability	  to	  process	  
small	  RNAs.	  rde-­1	  (ne219)	  mutants,	  however,	  show	  no	  canal	  defects	  even	  though	  they	  are	  
deficient	  in	  RNAi	  activity.	  Only	  when	  RDE-­‐1	  was	  overexpressed	  in	  the	  canal	  was	  there	  a	  
defect.	  Why	  this	  occurred	  is	  unclear.	  Perhaps	  there	  is	  an	  increase	  of	  the	  normal	  small	  RNA	  
silencing	  mechanisms	  present	  in	  the	  canal	  when	  RDE-­‐1	  is	  overexpressed.	  The	  increased	  
activity	  of	  RDE-­‐1	  may	  cause	  too	  much	  gene	  silencing	  to	  occur,	  the	  effect	  of	  which	  is	  to	  
knock	  down	  genes	  that	  are	  essential	  to	  proper	  canal	  formation	  and	  create	  morphologically	  
defective	  excretory	  canals.	  
Failure	  of	  BK143	  to	  show	  any	  RNAi	  effects	  in	  the	  canal	  may	  be	  a	  result	  of	  the	  canal	  being	  
refractory	  to	  RNAi.	  Other	  tissues,	  specifically	  neurons,	  have	  also	  been	  shown	  to	  be	  
refractory	  to	  RNAi	  effects	  87.	  	  Since	  2006,	  when	  this	  work	  was	  done,	  another	  group	  
successfully	  used	  a	  similar	  strategy	  to	  perform	  tissue-­‐specific	  RNAi	  in	  the	  muscle	  and	  
hypodermis	  of	  C.	  elegans	  88.	  This	  suggests	  that	  the	  canal	  cell	  may	  indeed	  be	  less	  susceptible	  
to	  RNAi	  than	  are	  other	  tissues.	  
There	  have	  been	  two	  methods	  successfully	  described	  for	  RNAi	  in	  neurons.	  The	  first	  is	  
similar	  to	  the	  previously	  described	  hairpin	  method.	  Instead	  of	  creating	  one	  construct	  with	  
both	  a	  forward	  and	  reverse	  element	  in	  it,	  the	  authors	  used	  two	  different	  constructs	  89.	  Both	  
had	  the	  same	  cell-­‐specific	  promoter,	  but	  one	  construct	  contained	  a	  coding	  sequence	  in	  the	  
forward	  orientation,	  while	  the	  other	  construct	  contained	  the	  coding	  sequence	  in	  a	  reverse	  
orientation;	  eliminating	  the	  problem	  of	  cloning	  an	  inverted	  repeat	  in	  a	  single	  DNA	  
construct.	  They	  then	  injected	  both	  constructs	  into	  the	  animals	  where	  they	  were	  expressed	  
only	  in	  the	  intended	  cell,	  and	  created	  a	  dsRNA	  by	  the	  transcription	  of	  separate	  but	  
complementary	  mRNAs.	  Future	  work	  to	  create	  DNA	  constructs	  that	  express	  dsRNA	  only	  in	  
the	  canal	  could	  use	  this	  method.	  
The	  second	  method	  is	  based	  on	  SID-­‐1,	  a	  dsRNA	  transporter	  required	  for	  systemic	  RNAi	  in	  C.	  
elegans	  90,91.	  Recently,	  a	  group	  showed	  that	  overexpression	  of	  SID-­‐1	  enhanced	  RNAi	  effects	  
in	  neurons	  using	  an	  RNAi	  feeding	  trigger,	  and	  that	  cell-­‐specific	  expression	  of	  SID-­‐1	  can	  
produce	  cell-­‐specific	  RNAi	  92.	  We	  have	  just	  started	  to	  implement	  this	  method	  by	  adapting	  
SID-­‐1	  expression	  only	  in	  the	  canal	  cell.	  Our	  plans	  include	  using	  this	  technique	  for	  a	  
genome-­‐wide,	  canal-­‐specific	  RNAi	  feeding	  screen.	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Chapter	  5:	  Genetic	  Interactions	  of	  exc-­5	  
	  
Abstract	  
EXC-­‐5	  is	  a	  putative	  GEF	  for	  CDC-­‐42.	  In	  addition	  to	  examining	  the	  genetic	  interactions	  
between	  these	  two	  proteins,	  we	  also	  looked	  at	  genetic	  interactions	  of	  exc-­5	  with	  mig-­2	  and	  
ced-­10,	  genes	  encoding	  Rac	  GTPases.	  	  Previous	  reports	  have	  indicated	  that	  EXC-­‐5	  interacts	  
with	  MIG-­‐2.	  In	  support	  of	  these	  previous	  observations,	  we	  found	  that	  EXC-­‐5	  shows	  
interactions	  with	  both	  CDC-­‐42	  and	  MIG-­‐2	  and	  that	  these	  interactions	  indicate	  that	  all	  three	  
proteins	  may	  work	  in	  the	  same	  pathway	  either	  directly	  or	  indirectly.	  In	  addition,	  we	  found	  
that	  EXC-­‐5	  works	  downstream	  of	  two	  other	  EXC	  proteins,	  EXC-­‐1	  and	  EXC-­‐9.	  
Rationale	  
“What	  other	  gene	  products	  interact	  with	  EXC-­‐5?”	  
The	  C.	  elegans	  genome	  contains	  seven	  members	  of	  the	  Rho-­‐family	  of	  GTPases:	  one	  Rho	  
protein	  (RHO-­‐1),	  three	  Racs	  (CED-­‐10,	  MIG-­‐2,	  RAC-­‐2),	  CDC-­‐42,	  and	  two	  CDC-­‐42-­	  related	  
proteins	  (CRP-­‐1,	  CHW-­‐1)	  93,94.	  EXC-­‐5	  is	  a	  putative	  GEF	  for	  CDC-­‐42.	  Previous	  work,	  however,	  
has	  shown	  that	  a	  gain-­‐of-­‐function	  Rac	  mutation	  (mig-­2(gm38))	  can	  also	  rescue	  the	  Exc-­‐5	  
mutant	  phenotype	  (57	  and	  personal	  observations).	  We	  examined	  the	  genetic	  interactions	  
between	  exc-­5,	  cdc-­42,	  mig-­2,	  and	  ced-­10.	  CED-­‐10	  and	  MIG-­‐2	  act	  redundantly	  in	  several	  
neuronal	  processes	  and	  both	  may	  interact	  with	  EXC-­‐5	  95.	  	  
In	  addition	  to	  our	  interest	  in	  the	  interactions	  between	  the	  RhoGTPases	  and	  EXC-­‐5,	  we	  were	  
also	  eager	  to	  explore	  the	  possible	  genetic	  interactions	  between	  other	  exc	  genes.	  While	  all	  
exc	  mutants	  cause	  cyst	  formation	  in	  the	  canal,	  the	  size	  and	  location	  of	  those	  cysts	  varies	  
depending	  on	  the	  gene	  mutated.	  Two	  of	  the	  exc	  genes,	  exc-­1	  and	  exc-­9,	  show	  very	  similar	  
mutant	  phenotypes	  to	  that	  of	  exc-­5,	  which	  indicates	  that	  they	  may	  function	  in	  the	  same	  
genetic	  pathway.	  I	  looked	  at	  the	  effects	  of	  introducing	  increased	  EXC-­‐5	  activity	  into	  several	  
other	  exc	  mutant	  strains	  to	  see	  if	  EXC-­‐5	  was	  able	  to	  alter	  the	  other	  mutant	  phenotypes.	  	  
A	  classical	  way	  to	  demonstrate	  genetic	  interactions	  between	  different	  genes	  is	  to	  look	  at	  
epistatic	  effects	  between	  them.	  In	  an	  effort	  to	  identify	  genetic	  interactions	  between	  exc-­5	  
and	  other	  RhoGTPases,	  I	  looked	  at	  animals	  containing	  mutations	  in	  a	  loss-­‐of-­‐function	  cdc-­
42	  (gk388)	  allele,	  a	  cdc-­42	  dominant-­‐negative	  (DN)	  mutation,	  a	  cdc-­42	  constitutively	  active	  
(CA)	  mutation	  (both	  generous	  gifts	  from	  E.	  Lundquist),	  a	  loss-­‐of-­‐function	  mig-­2	  (mu28)	  
allele,	  a	  gain-­‐of-­‐function	  mig-­2	  (gm38)	  allele,	  or	  a	  hypomorphic	  loss-­‐of-­‐function	  ced-­10	  
(n2993)	  allele	  in	  conjunction	  with	  exc-­5	  (rh232)	  (also	  a	  gift	  from	  E.	  Lundquist),	  and	  
recorded	  the	  changes	  in	  canal	  length	  and	  cyst	  formation.	  If	  gain-­‐of-­‐function	  mutations	  can	  
rescue	  or	  reduce	  the	  mutant	  phenotype	  of	  exc-­5	  mutant	  animals,	  it	  is	  likely	  that	  EXC-­‐5	  is	  
working	  upstream	  of	  these	  gain-­‐of-­‐function	  proteins.	  If	  combinations	  of	  other	  knockout	  or	  
knockdown	  mutations	  can	  increase	  the	  severity	  of	  the	  EXC-­‐5	  mutant	  phenotype	  and	  
produce	  a	  synergistic	  effect,	  then	  the	  two	  mutations	  may	  act	  in	  separate	  parallel	  pathways	  
or	  have	  redundant	  roles.	  If	  there	  is	  no	  synergistic	  effect	  when	  combined	  with	  other	  loss-­‐of-­‐
function	  alleles,	  then	  it	  is	  likely	  that	  the	  two	  mutations	  are	  in	  the	  same	  pathway.	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Overexpression	  of	  EXC-­‐5	  or	  EXC-­‐9	  causes	  convoluted	  tubules;	  a	  phenotype	  where	  the	  
lumen	  of	  the	  canal	  forms	  properly	  but	  the	  basal	  surface	  of	  the	  canal	  does	  not	  extend,	  which	  
causes	  the	  lumen	  to	  become	  convoluted	  within	  the	  smaller	  and	  now	  spherically	  shaped	  
canal	  cell	  51,57,	  (Fig.	  8).	  If	  overexpression	  of	  EXC-­‐5	  in	  the	  mutant	  cystic	  strains	  causes	  a	  
convoluted	  tubule	  phenotype,	  it	  may	  indicate	  that	  EXC-­‐5	  is	  working	  downstream	  of	  the	  
mutant	  gene,	  as	  excess	  EXC-­‐5	  activity	  is	  epistatic	  to	  the	  other	  mutation	  and	  can	  override	  
that	  mutant’s	  cystic	  phenotype.	  If	  overexpression	  of	  EXC-­‐5	  in	  a	  mutant	  strain	  does	  not	  
cause	  a	  convoluted	  tubule	  phenotype,	  then	  EXC-­‐5	  may	  work	  upstream	  of	  the	  mutation.	  
Materials	  and	  Methods	  
Strains	  Used	  
The	  gk388,	  mu28,	  and	  gm38	  alleles	  were	  provided	  by	  the	  Caenorhabditis	  Genetics	  Center.	  
The	  ced-­10	  (n2993),	  exc-­5	  (rh232)	  double	  mutant	  was	  made	  by	  E.	  Struckhoff	  and	  was	  a	  gift	  
from	  E.	  Lundquist.	  Animals	  containing	  the	  cdc-­42	  DN	  or	  CA	  construct	  had	  an	  unstable	  
transgenic	  array	  containing	  the	  gene.	  All	  strains	  except	  for	  those	  with	  the	  gk388	  allele	  also	  
contained	  qpIs11.	  
DNA	  Constructs	  
Plasmids	  containing	  constructs	  expressing	  constitutively	  active	  (CA,	  G12V)	  and	  dominant-­‐
negative	  (DN,	  T17N)	  forms	  of	  nematode	  cdc-­42	  were	  the	  gift	  of	  E.	  Lundquist.	  	  A	  1.2kb	  NheI	  
fragment	  was	  amplified	  from	  these	  plasmids	  containing	  cdc-­42	  and	  re-­‐cloned	  by	  use	  of	  
standard	  molecular	  techniques	  into	  plasmid	  L3691	  (gift	  from	  L.	  Timmons)	  which	  N-­‐
terminally	  labels	  the	  cdc-­42	  gene	  with	  gfp.	  
To	  overexpress	  EXC-­‐5,	  a	  plasmid	  containing	  the	  genomic	  copy	  of	  exc-­5	  under	  its	  native	  
promoter	  with	  a	  C-­‐terminal	  GFP	  tag	  was	  injected	  into	  mutant	  strains	  (See	  Chapter	  3	  for	  
construct	  details).	  
Measurement	  of	  Canals	  
Methods	  describing	  the	  measurement	  of	  the	  excretory	  canal	  cell	  can	  be	  found	  in	  the	  
Materials	  and	  Methods	  section	  in	  Chapter	  2,	  “Characterizing	  the	  Cystic	  Phenotype	  between	  
Animals”	  and	  in	  Figure	  Legend	  2.2.	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Results	  
Injection	  of	  a	  cdc-­42	  dominant-­‐negative	  or	  constitutively	  active	  construct	  caused	  significant	  
changes	  in	  canal	  morphology	  in	  a	  wild-­‐type	  background	  	  (Table	  5.1).	  The	  gain-­‐of-­‐function	  
cdc-­42	  (CA)	  transgene	  caused	  a	  high	  percentage	  (>80%)	  of	  animals	  to	  show	  a	  shortened	  
and	  convoluted	  tubule	  phenotype.	  The	  cdc-­42	  (DN)	  transgene	  caused	  over	  half	  the	  animals	  
(56%)	  to	  develop	  cysts.	  These	  effects	  mimic	  exc-­5	  gain-­‐of-­‐function	  and	  loss-­‐of-­‐function	  
phenotypes	  in	  wild-­‐type	  worms,	  and	  are	  consistent	  with	  the	  hypothesis	  that	  CDC-­‐42	  and	  
EXC-­‐5	  function	  in	  the	  same	  pathway.	  Interestingly,	  the	  cdc-­42	  (gk388)	  mutation	  does	  not	  
produce	  cysts	  in	  the	  canal	  (Table	  5.1,	  Fig.	  5.1).	  	  
Expression	  of	  CDC-­‐42	  (CA)	  caused	  the	  same	  number	  of	  convoluted	  canals	  in	  an	  exc-­5	  
(rh232)	  mutant	  background	  as	  it	  did	  when	  expressed	  in	  a	  wild-­‐type	  background	  
(>80%)(Table	  5.1).	  This	  convolution	  phenotype	  induced	  by	  CDC-­‐42	  (CA)	  appears	  to	  be	  
independent	  of	  cyst	  formation	  and	  the	  length	  of	  the	  canal.	  Convolutions	  occurred	  near	  the	  
cell	  body,	  but	  did	  not	  alter	  canal	  length,	  nor	  the	  number	  or	  sizes	  of	  cysts.	  This	  result	  
indicates	  that	  excess	  CDC-­‐42	  activity	  is	  unable	  to	  compensate	  for	  the	  lack	  of	  EXC-­‐5	  activity	  
in	  cyst	  formation,	  but	  can	  still	  cause	  convoluted	  lumen	  defects	  by	  itself.	  	  
Expression	  of	  	  the	  CDC-­‐42	  (DN)	  construct	  in	  the	  exc-­5(rh232)	  background	  showed	  a	  small	  
increase	  in	  the	  average	  number	  of	  cysts	  but	  did	  not	  increase	  cyst	  size.	  Similarly,	  the	  gk388	  
cdc-­42	  mutant	  allele	  in	  combination	  with	  exc-­5(rh232)	  also	  increased	  the	  average	  number	  
of	  cysts.	  The	  gk388	  allele,	  however,	  did	  slightly	  increase	  cyst	  size	  in	  the	  rh232	  background	  
(Table	  5.1).	  Overall,	  expression	  of	  CDC-­‐42	  (DN)	  or	  the	  combination	  of	  the	  gk388	  allele	  did	  
not	  have	  large	  effects	  on	  the	  rh232	  phenotype.	  The	  results	  from	  the	  loss-­‐of-­‐function	  CDC-­‐42	  
mutations	  indicate	  that	  CDC-­‐42	  and	  EXC-­‐5	  may	  work	  in	  the	  same	  pathway,	  as	  the	  cystic	  
phenotype	  does	  not	  get	  significantly	  worse	  in	  combination	  with	  rh232.	  In	  addition,	  the	  
convoluting	  effect	  that	  expression	  of	  CDC-­‐42	  (CA)	  had	  even	  in	  the	  absence	  of	  EXC-­‐5	  activity	  
would	  indicate	  that	  CDC-­‐42	  acts	  downstream	  of	  EXC-­‐5.	  Contradicting	  this,	  however,	  is	  the	  
result	  that	  CDC-­‐42	  (CA)	  does	  not	  have	  as	  severe	  a	  convoluted	  tubule	  phenotype	  and	  does	  
not	  shorten	  canals	  like	  EXC-­‐5	  overexpression	  does.	  In	  addition,	  the	  CA	  activity	  of	  CDC-­‐42	  
does	  not	  rescue	  the	  cystic	  phenotype	  of	  rh232	  animals.	  This	  last	  result	  indicates	  that	  EXC-­‐5	  
may	  additionally	  function	  with	  another	  GTPase	  such	  as	  MIG-­‐2.	  	  
mig-­2	  (mu28)	  and	  ced-­10	  (n2993)	  mutations	  have	  not	  been	  reported	  to	  exhibit	  cystic	  
phenotypes	  96(personal	  observations).	  A	  mig-­2	  (mu28);	  exc-­5	  (rh232)	  double	  mutant	  
animal	  shows	  a	  slight	  lengthening	  of	  the	  canal	  but	  no	  large	  differences	  in	  cyst	  formation	  
from	  that	  of	  the	  rh232	  background	  (Table	  5.1).	  	  The	  gain-­‐of-­‐function	  mig-­2	  allele	  gm38	  does	  
not	  show	  any	  large	  effects	  with	  rh232	  except	  in	  the	  number	  of	  canals	  that	  had	  cysts,	  
reducing	  the	  normally	  100%	  cystic	  phenotype	  to	  93.6%.	  It	  should	  also	  be	  noted	  that	  4%	  (4	  
out	  of	  94)	  of	  the	  canals	  showed	  a	  complete	  rescue	  by	  being	  both	  full-­‐length	  and	  having	  no	  
cysts.	  This	  rescue	  was	  not	  observed	  in	  other	  strains	  tested.	  This	  indicates	  that	  although	  
mig-­2	  may	  not	  have	  a	  highly	  penetrant	  effect	  on	  exc-­5,	  it	  is	  capable	  of	  fully	  rescuing	  rh232	  
defects.	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Table	  5.1.	  	  Effects	  of	  other	  mutations	  on	  excretory	  canal	  phenotypea 
 











# Cystsf Small Medium Large 
N2  (Wild-type)  100 0 4.0 0     
VC898 cdc-42 (gk388) 24 0 4.0 0     
Trans. Express.:  
gfp::CA cdc-42; N2 84 83.3 2.7 1.2 0 1.0 0 0 
Trans. Express.:  
               gfp::DN cdc-42; N2 48 0 3.1 56.3 2.8 2.6 0.2 0 
NJ731 exc-5 (rh232) mutants 96 0 1.2 100 8.6 7.5 1.7 1.1 
cdc-42 (gk388); exc-5 (rh232) 39 0 1.1 97.4 12.0 10.7 2.3 1.4 
Trans. Express.: 
gfp::CA cdc-42; exc-5 (rh232) 54 81.5 1.6 100 8.0 6.7 1.0 0.3 
Trans. Express.: 
gfp::DN cdc-42; exc-5 (rh232) 42 0 1.6 100 11.7 9.7 1.5 0.5 
mig-2 (mu28); exc-5 (rh232) 44 0 2.3 97.7 7.9 6.9 1.9 1.1 
mig-2 (gm38); exc-5 (rh232) 94 0 2.1 93.6 7.1 6.7 1.7 1.3 
ced-10 (n2993) exc-5 (rh232)  47 0 1.7 97.9 22 20 3.2 1.3 
 
aSubstantial increases in cyst number or size from those of controls are indicated in boldface.  
Increases in number of convoluted tubules and decreases in number of cysts are underlined. 
bNumber of canals examined.   
cPercentage of canals that exhibited a lumen that traversed itself more than once.   
dAverage canal length relative to body length as described in Materials & Methods; 0 means no 
canal growth, 4 is full-length. 
ePercentage of canals that exhibited any visible cysts at all. 
fAverage number of cysts observed for all animals 
gAverage number of large, medium, and small cysts (size determined as described in Materials & 
Methods) seen for animals exhibiting cysts. 
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Contrary	  to	  the	  other	  strains	  tested,	  a	  ced-­10	  (n2993)	  exc-­5	  (rh232)	  double	  mutant	  showed	  
significant	  increases	  in	  the	  number	  of	  cysts	  formed	  in	  each	  canal.	  The	  double	  mutant	  
roughly	  doubled	  the	  total	  number	  of	  cysts	  in	  these	  animals	  (Table	  5.1).	  This	  doubling	  in	  
cyst	  number	  was	  due	  to	  the	  increase	  in	  both	  small	  and	  medium	  sized	  cysts.	  These	  results	  
indicate	  that	  in	  the	  excretory	  canal	  cell	  CED-­‐10	  and	  EXC-­‐5	  may	  have	  separate	  but	  
overlapping	  roles	  in	  maintaining	  the	  integrity	  of	  the	  canal’s	  tubular	  structure.	  	  
Injection	  of	  the	  exc-­5::gfp	  construct	  at	  20-­‐25ng/µl	  into	  both	  exc-­1	  (rh26)	  and	  exc-­9	  (n2669)	  
mutants	  resulted	  in	  >90%	  of	  transgenic	  animals	  showing	  a	  convoluted	  tubule	  phenotype	  51,	  
(personal	  observations).	  In	  contrast,	  injection	  of	  the	  exc-­5::gfp	  construct	  into	  exc-­4	  (rh133)	  
and	  exc-­3	  (rh251)	  animals	  resulted	  in	  transgenic	  animals	  that	  were	  still	  mutant	  for	  their	  
respective	  phenotypes.	  Very	  few	  transgenic	  animals	  were	  obtained	  from	  both	  exc-­4	  and	  
exc-­3	  mutant	  backgrounds,	  however	  (one	  animal	  per	  30-­‐40	  animals	  injected),	  and	  injection	  
of	  the	  exc-­5::gfp	  construct	  into	  these	  strains	  may	  be	  causing	  a	  higher	  than	  normal	  toxic	  
effect.	  This	  was	  most	  obvious	  in	  the	  sma-­1	  (ru18)	  background	  where	  injecting	  exc-­5::gfp	  at	  
25ng/µl	  into	  27	  animals	  resulted	  in	  100%	  lethality	  in	  transgenic	  animals;	  8	  dead	  embryos	  
and	  24	  animals	  died	  as	  L1’s.	  
	  
Discussion	  
Although	  gk388	  is	  a	  presumably	  null	  allele	  of	  cdc-­42	  (it	  contains	  a	  478bp	  deletion	  that	  
includes	  a	  portion	  of	  upstream	  sequence	  as	  well	  as	  the	  first	  two	  exons	  96),	  animals	  
homozygous	  for	  the	  deletion	  survive	  into	  adulthood.	  These	  animals	  are	  sterile,	  however,	  
and	  the	  deletion	  must	  be	  maintained	  as	  a	  heterozygote.	  Because	  animals	  homozygous	  for	  
the	  cdc-­42	  deletion	  arise	  through	  a	  mother	  that	  had	  functional	  CDC-­‐42	  and	  are	  able	  to	  
survive,	  it	  is	  likely	  that	  there	  is	  a	  significant	  maternal	  effect	  in	  the	  animals	  homozygous	  for	  
the	  cdc-­42	  deletion.	  This	  residual	  CDC-­‐42	  activity	  may	  be	  sufficient	  to	  allow	  normal	  
development	  and	  maintenance	  of	  the	  excretory	  canals.	  Although	  there	  were	  cysts	  that	  
appeared	  in	  these	  animals,	  they	  did	  not	  appear	  directly	  connected	  to	  the	  lumen	  of	  the	  canal	  
(Fig.	  5.1B).	  Canal-­‐specific	  RNAi	  of	  cdc-­42	  would	  be	  most	  useful	  here	  in	  order	  to	  avoid	  the	  
lethality	  and	  gross	  body	  morphology	  defects	  associated	  with	  cdc-­42	  loss-­‐of-­‐function	  in	  the	  
entire	  animal,	  and	  to	  examine	  more	  closely	  what	  perturbations	  there	  would	  be	  on	  the	  canal	  
when	  cdc-­42	  activity	  is	  eliminated.	  
In	  lieu	  of	  such	  a	  system,	  expression	  of	  a	  DN	  CDC-­‐42	  only	  in	  the	  canal	  should	  be	  able	  to	  
interfere	  with	  normal	  cdc-­42	  activity	  and	  possibly	  mimic	  a	  cdc-­42	  loss-­‐of-­‐function	  
mutation.	  Indeed,	  expression	  of	  cdc-­42	  DN	  in	  the	  canal	  caused	  a	  mild	  shortening	  of	  the	  
canal,	  as	  well	  as	  cysts	  in	  slightly	  over	  half	  of	  the	  animals.	  Animals	  that	  did	  have	  cysts	  had	  
only	  a	  few	  and	  none	  of	  them	  were	  very	  large	  (Table	  5.1).	  These	  effects	  are	  much	  more	  mild	  
than	  are	  the	  effects	  of	  an	  exc-­5	  null	  mutation	  and	  may	  indicate	  that	  CDC-­‐42	  is	  not	  the	  only	  
downstream	  target	  of	  EXC-­‐5.	  Alternatively,	  the	  CDC-­‐42	  DN	  activity	  may	  not	  be	  as	  strong	  as	  
a	  genuine	  null	  mutation	  of	  cdc-­42	  would	  be,	  and	  the	  effects	  of	  the	  DN	  form	  are	  similarly	  less	  
severe.	  Nevertheless,	  impairing	  CDC-­‐42	  activity	  did	  show	  a	  similar	  effect	  to	  that	  of	  
knocking	  out	  EXC-­‐5,	  which	  indicates	  that	  the	  proteins	  may	  be	  working	  together	  in	  the	  same	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pathway.	  This	  conclusion	  is	  supported	  by	  the	  fact	  that	  introducing	  CDC-­‐42	  DN	  activity	  in	  
animals	  already	  deleted	  for	  exc-­5	  shows	  no	  significant	  change	  in	  the	  phenotype.	  
The	  result	  from	  introducing	  a	  CA	  cdc-­42	  transgene	  into	  wild-­‐type	  animals	  mimicked,	  but	  
was	  not	  the	  same	  as,	  overexpressing	  exc-­5.	  Canals	  showed	  convolutions,	  but	  these	  were	  not	  
as	  severe	  or	  as	  shortened	  as	  they	  are	  in	  animals	  overexpressing	  a	  similar	  amount	  of	  EXC-­‐5.	  
These	  convolutions	  were	  present	  even	  in	  animals	  that	  had	  no	  EXC-­‐5	  activity,	  which	  does	  
indicate	  that	  CDC-­‐42	  may	  be	  acting	  downstream	  of	  EXC-­‐5.	  However,	  CDC-­‐42	  CA	  was	  unable	  
to	  rescue	  the	  cystic	  phenotype	  of	  the	  exc-­5	  null	  mutation.	  This	  result	  makes	  interpretation	  
difficult.	  One	  reason	  for	  the	  apparent	  discrepancy	  may	  be	  due	  to	  the	  importance	  of	  CDC-­‐42	  
cycling	  between	  its	  inactive	  GDP-­‐bound	  state	  and	  its	  active	  GTP-­‐bound	  state	  in	  order	  to	  
maintain	  its	  wild-­‐type	  effects	  97,98.	  Forcing	  a	  significant	  amount	  of	  CDC-­‐42	  into	  either	  a	  CA	  
or	  DN	  state	  may	  not	  accurately	  reflect	  the	  wild-­‐type	  activity	  of	  activated	  or	  inactivated	  
CDC-­‐42	  when	  it	  is	  allowed	  to	  cycle	  between	  these	  two	  states.	  
	  
If	  these	  constructs	  are	  accurately	  reflecting	  CDC-­‐42	  loss-­‐	  and	  gain-­‐of-­‐function	  properties,	  
and	  if	  CDC-­‐42	  were	  working	  downstream	  of	  EXC-­‐5,	  then	  providing	  more	  CDC-­‐42	  activity	  
would	  restore	  normal	  function	  of	  the	  canal.	  This	  is	  not	  the	  case.	  Instead,	  these	  data	  indicate	  
that	  rather	  than	  working	  directly	  with	  EXC-­‐5,	  CDC-­‐42	  is	  working	  only	  in	  part	  with	  EXC-­‐5.	  
They	  both	  function	  in	  the	  same	  pathway	  to	  create	  convolutions	  but	  work	  independently	  
during	  cyst	  formation.	  	  This	  is	  partially	  supported	  by	  the	  genetic	  effects	  seen	  with	  mig-­2.	  
	  
Mutation	  of	  mig-­2	  seems	  to	  have	  little	  or	  no	  synergistic	  effect	  with	  EXC-­‐5,	  	  nor	  does	  it	  show	  
any	  increase	  in	  the	  cystic	  phenotype	  of	  rh232.	  Taken	  together,	  these	  results	  indicate	  that	  
these	  two	  proteins	  may	  act	  in	  the	  same	  pathway.	  Additionally,	  when	  a	  gain-­‐of-­‐function	  
allele	  of	  mig-­2	  (gm38)	  is	  present	  with	  the	  exc-­5	  (rh232)	  null	  allele,	  a	  very	  low	  percentage	  of	  
canals	  show	  full	  rescue.	  Though	  the	  effect	  is	  small,	  the	  ability	  to	  rescue	  rh232	  is	  not	  present	  
in	  animals	  containing	  a	  CA	  copy	  of	  cdc-­42.	  Consistent	  with	  EXC-­‐5	  acting	  with	  MIG-­‐2	  only	  
partially,	  the	  mig-­2	  loss-­‐of-­‐function	  mu28	  allele	  is	  not	  sufficient	  to	  cause	  cysts	  to	  form	  in	  the	  
canal.	  This	  is	  similar	  to	  what	  is	  seen	  with	  the	  cdc-­42	  (gk388)	  allele.	  It	  would	  be	  interesting	  
to	  see	  whether	  a	  double	  mutant	  of	  cdc-­42	  and	  mig-­2	  would	  cause	  cysts	  to	  form	  in	  the	  canal.	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Figure	  5.1	  –	  cdc-­42	  (gk388)	  Mutants	  do	  Not	  form	  Cysts	  in	  the	  Canal	  
	  
DIC	  images	  of	  young	  adult	  animals	  homozygous	  for	  the	  cdc-­42	  (gk388)	  loss-­‐of-­‐function	  
allele	  taken	  at	  630x	  magnification.	  (A)	  Animals	  mutant	  for	  CDC-­‐42	  do	  not	  display	  
significant	  canal	  defects	  (solid	  arrowheads).	  (B)	  Occasionally	  these	  animals	  develop	  cysts	  
(open	  arrowheads;	  2/24	  animals	  observed).	  These	  cysts,	  however,	  do	  not	  appear	  to	  be	  
connected	  to	  the	  excretory	  canal	  (solid	  arrowheads).	  
	   60	  
	  
	   	  
The	  ced-­10	  (n2993)	  exc-­5	  (rh232)	  strain	  showed	  a	  significant	  increase	  in	  cyst	  formation	  
over	  that	  of	  the	  rh232	  background.	  The	  fact	  that	  knocking	  down	  CED-­‐10	  function	  in	  an	  
animal	  that	  has	  no	  EXC-­‐5	  activity	  produces	  a	  different	  phenotype	  means	  that	  CED-­‐10	  is	  not	  
dependent	  on	  EXC-­‐5	  activity	  in	  order	  to	  function.	  At	  the	  same	  time,	  it	  also	  indicates	  that	  
CED-­‐10	  activity	  does	  help	  maintain	  the	  excretory	  canal	  shape	  in	  the	  absence	  of	  EXC-­‐5.	  Since	  
ced-­10	  mutations	  alone	  have	  not	  been	  shown	  to	  cause	  cysts	  in	  the	  canal,	  CED-­‐10	  function	  
must	  not	  be	  necessary	  to	  prevent	  cysts	  from	  developing.	  Its	  synergistic	  effect	  with	  exc-­5	  
however,	  shows	  that	  there	  must	  be	  a	  small	  amount	  of	  activity	  in	  maintaining	  the	  integrity	  
of	  the	  canal	  lumen.	  One	  possible	  explanation	  is	  that	  EXC-­‐5	  and	  CED-­‐10	  work	  in	  different,	  
but	  slightly	  overlapping	  pathways	  in	  that	  they	  both	  contribute	  to	  the	  lumen’s	  structural	  
integrity	  by	  maintaining	  the	  actin	  cytoskeleton.	  In	  the	  absence	  of	  CED-­‐10’s	  normal	  activity	  
to	  help	  reinforce	  the	  integrity	  of	  the	  canal	  lumen,	  the	  exc-­5	  mutation	  causes	  more	  cysts	  
than	  normal	  to	  form	  in	  the	  canal	  due	  to	  its	  weakened	  state.	  	  
	  
Injection	  of	  an	  exc-­5::gfp	  construct	  into	  other	  exc	  mutants	  showed	  that	  EXC-­‐5	  activity	  is	  
working	  downstream	  of	  both	  exc-­1	  and	  exc-­9.	  EXC-­‐9	  is	  a	  homologue	  of	  the	  intestinal	  
protein	  CRIP	  whose	  specific	  biological	  function	  is	  unclear	  except	  for	  the	  fact	  that	  it	  is	  
required	  to	  maintain	  the	  structure	  of	  the	  canal	  51.	  EXC-­‐1	  has	  recently	  been	  cloned	  by	  fellow	  
lab	  member	  Kelly	  Grussendorf	  and	  shows	  highest	  homology	  to	  a	  part	  of	  the	  Ras	  GTPase	  
domain	  of	  IIGP	  (personal	  communication).	  It	  is	  unclear	  how	  these	  three	  proteins	  interact	  
and	  whether	  they	  are	  acting	  directly	  or	  indirectly	  with	  each	  other.	  Future	  plans	  include	  
using	  a	  yeast	  two-­‐hybrid	  assay	  to	  test	  whether	  EXC-­‐5,	  EXC-­‐9,	  and	  EXC-­‐1	  can	  bind	  to	  each	  
other	  directly.	  
	  
Our	  model	  of	  EXC-­‐5	  interacting	  with	  both	  CDC-­‐42	  and	  MIG-­‐2	  is	  consistent	  with	  previous	  
work	  showing	  that	  FGD1	  and	  Frabin	  (mammalian	  homologues	  of	  EXC-­‐5)	  activity	  is	  
mediated	  in	  both	  a	  CDC-­‐42-­‐dependent	  and	  -­‐independent	  manner,	  and	  that	  their	  interaction	  
with	  Rac	  proteins	  is	  indirect	  77,78.	  In	  the	  next	  chapter,	  I	  discuss	  how	  EXC-­‐5	  is	  involved	  in	  
membrane	  trafficking.	  Interestingly,	  the	  intracellular	  trafficking	  of	  Rac	  has	  been	  shown	  to	  
be	  involved	  in	  the	  actin	  dynamics	  that	  control	  cell	  morphology	  18.	  Providing	  an	  excess	  of	  
MIG-­‐2	  activity	  may	  be	  able	  to	  compensate	  for	  the	  lack	  of	  its	  activation	  and	  transport	  to	  the	  
apical	  surface	  in	  an	  rh232	  mutant.	  In	  addition	  to	  creating	  a	  double	  mutant	  of	  cdc-­42	  and	  
mig-­2	  to	  see	  if	  there	  are	  any	  synergistic	  effects,	  future	  work	  could	  include	  using	  an	  
antibody	  to	  activated	  MIG-­‐2	  and	  comparing	  its	  distribution	  in	  the	  canal	  cell	  in	  both	  wild-­‐
type	  and	  rh232	  animals.	  Activated	  MIG-­‐2	  should	  be	  enriched	  at	  the	  apical	  surface	  in	  wild-­‐
type	  animals	  in	  this	  model.	  In	  rh232	  mutants,	  MIG-­‐2	  may	  not	  be	  activated	  on	  the	  early	  
endosomes	  as	  it	  normally	  should	  be,	  and	  therefore	  not	  be	  able	  to	  recycle	  back	  to	  the	  apical	  
surface	  where	  it	  is	  needed	  to	  help	  reinforce	  the	  actin	  cytoskeleton	  in	  order	  to	  prevent	  cyst	  
formation.	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Chapter	  6:	  Organization	  of	  Subcellular	  Organelles	  within	  the	  Excretory	  
Canal	  and	  in	  exc-­5	  Mutants	  
	  
The	  bulk	  of	  this	  chapter	  has	  been	  submitted	  as	  a	  manuscript	  with	  the	  title	  “The	  FGD	  
Homologue	  EXC-­‐5	  Regulates	  Apical	  Trafficking	  in	  C.	  elegans	  Tubules”,	  authors	  B.	  Mattingly	  
and	  M.	  Buechner.	  
Abstract	  
Due	  to	  the	  ability	  of	  EXC-­‐5	  to	  alter	  both	  the	  apical	  and	  basal	  surfaces	  of	  the	  canal	  as	  well	  as	  
its	  interactions	  with	  CDC-­‐42,	  we	  hypothesized	  that	  EXC-­‐5	  may	  direct	  trafficking	  inside	  the	  
excretory	  canal	  cell.	  We	  examined	  the	  effects	  of	  altering	  expression	  levels	  of	  exc-­5	  on	  the	  
distribution	  of	  fluorescently-­‐marked	  subcellular	  organelles.	  	  In	  exc-­5	  mutants,	  early	  
endosomes	  build	  up	  in	  the	  cell,	  especially	  in	  areas	  close	  to	  cysts,	  while	  recycling	  endosomes	  
are	  depleted.	  	  Endosome	  morphology	  changes	  prior	  to	  cyst	  formation.	  	  Conversely,	  when	  
exc-­5	  is	  overexpressed,	  recycling	  endosomes	  are	  enriched.	  	  Since	  FGD	  proteins	  activate	  the	  
small	  GTPases	  CDC42	  and	  Rac,	  these	  results	  support	  the	  hypothesis	  that	  EXC-­‐5	  acts	  
through	  small	  GTPases	  to	  move	  material	  from	  apical	  early	  endosomes	  to	  recycling	  
endosomes,	  and	  that	  loss	  of	  such	  movement	  is	  likely	  the	  cause	  of	  tubule	  deformation	  both	  
in	  nematodes	  and	  in	  tissues	  affected	  by	  FGD	  dysfunction	  such	  as	  Charcot-­‐Marie-­‐Tooth	  
Syndrome	  type	  4H.	  
Rationale	  
“How	  does	  EXC-­‐5	  affect	  the	  cellular	  processes	  of	  the	  canal	  in	  order	  to	  form	  cysts	  and	  
convoluted	  tubules?”	  
By	  comparing	  the	  loss-­‐of-­‐function	  and	  gain-­‐of-­‐function	  phenotypes	  for	  EXC-­‐5,	  it	  is	  clear	  
that	  EXC-­‐5	  has	  complementary	  effects	  on	  the	  apical	  and	  basal	  surfaces	  of	  the	  canal.	  This	  
characteristic	  immediately	  brings	  to	  mind	  cell	  polarization.	  In	  exc-­5	  mutants,	  however,	  
there	  appears	  to	  be	  no	  defects	  in	  the	  initial	  polarization	  of	  the	  cell.	  The	  excretory	  canal	  
initially	  forms	  normally	  in	  rh232	  mutants,	  and	  in	  EXC-­‐5-­‐overexpressing	  animals	  there	  
appears	  to	  be	  no	  defects	  in	  the	  differentiation	  between	  the	  apical	  and	  basal	  surfaces.	  Due	  to	  
our	  observations	  that	  cell	  polarization	  does	  not	  seem	  to	  be	  grossly	  affected	  in	  the	  canal	  cell,	  
that	  CDC-­‐42	  interacts	  with	  EXC-­‐5	  and	  that	  CDC-­‐42	  is	  closely	  associated	  with	  intracellular	  
transport,	  and	  that	  other	  mutations	  that	  cause	  Charcot-­‐Marie-­‐Tooth-­‐Syndrome	  type	  4H	  are	  
in	  transport	  proteins,	  we	  hypothesized	  that	  EXC-­‐5	  may	  be	  involved	  in	  directing	  
intracellular	  transport.	  
Supporting	  this	  hypothesis	  are	  the	  effects	  seen	  with	  EXC-­‐5	  homologues.	  All	  FGD	  proteins	  
contain	  a	  FYVE	  domain	  that	  binds	  to	  PI3P,	  a	  phospholipid	  characteristic	  of	  early	  
endosomes	  63.	  In	  addition,	  FGD1	  is	  associated	  with	  transport	  from	  the	  trans-­‐Golgi	  network	  
72,99	  as	  well	  as	  being	  located	  on	  the	  plasma	  membrane	  72.	  FGD2	  is	  associated	  with	  early	  
endosomes	  100.	  Even	  other	  proteins	  involved	  in	  Charcot-­‐Marie-­‐Tooth	  syndrome	  are	  
necessary	  for	  proper	  membrane	  trafficking	  101-­‐103.	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In	  order	  to	  understand	  the	  subcellular	  processes	  that	  underlie	  the	  cystic	  and	  convoluted	  
tubule	  phenotypes	  we	  observe	  when	  EXC-­‐5	  activity	  is	  either	  lost	  or	  overexpressed,	  we	  
created	  a	  set	  of	  excretory	  canal	  markers	  to	  label	  various	  subcellular	  compartments.	  	  We	  
found	  that	  within	  the	  excretory	  canals,	  the	  number	  and	  distribution	  of	  several	  of	  the	  
compartments	  depended	  heavily	  on	  normal	  levels	  of	  EXC-­‐5.	  	  The	  most	  strongly	  affected	  
compartments	  were	  the	  early	  endosomes	  and	  recycling	  endosomes.	  	  In	  addition,	  
expression	  of	  a	  fragment	  of	  WSP-­‐1	  that	  binds	  to	  activated	  CDC-­‐42	  (the	  G-protein-binding 
domain)	  caused	  similar	  effects	  on	  canal	  structure	  as	  did	  expression	  of	  EXC-­‐5.	  	  These	  results	  
support	  the	  hypothesis	  that	  EXC-­‐5	  and	  other	  FGD	  proteins	  modulate	  small	  GTPase	  activity	  
to	  move	  material	  from	  early	  endosomes	  to	  recycling	  endosomes,	  and	  this	  movement	  
maintains	  the	  structure	  of	  the	  apical	  surface	  of	  these	  epithelia.	  
	  
Materials	  and	  Methods	  
Nematode	  Genetics	  
C.	  elegans	  mutants	  were	  derived	  from	  the	  N2	  Bristol	  strain	  background.	  	  All	  strains	  were	  
grown	  on	  E.	  coli	  strain	  BK16	  (a	  Streptomycin-­‐resistant	  derivative	  of	  OP50)	  and	  maintained	  
as	  described	  43.	  
DNA	  Constructs	  
The	  exc-­5::gfp	  construct	  was	  a	  gift	  from	  K.	  Matsumoto.	  	  It	  contains	  12.6kb	  of	  genomic	  DNA	  
comprised	  of	  7.2kb	  of	  upstream	  sequence	  from	  exc-­5	  and	  5.3kb	  of	  exc-­5	  coding	  region	  
placed	  into	  pPD95.75	  (gift	  from	  A.	  Fire)	  in	  front	  of	  the	  gfp	  gene	  and	  an	  unc-­54	  3’	  UTR.	  
Plasmid	  pCV01	  is	  the	  generous	  gift	  of	  T.	  Oka	  and	  M.	  Futai,	  and	  contains	  the	  promoter	  for	  
vha-­1	  in	  front	  of	  gfp	  104;	  this	  construct	  is	  strongly	  expressed	  in	  the	  excretory	  canal	  cell	  and	  
head	  mesodermal	  cell.	  	  Nematode	  lines	  BK30	  and	  BK36	  contain	  a	  stable	  integration	  
(qpIs11)	  of	  pCVO1	  together	  with	  the	  unc-­119	  gene,	  transformed	  into	  unc-­119	  animals	  that	  
were	  either	  wild-­‐type	  (BK36)	  or	  exc-­5(rh232)	  (BK36)	  for	  canal	  morphology,	  via	  biolistic	  
transformation	  by	  the	  method	  of	  105.	  	  Each	  integrant	  was	  outcrossed	  at	  least	  5	  times.	  	  For	  
BK36,	  the	  site	  of	  integration	  was	  mapped	  to	  LG	  I.	  
Plasmids	  containing	  constructs	  expressing	  constitutively	  active	  (CA,	  G12V)	  and	  dominant-­‐
negative	  (DN,	  T17N)	  forms	  of	  nematode	  cdc-­42	  were	  the	  gift	  of	  E.	  Lundquist.	  	  A	  1.2kb	  NheI	  
fragment	  was	  amplified	  from	  these	  plasmids	  containing	  cdc-­42	  and	  re-­‐cloned	  into	  L3691	  
(gift	  from	  L.	  Timmons),	  N-­‐terminally	  labeling	  the	  cdc-­42	  gene	  with	  GFP,	  by	  use	  of	  standard	  
molecular	  techniques.	  
Subcellular	  marker	  Gateway®	  (Invitrogen	  Corporation)	  constructs	  were	  a	  generous	  gift	  
from	  B.	  Grant.	  	  The	  vit-­2	  promoter	  in	  the	  mCherry	  expression	  vector	  was	  excised	  as	  a	  
326bp	  SphI-­‐KpnI	  fragment	  and	  replaced	  with	  a	  1.4kb	  exc-­9	  promoter	  by	  use	  of	  standard	  
molecular	  techniques.	  	  The	  modified	  vector	  was	  then	  used	  in	  a	  series	  of	  nine	  Gateway®	  
reactions	  with	  each	  of	  the	  donor	  vectors	  containing	  either	  the	  cDNA	  of	  nematode	  rab-­5,	  
rab-­7,	  rab-­11,	  glo-­1,	  or	  rme-­1	  (splice	  form	  d);	  or	  genomic	  copy	  of	  nematode	  cdc-­42,	  eea-­1,	  or	  
chc-­1	  genes;	  or	  the	  GRIP	  (Glutamate	  Receptor-­‐Interacting	  Protein)	  domain	  of	  nematode	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gene	  T05G5.9	  (gift	  of	  B.	  Grant	  and	  S.	  Eimer).	  	  The	  result	  of	  each	  reaction	  was	  the	  exc-­9-­‐
promoted	  mCherry	  cDNA	  fused	  N-­‐terminally	  to	  the	  specific	  subcellular	  gene.	  
The	  G-­‐protein-­‐binding	  domain	  (GBD)	  of	  wsp-­1	  106	  was	  PCR-­‐amplified	  from	  constructs	  
generously	  provided	  by	  Jayne	  Squirrel,	  Kraig	  Kumfer,	  and	  John	  White,	  and	  then	  cloned	  into	  
a	  pENTR™/D-­‐TOPO®	  vector	  (Invitrogen	  Corporation).	  	  This	  sub-­‐clone	  was	  used	  as	  above	  
to	  create	  mCherry	  cDNA	  fused	  N-­‐terminally	  to	  GBDwsp-­1	  expressed	  via	  the	  exc-­9	  promoter.	  
Microinjection	  and	  Integration	  of	  Constructs	  
Subcellular	  constructs	  were	  injected	  into	  the	  rachis	  of	  young	  adult	  N2	  animals	  at	  a	  
concentration	  of	  50	  and	  100ng/ml.	  Transgenic	  F1	  animals	  were	  isolated	  to	  separate	  plates	  
and	  screened	  for	  array	  transmission.	  
A	  stable	  low-­‐copy-­‐number	  array	  of	  exc-­5::gfp	  driven	  by	  the	  exc-­5	  promoter	  was	  obtained	  
via	  microinjection	  of	  the	  Pexc-­5::exc-­5::gfp	  construct	  at	  15ng/ml	  mixed	  with	  25ng/ml	  of	  N2	  
genomic	  DNA.	  	  Array	  transmission	  in	  this	  strain	  was	  0.6%	  (n=300).	  	  Unstable	  low-­‐copy	  
transient	  arrays	  of	  altered	  cdc-­42	  forms	  driven	  by	  the	  vha-­1	  promoter	  were	  obtained	  via	  
microinjection	  of	  the	  Pvha-­1::gfp::cdc-­42	  (DN	  or	  CA)	  construct	  at	  10ng/ml.	  	  	  
Stable	  arrays	  were	  integrated	  into	  the	  nematode	  chromosome	  using	  4,5’,8-­‐
trimethylpsoralen	  (TMP)	  79.	  Nematodes	  were	  washed	  off	  plates	  with	  M9	  buffer,	  pelleted,	  
and	  resuspended	  in	  a	  minimal	  volume.	  	  TMP	  was	  added	  to	  a	  final	  concentration	  of	  30µg/ml.	  	  	  
Animals	  were	  soaked	  in	  the	  TMP	  solution	  for	  15	  minutes	  in	  the	  dark	  and	  washed	  twice	  in	  
M9	  buffer.	  	  Nematodes	  were	  then	  plated	  and	  irradiated	  by	  use	  of	  a	  Spectrolinker™	  
(Spectronics	  Corporation,	  New	  York)	  set	  to	  350µJ	  at	  360nm.	  	  F2	  progeny	  from	  the	  
irradiated	  animals	  were	  isolated	  and	  screened	  for	  integrants.	  	  Plates	  containing	  all	  
fluorescent	  transgenic	  progeny	  were	  identified	  as	  having	  the	  transgene	  homozygously	  
integrated.	  	  Integrants	  were	  then	  outcrossed	  at	  least	  five	  times	  to	  create	  strain	  BK178.	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Strains	  Used	  
Table 6.1 - Strains	  Used	  for	  Subcellular	  Marker	  Study 
 
	  
Strain  Genotype Description Reference 
N2  wild-type 43 
NJ731 exc-5(rh232) exc-5 deletion 57 
BK36 unc-119(ed3); qpIs11[unc-119; Pvha-1::gfp] I wild-type with integrated GFP 
marker expressed in excretory 
canals  
This study 
BK30 exc-5(rh232); qpIs11[unc-119; Pvha-1::gfp] I NJ731 crossed to BK36 to express 
integrated GFP marker in an exc-5 
mutant background 
This study 
BK179 N2; qpIs78[exc-5::gfp; N2 DNA] X integrated low-copy-number EXC-
5::GFP fusion 
This study 
Wild-type strains expressing mCherry-labeled marker genes mCherry Marker labels:  
BK219 N2; qpIs102[Pexc-9::mCherry::chc-1] CHC-1:  clathrin-coated pits This study 
BK201 N2; qpIs95[Pexc-9::mCherry::eea-1] X EEA-1:  early endosomes This study 
BK209 N2; qpIs99[Pexc-9::mCherry::rab-5] IV RAB-5:  early endosomes This study 
BK210 N2; qpIs100[Pexc-9::mCherry::rab-7] RAB-7:  late endosomes This study 
BK206 N2; qpIs98[Pexc-9::mCherry::glo-1] GLO-1:  lysosomes This study 
BK211 N2; qpIs101[Pexc-9::mCherry::rme-1] X RME-1:  recycling endosomes This study 
BK205 N2; qpIs97[Pexc-9::mCherry::rab-11] V RAB-11:  recycling endosomes This study 
BK220 N2; qpIs103[Pexc-9::mCherry::GRIP] GRIP:  Golgi apparatus This study 
BK204 N2; qpIs96[Pexc-9::mCherry::cdc-42] CDC-42:  cytoplasm This study 
BK262 N2; qpIs104[Pexc-9::mCherry::GBDwsp-1] GBD domain of WSP-1:  cytoplasm This study 
exc-5 deletion strains with mCherry-labeled markers   
BK221 NJ731; qpIs102[Pexc-9::mCherry::chc-1] CHC-1:  clathrin-coated pits This study 
BK218 NJ731; qpIs95[Pexc-9::mCherry::eea-1] X EEA-1:  early endosomes This study 
BK217 NJ731; qpIs99[Pexc-9::mCherry::rab-5] IV RAB-5:  early endosomes This study 
BK216 NJ731; qpIs100[Pexc-9::mCherry::rab-7] RAB-7:  late endosomes This study 
BK213 NJ731; qpIs98[Pexc-9::mCherry::glo-1] GLO-1:  lysosomes This study 
BK214 NJ731; qpIs101[Pexc-9::mCherry::rme-1] X RME-1:  recycling endosomes This study 
BK215 NJ731; qpIs97[Pexc-9::mCherry::rab-11] V RAB-11:  recycling endosomes This study 
BK222 NJ731; qpIs103[Pexc-9::mCherry::GRIP] GRIP:  Golgi apparatus This study 
BK212 NJ731; qpIs96[Pexc-9::mCherry::cdc-42] CDC-42:  cytoplasm This study 
BK273 NJ731; qpIs104[Pexc-9::mCherry::GBDwsp-1] GBD domain of WSP-1:  cytoplasm This study 
Strains with slight overexpression of exc-5 (labeled with GFP) containing mCherry-labeled markers  
BK227 BK179; qpIs102[Pexc-9::mCherry::chc-1] CHC-1:  clathrin-coated pits This study 
BK230 BK179; qpIs95[Pexc-9::mCherry::eea-1] X EEA-1:  early endosomes This study 
BK226 BK179; qpIs99[Pexc-9::mCherry::rab-5] IV RAB-5:  early endosomes This study 
BK224 BK179; qpIs100[Pexc-9::mCherry::rab-7] RAB-7:  late endosomes This study 
BK228 BK179; qpIs98[Pexc-9::mCherry::glo-1] GLO-1:  lysosomes This study 
BK223 BK179; qpIs101[Pexc-9::mCherry::rme-1] X RME-1:  recycling endosomes This study 
BK225 BK179; qpIs97[Pexc-9::mCherry::rab-11] V RAB-11:  recycling endosomes This study 
BK229 BK179; qpIs103[Pexc-9::mCherry::GRIP] GRIP:  Golgi apparatus This study 
BK231 BK179; qpIs96[Pexc-9::mCherry::cdc-42] CDC-42:  cytoplasm This study 
BK274 BK179; qpIs104[Pexc-9::mCherry::GBDwsp-1] GBD domain of WSP-1:  cytoplasm This study 
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Microscopy	  
Nematodes	  were	  observed	  via	  a	  Zeiss	  Axioskop	  microscope	  with	  Nomarski	  optics	  and	  
epifluorescence	  using	  40x	  and	  63x	  oil-­‐immersion	  objectives.	  	  Animals	  were	  placed	  on	  5%	  
agarose	  pads	  in	  water	  or	  PBS	  containing	  0.8%	  1-­‐phenoxy-­‐2-­‐propanol	  as	  anaesthetic.	  	  All	  
images	  were	  taken	  with	  an	  Optronics	  MagnaFire	  Camera.	  	  Images	  were	  cropped	  and	  
merged	  using	  the	  programs	  GIMP	  and	  Graphic	  Converter	  (Lemke	  Software,	  Peine,	  
Germany).	  	  
Time-­‐lapse	  images	  were	  taken	  by	  use	  of	  the	  same	  equipment,	  except	  that	  animals	  were	  
anaesthetized	  with	  10mM	  muscimol.	  	  Animals	  were	  kept	  at	  20°C	  prior	  to	  microscopic	  
observation.	  	  Cover	  slips	  were	  sealed	  with	  mineral	  oil	  to	  prevent	  desiccation	  of	  the	  animals.	  
Canal	  Measurements	  
Posterior	  excretory	  canal	  length	  was	  measured	  relative	  to	  the	  animal	  length	  as	  described	  in	  
Chapter	  2	  and	  51.	  Animals	  were	  kept	  at	  20°C	  and	  generally	  scored	  as	  L4	  larvae.	  	  Canals	  that	  
did	  not	  extend	  at	  all	  or	  remained	  near	  the	  cell	  body	  were	  scored	  as	  (0).	  	  Posterior	  canals	  
that	  extended	  to	  between	  the	  cell	  body	  and	  the	  vulva	  were	  scored	  as	  (1),	  at	  the	  vulva	  (2),	  
between	  the	  vulva	  and	  the	  tail	  (3),	  and	  full-­‐length	  canals	  were	  scored	  as	  a	  (4).	  	  Cysts	  were	  
counted	  and	  grouped	  according	  to	  size.	  	  Cysts	  with	  a	  diameter	  of	  over	  half	  the	  body	  width	  
were	  labeled	  as	  large	  cysts;	  cysts	  larger	  than	  a	  quarter	  of	  the	  body	  diameter	  up	  to	  half	  the	  
diameter	  were	  labeled	  as	  medium;	  cysts	  a	  quarter	  of	  the	  body	  diameter	  or	  smaller	  were	  
labeled	  as	  small	  cysts.	  	  A	  canal	  that	  exhibited	  a	  lumen	  that	  traversed	  itself	  more	  than	  once	  
was	  counted	  as	  a	  convoluted	  tubule.	  
Relative brightness of markers in cysts vs. non-cystic tubules was measured by use of the 
program NIH ImageJ.  Micrographs showing the most anterior cyst of a posterior canal were 
used, and where possible, micrographs presenting a cyst not adjacent to other cysts were used, 
since two or more closely spaced cysts concentrated cytoplasm more than did a single cyst.  A 
segmented line of width equal to the widest cyst to be measured was placed along the entire 
length of the canal, and plot profile was recorded.  The average value of the plot profile of the 
same width of a dark section of the micrograph was subtracted as background.  A section of non-
cystic canal not overlapping out-of-focus fluorescence from other tissues or the opposite-side 
canal was normalized to relative brightness = 100.  The brightest reading of cytoplasm at the 
junction of cyst and non-cystic canals was recorded as “peak brightness,” while the lowest 
fluorescence along the center of the cyst was recorded as “trough brightness.” 
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Results 
EXC-­5	  dosage	  at	  the	  apical	  surface	  determines	  canal	  morphology	  
Previous	  work	  has	  shown	  that	  null	  mutation	  of	  exc-­5	  in	  the	  excretory	  canal	  results	  in	  the	  
formation	  of	  large	  fluid-­‐filled	  cysts	  along	  the	  length	  of	  and	  especially	  at	  the	  distal	  tips	  of	  the	  
canal	  (Fig.	  6.1B),	  while	  strong	  overexpression	  of	  exc-­5	  in	  the	  canal	  causes	  a	  “convoluted	  
tubule”	  phenotype	  in	  which	  the	  apical	  surface	  and	  cytoskeleton	  maintain	  the	  correct	  
diameter,	  but	  are	  wrapped	  inside	  a	  large	  cell	  body	  that	  fails	  to	  extend	  processes	  along	  the	  
hypoderm	  (Fig.	  6.1C)	  57.	  We	  found	  that	  microinjection	  of	  higher	  concentrations	  (>50	  
ng/ml)	  of	  an	  exc-­5::gfp	  construct	  resulted	  in	  dead	  eggs	  and	  larvae	  that	  died	  at	  the	  L1	  or	  L2	  
stage.	  	  Microinjection	  of	  varying	  concentrations	  of	  the	  exc-­5::gfp	  construct	  at	  lower	  levels	  
(5-­‐25	  ng/ml)	  resulted	  in	  progeny	  exhibiting	  tubule	  convolutions	  of	  severity	  proportionate	  
to	  concentration	  of	  DNA	  injected	  (data	  not	  shown).	  	  In	  order	  to	  examine	  the	  subcellular	  
location	  of	  EXC-­‐5	  within	  the	  canal,	  we	  integrated	  a	  stable	  low-­‐copy-­‐number	  exc-­5::gfp	  
transgene	  into	  the	  chromosome	  (integrant	  qpIs78).	  This	  integrated	  construct	  fluoresces	  
very	  weakly	  (barely	  visible	  in	  a	  compound	  fluorescence	  microscope),	  and	  rescues	  the	  null	  
mutant	  Exc-­‐5	  phenotype	  to	  create	  near-­‐normal-­‐length	  canals	  that	  each	  contain	  a	  normal-­‐
diameter	  lumen	  (data	  not	  shown).	  When	  the	  transgene	  is	  present	  homozygously	  in	  an	  N2	  
background	  (strain	  BK179),	  the	  canals	  are	  slightly	  shortened,	  and	  occasionally	  (8%)	  form	  
highly	  convoluted	  tubules	  (Table	  6.2).	  	  In	  addition,	  the	  diameter	  of	  the	  apical	  surface	  was	  
occasionally	  irregular,	  with	  constricted	  areas	  (Fig.	  6.1E).	  	  Examination	  at	  high	  
magnification	  confirmed	  previous	  results	  demonstrating	  that	  the	  EXC-­‐5	  protein	  is	  
expressed	  both	  in	  the	  cell	  body	  and	  throughout	  the	  length	  of	  the	  canal.	  	  The	  apical	  surface	  
of	  the	  canal	  extends	  into	  the	  cell	  cytoplasm	  through	  a	  network	  of	  small	  vesicular	  tubules	  
called	  canaliculi	  107(Fig.	  1.1C),	  so	  that	  apical	  expression	  generally	  appears	  as	  a	  thick	  layer	  
surrounding	  the	  lumen	  when	  viewed	  via	  light	  microscopy.	  	  Nevertheless,	  we	  found	  that	  
EXC-­‐5	  is	  enriched	  on	  the	  apical	  (luminal)	  side	  of	  the	  cytoplasm,	  but	  beneath	  the	  surface	  of	  
the	  tubules	  (Fig.	  6.1E-­‐G).	  	  Apical	  clathrin	  (CHC-­‐1)	  appears	  enriched	  in	  the	  same	  area	  of	  high	  
expression	  as	  is	  EXC-­‐5,	  which	  may	  indicate	  that	  clathrin-­‐coated	  pits	  and	  EXC-­‐5	  are	  both	  
found	  in	  the	  region	  of	  myriad	  tubulovesicular	  canaliculi	  that	  extend	  into	  the	  cytoplasm	  
from	  the	  apical	  surface.	  Canal	  structure	  appears	  to	  provide	  a	  sensitive	  reflection	  of	  EXC-­‐5	  
dosage,	  with	  the	  degree	  of	  shortening	  and	  convolution	  indicating	  higher	  levels	  of	  EXC-­‐5	  
dosage	  at	  the	  apical	  surface.
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Figure	  6.1	  –	  EXC-­5	  is	  Enriched	  at	  the	  Apical	  Surface	  and	  Regulates	  Canal	  Morphology	  
	  
Varying	  expression	  of	  EXC-­‐5	  alters	  canal	  
morphology.	  	  Animals	  in	  panels	  (A)	  and	  
(B)	  contain	  the	  stable	  integrant	  qpIs11,	  
which	  strongly	  expresses	  GFP	  driven	  by	  
the	  vha-­1	  promoter	  throughout	  the	  
cytoplasm	  of	  the	  excretory	  canal	  cell	  
and	  head	  mesodermal	  cell	  beginning	  in	  
embryogenesis	  prior	  to	  canal	  extension	  
50.	  (A)	  Fluorescence	  micrograph	  of	  
animal	  wild-­‐type	  for	  exc-­5	  shows	  
normal	  canal	  morphology.	  	  Left-­‐hand	  
anterior	  and	  posterior	  canals	  are	  shown	  
(right-­‐hand	  canal	  is	  out	  of	  plane	  of	  
focus)	  branching	  from	  cell	  body	  
(arrowhead).	  	  Open	  arrowhead	  marks	  
position	  of	  vulva	  in	  center	  of	  animal.	  	  
(B)	  Animal	  deleted	  for	  exc-­5	  shows	  a	  
posterior	  canal	  terminating	  in	  a	  large	  
fluid-­‐filled	  cyst	  (arrow)	  anterior	  to	  the	  
vulva	  (open	  arrowhead).	  	  Cyst	  
terminating	  opposing	  posterior	  canal	  is	  
partially	  visible	  as	  a	  blur	  at	  even	  more	  
anterior	  position	  (arrowhead).	  	  (C)	  DIC	  
image	  of	  animal	  overexpressing	  exc-­
5::gfp.	  	  Excretory	  canal	  cell	  body,	  located	  
just	  posterior	  of	  posterior	  pharyngeal	  
bulb	  (asterisk)	  is	  filled	  with	  convoluted	  
normal-­‐diameter	  excretory	  tubule	  
(arrows);	  nucleus	  of	  excretory	  cell	  is	  
shown	  by	  arrowheads.	  	  (D)	  
Homozygous	  expression	  of	  low-­‐copy	  
number	  integrant	  qpIs78	  (exc-­5::gfp)	  in	  
an	  N2	  (wild-­‐type)	  background	  (4	  copies	  
total	  of	  exc-­5)	  caused	  shortening	  of	  the	  
canals	  and	  moderate	  tubule	  
convolution,	  but	  canal	  extension	  
occurred,	  and	  cysts	  did	  not	  form.	  	  
Asterisk	  indicates	  position	  of	  posterior	  
pharyngeal	  bulb,	  arrowhead	  is	  canal	  cell	  
body.	  	  (E-­G)	  	  Higher	  magnification	  of	  
posterior	  canal	  expressing	  integrated	  
low-­‐copy-­‐number	  constructs	  of	  exc-­
5::gfp	  and	  membrane-­‐delimited	  marker	  
mCherry::chc-­1	  (clathrin)	  indicates	  that	  
EXC-­‐5	  is	  primarily	  expressed	  at	  apical	  
(luminal)	  side	  of	  cytoplasm,	  but	  not	  on	  
membrane	  surface	  where	  clathrin-­‐
coated	  pits	  form:	  (E)	  EXC-­‐5,	  green;	  (F)	  CHC-­‐1,	  red;	  (G)	  superimposed.	  	  Anterior	  is	  to	  the	  left	  in	  all	  figures,	  
ventral	  to	  the	  bottom	  in	  all	  figures	  except	  C.	  	  All	  animals	  are	  either	  L4s	  or	  young	  adults.	  	  All	  fluorescence	  
panels	  brightened	  and	  contrast-­‐enhanced	  to	  show	  location	  of	  highest	  concentrations	  of	  weak	  GFP	  
fluorescence.	  	  Bars,	  100	  µm	  in	  panels	  A	  and	  B,	  50	  µm	  in	  all	  others.
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Table	  6.2	  -­	  Effects	  of	  Subcellular	  Marker	  Expression	  on	  Excretory	  Canal	  Phenotypea	  
 











# Cystsf Small Medium Large 
N2  (Wild-type) 
animals: 
100 0 4.0 0     
  expressing: 
mCherry::cdc-42 
92 0 3.2 20.7 0.4 2.0 0 0 
   mCherry::wsp-1GBD 100 7.0 1.4 2.0 0 1.0 1.0 1.0 
mCherry::chc-1 100 0 4.0 0     
mCherry::eea-1 99 0 3.3 0     
mCherry::glo-1 100 0 4.0 0     
mCherry::GRIP 100 0 3.4 0     
  mCherry:rab-5 100 9.0 2.9 0     
mCherry::rab-7 100 0 2.5 0     
mCherry::rab-11 100 7.0 3.0 2.0 0.1 2.5 0 0 
mCherry::rme-1 100 0 3.8 0     
trans. express:  
gfp::CA cdc-42 
  84 83.3 2.7 1.2 0 1.0 0 0 
          gfp::DN cdc-42 48 0 3.1 56.3 2.8 2.6 0.2 0 
NJ731   exc-5 (rh232) 
mutants 
96 0 1.2 100 8.6 7.5 1.7 1.1 
  expressing: 
mCherry::cdc-42 
100 0 1.3 100 9.8 6.9 2.3 2.0 
mCherry::wsp-1GBD 104 20.2 0.5 50.0 1.8 3.8 1.1 1.0 
mCherry::chc-1 92 0 1.4 98.9 6.4 4.4 2.2 1.2 
mCherry::eea-1 100 0 1.6 97 5.6 4.4 2.0 1.3 
mCherry::glo-1 100 0 1.3 98 7.8 6.0 2.2 1.2 
mCherry::GRIP 100 0 1.1 98 8.7 6.6 2.4 1.3 
 mCherry:rab-5 99 0 1.1 100 9.0 7.6 1.9 1.3 
mCherry::rab-7 100 0 1.2 100 12.0 10.0 2.5 1.4 
mCherry::rab-11 100 0 1.3 99 8.3 7.3 1.9 1.2 
mCherry::rme-1 99 0 1.3 89.9 3.8 3.4 1.8 1.4 
trans. express:  
gfp::CA cdc-42 
54 81.5 1.6 100 8.0 6.7 1.0 0.3 
                  gfp::DN 
cdc-42 
42 0 1.6 100 11.2 9.7 1.5 0.5 
BK179 Low exc-5 
overexpress 
100 8.0 1.5 0.0     
  expressing: 
mCherry::cdc-42 
100 84.0 0.5 5.0 0.2 3.7 1.0 1.0 
  mCherry::wsp-1GBD 102 14.7 1.1 0.0     
mCherry::chc-1 100  2.6 1.0 0 3.0 0.0 0.0 
mCherry::eea-1 74  0.6 0.0     
mCherry::glo-1 100  1.3 0.0     
mCherry::GRIP 102  1.8 0.0     
mCherry::rab-5 99 13.1 1.1 2.0 0 2.0 0.0 0.0 
mCherry::rab-7 99 37.4 0.9 0.0     
mCherry::rab-11 103 68.8 0.6 0.0     
mCherry::rme-1 100  2.1 0.0     
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Table	  6.2	  -­	  Effects	  of	  Subcellular	  Marker	  Expression	  on	  Excretory	  Canal	  Phenotype	  
  
aSubstantial increases in cyst number or size from those of controls without mCherry constructs are indicated in 
boldface.  Increases in number of convoluted tubules and decreases in number of cysts are underlined. 
bNumber of canals examined.   
cPercentage of canals that exhibited a lumen that traversed itself more than once.   
dAverage canal length relative to body length as described in Materials & Methods; 0 means no canal growth, 4 is 
full-length. 
ePercentage of canals that exhibited any visible cysts at all. 
fAverage number of cysts observed for all animals 
gAverage number of large, medium, and small cysts (size determined as described in Materials & Methods) seen for 
animals exhibiting cysts. 
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Subcellular	  Organelles	  Appear	  Throughout	  the	  Entire	  Length	  of	  the	  Excretory	  Canals	  
	  
In	  exc-­5	  mutants	  the	  canals	  initially	  form	  normally,	  but	  then	  develop	  large	  cysts	  
predominantly	  at	  the	  growing	  tips	  of	  the	  tubules	  48.	  Since	  the	  majority	  of	  lumen	  initially	  
forms	  with	  a	  normal	  diameter,	  it	  is	  likely	  that	  the	  defect	  in	  these	  mutants	  involves	  the	  
continual	  reformation	  of	  components	  directed	  to	  maintain	  apical	  structure	  as	  the	  animal	  
grows	  and	  moves,	  rather	  than	  the	  initial	  placement	  of	  cytoskeleton.	  	  During	  recycling,	  
membrane-­‐bound	  proteins	  are	  taken	  up	  either	  via	  clathrin-­‐coated	  pits	  or	  via	  clathrin-­‐
independent	  pathways	  15	  (Fig.	  6.2A).	  	  The	  material	  is	  transported	  via	  endocytic	  vesicles	  
into	  early	  endosomes,	  where	  the	  material	  is	  either	  shuttled	  via	  late	  endosomes	  to	  
lysosomes	  to	  be	  destroyed,	  or	  brought	  back	  to	  the	  surface	  by	  way	  of	  recycling	  endosomes	  
(see	  Chapter	  1	  for	  more	  details).	  	  We	  examined	  the	  location	  of	  multiple	  components	  of	  the	  
recycling	  machinery	  within	  the	  excretory	  canals	  by	  adapting	  a	  set	  of	  eight	  constructs	  
expressing	  marker	  proteins	  specific	  to	  different	  subcellular	  organelles	  linked	  to	  the	  
fluorescent	  tag	  mCherry	  for	  canal	  expression.	  	  We	  also	  made	  similar	  markers	  for	  the	  
putative	  EXC-­‐5	  substrate	  protein	  CDC-­‐42	  (constructs	  generously	  provided	  by	  B.	  Grant)	  as	  
well	  as	  the	  G-­‐protein-­‐binding	  domain	  of	  the	  WASP	  homologue	  WSP-­‐1	  that	  binds	  to	  
activated	  CDC-­‐42	  (graciously	  provided	  by	  J.	  White,	  K.	  Kumfer,	  and	  J.	  Squirrell)	  106,	  and	  
transiently	  expressed	  constitutively-­‐active	  (T17N)	  or	  dominant-­‐negative	  (G12V)	  forms	  of	  
CDC-­‐42	  (constructs	  generously	  provided	  by	  E.	  Lundquist).	  	  Stably	  integrated	  markers	  were	  
expressed	  through	  the	  exc-­9	  promoter	  in	  the	  excretory	  canal	  starting	  at	  the	  3-­‐fold	  stage,	  as	  
well	  as	  in	  the	  uterine	  seam	  cell	  and	  several	  neurons	  51.	  The	  exc-­5	  promoter	  was	  not	  used,	  in	  
order	  to	  avoid	  the	  possibility	  that	  expression	  of	  the	  construct	  would	  deplete	  transcription	  
factors	  specific	  to	  exc-­5	  in	  the	  canal,	  and	  thereby	  decrease	  expression	  of	  EXC-­‐5	  in	  the	  cell.	  	  
Under	  control	  of	  the	  exc-­9	  promoter,	  some	  of	  the	  constructs	  did	  cause	  minor	  defects	  in	  
canal	  morphology	  in	  a	  wild-­‐type	  background	  (Fig.	  6.2B-­‐F)	  (Table	  6.2).	  	  Expression	  of	  the	  
wild-­‐type	  form	  of	  the	  small	  GTPase	  CDC-­‐42	  linked	  to	  mCherry	  caused	  21%	  of	  the	  animals	  
to	  develop	  very	  small	  cysts	  near	  the	  distal	  tips	  of	  the	  canals.	  	  Expression	  of	  mCherry-­‐linked	  
WSP-­‐1-­‐GBD,	  which	  binds	  to	  GTP-­‐bound	  CDC-­‐42,	  greatly	  shortened	  the	  canals,	  with	  a	  
widened	  (though	  only	  occasionally	  cystic)	  lumen	  diameter	  towards	  the	  distal	  end	  of	  the	  
lumen,	  sometimes	  followed	  by	  a	  “tail”	  of	  cytoplasm	  containing	  no	  lumen	  (Fig.	  6.2D).	  	  
Transient	  expression	  of	  constitutively-­‐active	  CDC-­‐42	  also	  caused	  formation	  of	  cytoplasmic	  
“tails,”	  while	  causing	  convolutions	  similar	  to	  those	  seen	  in	  animals	  overexpressing	  EXC-­‐5.	  	  
In	  contrast,	  the	  dominant-­‐negative	  form	  of	  CDC-­‐42	  caused	  formation	  of	  cysts	  throughout	  
the	  canal	  in	  a	  majority	  of	  animals	  examined,	  although	  the	  cysts	  were	  not	  quite	  as	  large	  or	  as	  
frequent	  as	  in	  mutants	  of	  exc-­5.	  	  These	  results	  are	  consistent	  with	  EXC-­‐5	  functioning	  at	  
least	  in	  part	  through	  the	  activation	  of	  CDC-­‐42	  which	  in	  turn	  activates	  WSP-­‐1.	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Figure	  6.2	  –	  Expression	  of	  Subcellular	  Markers	  Has	  Mild	  Effects	  on	  Canal	  Morphology	  
	  
Expression	  of	  some	  subcellular	  
markers	  within	  the	  excretory	  canals	  
occasionally	  altered	  canal	  
morphology.	  	  (A)	  Model	  of	  vesicular	  
transport	  in	  the	  excretory	  canals,	  with	  
markers	  used	  in	  this	  study	  to	  indicate	  
various	  subcellular	  compartments.	  	  (B-­‐
J)	  Fluorescence	  micrographs	  of	  typical	  
segments	  of	  posterior	  canal	  in	  young	  
adult	  animals.	  	  All	  markers	  were	  
expressed	  in	  constructs	  linked	  to	  
mCherry	  and	  driven	  by	  the	  exc-­9	  
promoter.	  	  (B)	  Small	  GTPase	  CDC-­‐42.	  	  
(C)	  The	  domain	  of	  WSP-­‐1	  that	  binds	  to	  
activated	  (GTP-­‐bound)	  CDC-­‐42.	  	  (D)	  
Enlarged	  and	  brightened	  area	  C,	  of	  
GBDwsp-­‐1-­‐labeled	  canal,	  shows	  “tail”	  
of	  cytoplasm	  disconnected	  from	  
lumen.	  	  (E)	  RAB-­‐5;	  (F)	  RAB-­‐7;	  (G)	  
RAB-­‐11.	  	  Bars,	  50	  µm.	  	  Micrographs	  
were	  taken	  with	  Optronics	  camera	  
either	  in	  black/white	  or	  RGB	  color	  
mode,	  and	  are	  not	  altered,	  except	  for	  
contrast	  enhancement	  of	  panel	  D	  and	  
converting	  panel	  G	  from	  color	  to	  b/w.
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Expression	  of	  markers	  labeling	  specific	  subcellular	  organelles	  had	  relatively	  smaller	  effects	  
on	  canal	  morphology	  (Table	  6.2).	  	  In	  35%	  of	  canals	  examined,	  RAB-­‐7	  expression	  caused	  
moderate	  shortening	  of	  the	  canal	  with	  neither	  cyst	  nor	  convoluted	  tubule	  formation.	  	  
Expression	  of	  the	  endocytic	  vesicle	  marker	  RAB-­‐5	  had	  less	  of	  a	  canal-­‐shortening	  effect	  
(19%	  moderately	  affected),	  and	  caused	  a	  convoluted	  tubule	  in	  9%	  of	  the	  animals.	  	  Finally,	  
expression	  of	  the	  recycling	  endosome	  marker	  RAB-­‐11	  on	  occasion	  caused	  small	  cysts	  to	  
form	  (2%	  of	  the	  animals),	  and	  also	  caused	  a	  convoluted	  tubule	  in	  7%	  of	  the	  animals.	  	  In	  the	  
great	  majority	  of	  animals	  expressing	  these	  constructs,	  however,	  the	  sensitive	  canal	  
morphology	  was	  normal,	  consistent	  with	  marker	  expression	  not	  causing	  substantial	  
changes	  in	  subcellular	  trafficking.	  
	  
Expression	  of	  all	  9	  marker	  proteins	  was	  highest	  near	  the	  excretory	  canal	  cell	  body,	  and	  
decreased	  along	  the	  length	  of	  the	  canals	  (Fig.	  6.3).	  	  This	  distribution	  mirrors	  the	  placement	  
of	  endoplasmic	  reticulum	  and	  Golgi	  bodies,	  which	  are	  also	  found	  throughout	  the	  canals	  as	  
well	  as	  in	  the	  cell	  body	  48,107.	  Since	  cysts	  initially	  develop	  toward	  the	  tips	  of	  exc-­5	  mutant	  
animals	  during	  late	  embryogenesis	  48,	  when	  the	  posterior	  canals	  have	  extended	  only	  
halfway	  towards	  their	  full	  length	  50,	  we	  examined	  expression	  primarily	  anterior	  to	  the	  
vulva	  in	  order	  to	  compare	  the	  distribution	  of	  subcellular	  components	  in	  wild	  type	  and	  in	  
cystic	  mutants.	  	  The	  canals	  are	  also	  wider	  closer	  to	  the	  excretory	  cell	  body	  107,108,	  which	  
facilitates	  determination	  of	  the	  apical/basal	  placement	  of	  vesicles	  in	  the	  canals.	  
	  
The	  marker	  for	  clathrin-­‐coated	  pits,	  CHC-­‐1	  (clathrin	  heavy	  chain),	  was	  expressed	  in	  a	  thin	  
uniform	  layer	  on	  both	  the	  apical	  and	  basolateral	  surfaces	  of	  the	  canals,	  with	  frequent	  
higher	  concentrations	  in	  discrete	  puncta	  (Figs.	  6.1f-­‐h,	  6.4a).	  	  The	  bulk	  of	  EXC-­‐5	  expression	  
did	  not	  overlap	  with	  the	  location	  of	  CHC-­‐1.	  
	  
Early	  endosomes,	  as	  marked	  by	  RAB-­‐5	  109	  and	  by	  EEA-­‐1	  110,	  are	  distributed	  irregularly	  
along	  the	  length	  of	  the	  canal	  (Fig.	  6.4B,	  C).	  	  Occasional	  larger	  accumulations	  of	  EEA-­‐1	  were	  
observed	  near	  the	  cell	  body	  at	  both	  the	  basal	  and	  apical	  surfaces	  of	  the	  canal.	  
	  
Lysosomes	  and	  late	  endosomes	  were	  found	  in	  puncta	  spaced	  irregularly	  along	  the	  length	  of	  
the	  canals	  (Fig.	  6.4D,	  E).	  	  Late	  endosomes	  were	  marked	  with	  a	  RAB-­‐7	  109	  marker,	  while	  the	  
marker	  GLO-­‐1/Rab38	  was	  used	  to	  detect	  lysosomes	  111.
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Figure	  6.3	  –	  Expression	  of	  Subcellular	  Markers	  is	  Highest	  at	  the	  Cell	  Body	  
	  
Expression	  of	  all	  subcellular	  
markers	  is	  highest	  at	  the	  cell	  
body,	  but	  proteins	  are	  
apparent	  throughout	  the	  
length	  of	  the	  canals.	  	  (A)	  Early	  
endosome	  marker	  EEA-­‐1.	  	  (B)	  
Lysosomal	  marker	  GLO-­‐1.	  	  
Relative	  brightness	  along	  the	  
length	  of	  the	  canals	  is	  shown	  
beneath	  each	  panel,	  
normalized	  to	  normal-­‐
diameter	  canals	  brightness	  
midway	  along	  the	  posterior	  
canal	  length.	  	  Micrographs	  
were	  taken	  with	  Optronics	  
camera	  either	  in	  black/white	  
or	  RGB	  color	  mode,	  and	  are	  
not	  altered,	  except	  that	  panel	  
A	  was	  converted	  from	  color	  to	  
b/w	  of	  equivalent	  brightness.	  	  
Bars,	  50	  µm.
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Figure	  6.4	  –	  Distribution	  of	  Subcellular	  Organelles	  in	  the	  Excretory	  Canal	  
Expression	  of	  subcellular	  markers	  within	  the	  excretory	  canals	  in	  wild-­‐type	  animals.	  	  
Fluorescence	  micrographs	  of	  typical	  segments	  of	  posterior	  canal	  in	  young	  adult	  animals.	  	  
All	  markers	  were	  expressed	  in	  constructs	  linked	  to	  mCherry	  and	  driven	  by	  the	  exc-­9	  
promoter.	  	  Bar,	  50	  µm.	  	  (A)	  CHC-­‐1;	  	  (B)	  RAB-­‐5;	  	  (C)	  EEA-­‐1;	  	  (D)	  RAB-­‐7;	  	  (E)	  GLO-­‐1;	  	  (F)	  
RAB-­‐11;	  	  (G)	  RME-­‐1;	  (H)	  GRIP;	  	  (I)	  CDC-­‐42;	  (J)	  WSP-­‐1	  GTP-­‐binding	  domain.	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Recycling	  endosomes	  were	  marked	  by	  RAB-­‐11	  and	  RME-­‐1	  112,113	  (Fig.	  6.4F,	  G).	  	  RAB-­‐11	  
displayed	  mainly	  diffuse	  expression	  throughout	  the	  cell,	  with	  a	  few	  puncta	  irregularly	  
placed	  along	  the	  canals.	  	  RME-­‐1-­‐marked	  vesicles	  were	  generally	  larger	  and	  far	  more	  
numerous	  than	  were	  puncta	  labeled	  by	  RAB-­‐11.	  	  In	  both	  cases,	  the	  number	  of	  puncta	  was	  
highest	  near	  the	  cell	  body,	  but	  puncta	  were	  evident	  throughout	  the	  entire	  length	  of	  the	  
canals.	  	  	  
Golgi	  bodies,	  marked	  by	  a	  Golgi-­‐targeting	  GRIP	  domain	  114,115	  were	  also	  seen	  throughout	  
the	  canals,	  though	  most	  prominently	  near	  the	  cell	  bodies	  (Fig.	  6.4I).	  	  GRIP	  expression	  also	  
was	  punctate	  throughout	  the	  distal	  canals.	  	  Finally,	  CDC-­‐42,	  the	  presumptive	  target	  of	  EXC-­‐
5,	  was	  expressed	  diffusely	  throughout	  the	  cytoplasm	  of	  the	  excretory	  canals,	  with	  highest	  
expression	  levels	  towards	  the	  apical	  surface	  of	  the	  canals.	  	  Expression	  of	  GBD-­‐WSP-­‐1	  linked	  
to	  mCherry,	  marking	  activated	  CDC-­‐42,	  showed	  expression	  throughout	  the	  cytoplasm	  
similar	  to	  that	  of	  CDC-­‐42,	  but	  in	  addition	  appeared	  as	  occasional	  puncta	  throughout	  the	  
canal	  (Fig.	  6.4J).	  
All	  of	  the	  markers	  were	  evident	  throughout	  the	  length	  of	  both	  growing	  and	  adult	  full-­‐
grown	  canals,	  which	  suggests	  that	  material	  throughout	  the	  canals	  is	  steadily	  and	  
continually	  being	  taken	  up	  from	  canal	  surfaces	  and	  recycled,	  while	  material	  from	  the	  Golgi	  
bodies	  can	  be	  transported	  to	  the	  canals.	  
Loss	  of	  EXC-­5	  Activity	  Disrupts	  Endosome	  Morphology	  
	  
In	  order	  to	  determine	  if	  EXC-­‐5	  mediates	  endocytic	  trafficking,	  as	  has	  been	  found	  for	  CDC-­‐42	  
38,	  the	  subcellular	  marker	  expression	  constructs	  were	  crossed	  into	  the	  exc-­5(rh232)	  null	  
allele	  strain.	  	  Cyst	  formation	  caused	  canal	  cytoplasm	  to	  accumulate	  at	  the	  point	  where	  the	  
tubule	  widened,	  and	  between	  adjoining	  cysts,	  as	  seen	  via	  a	  cytoplasmic	  GFP	  marker	  (Fig.	  
6.5A).	  	  The	  distribution	  of	  labeled	  CHC-­‐1,	  CDC-­‐42,	  GBD-­‐WSP-­‐1,	  RAB-­‐7,	  GLO-­‐1,	  RAB-­‐11,	  and	  
GRIP	  was	  generally	  unaffected	  by	  loss	  of	  EXC-­‐5	  activity,	  as	  compared	  to	  the	  cytoplasmic	  
GFP	  controls	  (Fig.	  6.6)	  (Table	  6.3).	  	  The	  placement,	  approximate	  number,	  and	  distribution	  
of	  puncta	  in	  these	  mutants	  appeared	  quite	  similar	  to	  their	  expression	  in	  wild-­‐type	  animals,	  
with	  similar	  amounts	  of	  marked	  clathrin-­‐coated	  pits,	  late	  endosomes,	  and	  lysosomes.	  
	  
Loss	  of	  EXC-­‐5	  activity	  often	  caused	  a	  strong	  effect	  on	  the	  distribution	  of	  EEA-­‐1	  and	  RME-­‐1	  
markers,	  however,	  as	  well	  as	  some	  infrequent	  but	  large	  effects	  on	  RAB-­‐5	  distribution	  
(Table	  6.3,	  Fig.	  6.5).	  	  Early	  endosome	  marker	  EEA-­‐1	  was	  no	  longer	  seen	  in	  discrete	  puncta,	  
but	  rather	  accumulated	  into	  large	  irregular	  shapes.	  	  These	  accumulations	  were	  often	  
evident	  in	  the	  areas	  of	  the	  canals	  immediately	  adjacent	  to	  and	  surrounding	  the	  large	  cysts.	  	  
In	  the	  majority	  of	  canals,	  the	  accumulation	  of	  labeled	  EEA-­‐1	  surrounding	  the	  cysts	  
appeared	  substantially	  brighter	  than	  in	  the	  normal-­‐diameter	  tubule	  anterior	  to	  the	  cyst.	  	  
Labeled	  RAB-­‐5	  (marking	  early	  endosomes)	  was	  also	  sometimes	  enriched	  near	  cysts	  in	  
rh232	  animals,	  but	  while	  these	  accumulations	  were	  much	  brighter	  than	  for	  most	  markers,	  
the	  frequency	  of	  RAB-­‐5	  accumulations	  was	  similar	  to	  that	  of	  cytoplasm	  surrounding	  the	  
cysts.	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Figure	  6.5	  –	  exc-­5	  lof	  Mutants	  Affect	  EEA-­1	  and	  RME-­1	  Distribution	  
 
Effect	  of	  loss	  of	  EXC-­‐5	  on	  subcellular	  
marker	  distribution.	  	  Young	  adult	  
animals	  of	  exc-­5	  (rh232)	  expressing	  
integrated	  constructs	  containing	  
subcellular	  markers.	  	  Relative	  
brightness	  along	  the	  length	  of	  the	  canals	  
is	  shown	  beneath	  each	  panel,	  
normalized	  to	  normal-­‐diameter	  canal	  
brightness	  midway	  along	  the	  posterior	  
canal	  length.	  	  	  
(A)	  Animal	  expresses	  cytoplasmic	  GFP	  
driven	  by	  the	  strong	  canal-­‐specific	  vha-­1	  
promoter.	  	  (B-­‐D)	  	  Animals	  express	  
subcellular	  markers	  linked	  to	  mCherry,	  
and	  driven	  by	  the	  exc-­9	  promoter;	  
stronger	  expression	  altered	  canal	  
morphology.	  	  	  
(B)	  EEA-­‐1.	  	  Highest	  levels	  of	  expression	  
surround	  area	  of	  fluid-­‐filled	  cysts	  at	  
canal	  terminus	  (arrow).	  	  	  
(C)	  RAB-­‐5	  shows	  higher	  levels	  of	  
expression	  surrounding	  the	  cyst	  than	  in	  
normal-­‐diameter	  tubule.	  	  	  
(D)	  RME-­‐1.	  	  Dashed	  grey	  circles	  outline	  
lumen	  of	  large	  fluid-­‐filled	  cysts	  (arrow)	  
at	  canal	  terminus.	  	  Bars,	  50	  µm.	  
	  
	   77	  
Figure	  6.6	  –	  exc-­5	  lof	  Mutants	  do	  not	  Effect	  Most	  Subcellular	  Markers	  
	  
Loss	  of	  EXC-­‐5	  does	  not	  affect	  distribution	  of	  many	  subcellular	  markers	  (as	  compared	  to	  
results	  in	  Fig.	  6.4).	  	  Typical	  examples	  of	  young	  adult	  animals	  of	  exc-­5	  (rh232)	  containing	  
integrated	  constructs	  of	  subcellular	  markers	  linked	  to	  mCherry	  driven	  by	  the	  exc-­9	  
promoter.	  	  (A)	  CHC-­‐1;	  	  (B)	  CDC-­‐42;	  	  (C)	  GLO-­‐1;	  	  (D)	  GRIP;	  	  (E)	  RAB-­‐7;	  (F)	  RAB-­‐11.	  	  Bars,	  50	  
µm.	  	  Micrographs	  were	  taken	  with	  Optronics	  camera	  either	  in	  black/white	  or	  RGB	  color	  
mode,	  and	  are	  not	  altered.	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% of animals with cysts 
noticeably brighter than in 
normal tubuleb 
% of animals with cysts 
noticeably fainter than in 
normal tubule 
exc-5 mutants expressing: 







  mCherry::cdc-42 135 34 0 
mCherry::GBDwsp-1 80 24 0 
                     mCherry::chc-1 90 17 4 
                     mCherry::eea-1 207 58 0 
                     mCherry::glo-1 100 26 0 
                     mCherry::GRIP 100 28 0 
                     mCherry:rab-5 100 24 0 
                     mCherry::rab-7 100 23 0 
                     mCherry::rab-11 135 30 0 
                     mCherry::rme-1 100 0 31 
aNumber of canals examined. 
bNumber of animals graded as “bright” was normalized to account for variations in brightness 
between wild-type animals viewed in different counting sessions.	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Most	  strikingly,	  labeled	  RME-­‐1	  was	  the	  only	  marker	  to	  exhibit	  a	  strong	  and	  opposite	  
phenotype:	  	  Other	  than	  near	  the	  excretory	  cell	  body,	  the	  amount	  of	  labeled	  RME-­‐1	  was	  
severely	  depleted	  throughout	  the	  canals,	  and	  almost	  entirely	  absent	  in	  the	  cytoplasm	  
surrounding	  large	  cysts.	  	  Taken	  together,	  these	  results	  suggest	  a	  defect	  in	  recycling	  
endosome	  transport	  in	  exc-­5	  mutants,	  similar	  to	  the	  defects	  previously	  reported	  in	  C.	  
elegans	  coelomocytes	  upon	  depletion	  of	  CDC-­‐42	  via	  RNAi	  116,	  in	  that	  material	  appears	  to	  be	  
taken	  up	  normally	  into	  canal	  early	  endosomes,	  but	  is	  unable	  to	  be	  passed	  further	  into	  
recycling	  endosomes.	  
	  
Overexpressed	  EXC-­5	  Affects	  Recycling	  Endosomes	  
	  
The	  subcellular	  markers	  were	  also	  crossed	  into	  strains	  containing	  the	  integrated	  exc-­5::gfp	  
construct.	  	  Overexpression	  of	  EXC-­‐5	  also	  showed	  little	  effect	  on	  most	  of	  the	  subcellular	  
markers	  (Fig.	  6.7),	  but	  showed	  strong	  interactions	  with	  RME-­‐1	  and	  EEA-­‐1	  (Fig.	  6.8).	  	  
Overexpression	  of	  exc-­5	  together	  with	  the	  rme-­1	  marker	  caused	  higher	  than	  normal	  
accumulation	  of	  RME-­‐1::mCherry	  puncta,	  whereas	  the	  level	  of	  labeled	  EXC-­‐5	  became	  
depleted	  (Figs.	  6.8a-­‐c),	  consistent	  with	  a	  model	  in	  which	  EXC-­‐5	  ferried	  excess	  amounts	  of	  
material	  from	  early	  endosomes	  to	  recycling	  endosomes.	  	  The	  effect	  of	  exc-­5	  overexpression	  
was	  even	  more	  striking	  when	  combined	  with	  the	  mCherry::eea-­1	  marker.	  	  Expression	  of	  
homozygous	  mCherry::eea-­1	  was	  lethal	  in	  the	  homozygous	  exc-­5::gfp	  strain;	  animals	  died	  
during	  late	  embryogenesis,	  though	  no	  effects	  on	  canal	  morphology	  were	  obvious	  (Fig.	  6.8D-­‐
F).	  	  Heterozygous	  expression	  of	  the	  eea-­1::mCherry	  construct	  in	  animals	  homozygous	  for	  
the	  exc-­5::gfp	  integrated	  transgene	  allowed	  animals	  to	  survive,	  and	  showed	  somewhat	  
fewer,	  but	  larger,	  puncta	  of	  mCherry::EEA-­‐1	  along	  the	  apical	  surface	  (Fig.	  6.8G-­‐I).	  	  Both	  loss	  
and	  overexpression	  of	  EXC-­‐5	  activity	  therefore	  perturbed	  EAA-­‐1-­‐	  and	  RME-­‐1-­‐marked	  
endosomes.	  
	  
EXC-­5	  Interacts	  with	  the	  Rho	  GTPase	  CDC-­42	  
	  
The	  human	  EXC-­‐5	  homologue	  FGD1	  activates	  the	  small	  Rho-­‐GTPase	  CDC42	  when	  
overexpressed	  in	  3T3	  fibroblasts	  in	  tissue	  culture	  75.	  As	  noted	  above,	  in	  C.	  elegans,	  
overexpression	  of	  mCherry::cdc-­42	  increased	  the	  formation	  of	  small	  cysts	  along	  the	  length	  
of	  shortened	  canals	  in	  wild-­‐type,	  exc-­5	  mutant,	  and	  exc-­5-­‐overexpressing	  animals	  (Table	  
6.2).	  	  Expression	  of	  mCherry::cdc-­42	  in	  animals	  that	  overexpressed	  EXC-­‐5	  resulted	  in	  
substantially	  shorter,	  more	  convoluted	  tubules.	  	  In	  those	  convoluted	  excretory	  cells,	  the	  
location	  of	  CDC-­‐42	  expression	  is	  strongly	  concentrated	  around	  the	  area	  of	  the	  canals	  where	  
the	  convoluted	  tubules	  and	  their	  associated	  canaliculi	  are	  located	  (Fig.	  6.9A).	  	  This	  is	  the	  
same	  area	  where	  EXC-­‐5	  is	  concentrated	  in	  these	  cells	  (Fig.	  6.9B,	  C),	  consistent	  with	  the	  
evidence	  from	  Table	  6.2	  that	  EXC-­‐5	  acts	  at	  least	  in	  part	  through	  activation	  of	  CDC-­‐42.
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Figure	  6.7	  –	  EXC-­5	  Overexpression	  does	  not	  Alter	  Most	  Subcellular	  Markers	  
Overexpression	  of	  exc-­5	  does	  not	  alter	  distribution	  of	  most	  subcellular	  markers.	  	  Excretory	  
canal	  cells	  of	  young	  adult	  animals	  containing	  integrated	  homozygous	  exc-­5::gfp	  constructs	  
in	  addition	  to	  integrated	  constructs	  of	  subcellular	  markers	  linked	  to	  mCherry	  driven	  by	  the	  
exc-­9	  promoter.	  	  Left-­‐hand	  panels	  show	  weak	  fluorescence	  of	  low	  overexpression	  of	  EXC-­‐
5::GFP	  as	  control,	  and	  right-­‐hand	  panels	  show	  expression	  of	  mCherry-­‐linked	  subcellular	  
markers:	  	  (A,	  B)	  GLO-­‐1;	  	  (C,	  D)	  GRIP;	  (E,	  F)	  RAB-­‐5;	  (G,	  H)	  RAB-­‐7;	  (I,	  J)	  RAB-­‐11.	  	  Bars,	  50	  
µm.	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Figure	  6.8	  –	  EXC-­5	  Overexpression	  Alters	  RME-­1	  and	  EEA-­1	  Distribution	  
EXC-­‐5	  overexpression	  alters	  subcellular	  marker	  distribution.	  	  Excretory	  canal	  cells	  of	  young	  adult	  animals	  
containing	  integrated	  homozygous	  exc-­5::gfp	  constructs,	  in	  addition	  to	  integrated	  constructs	  of	  subcellular	  
markers	  linked	  to	  mCherry	  driven	  by	  the	  exc-­9	  promoter.	  	  (A-­C)	  RME-­‐1;	  	  (D-­F)	  Dying	  L1	  larva	  homozygous	  
both	  for	  mCherry::eea-­1	  and	  for	  exc-­5::gfp	  (in	  a	  background	  wild-­‐type	  for	  exc-­5);	  (G-­I)	  Young	  adult	  animal	  
heterozygous	  for	  mCherry::eea-­1	  and	  homozygous	  for	  exc-­5::gfp	  (in	  a	  background	  wild-­‐type	  for	  exc-­5).	  	  Panels	  
A,	  D,	  G,	  DIC	  image;	  panels	  B,	  E,	  H,	  expression	  of	  EXC-­‐5::GFP;	  images	  contrast-­‐enhanced	  to	  emphasize	  position	  
of	  very	  weakly	  fluorescent	  GFP	  (especially	  in	  B,	  in	  which	  GFP	  expression	  was	  very	  low).	  	  Arrows	  indicate	  
position	  of	  canal.	  	  Panels	  C,	  F,	  I,	  expression	  of	  markers	  linked	  to	  mCherry.	  	  Bars,	  50	  µm.	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Figure	  6.9	  –	  CDC-­42	  and	  EXC-­5	  are	  Enriched	  at	  the	  Lumen	  
	  
Subcellular	  location	  of	  EXC-­‐5	  and	  
activated	  CDC-­‐42	  in	  convoluted	  
excretory	  canal	  tubule	  of	  animal	  
expressing	  both	  homozygous	  
mCherry::cdc-­42	  and	  functional	  exc-­
5::gfp	  constructs.	  	  DIC	  image	  of	  this	  
animal’s	  excretory	  canal	  cell	  body	  is	  
shown	  in	  Fig.	  6.1C.	  	  Arrows	  indicate	  
area	  filled	  with	  convoluted	  tubule	  and	  
associated	  canaliculi,	  arrowhead	  
indicates	  cell	  nucleus,	  and	  asterisk	  
indicates	  location	  of	  neighboring	  
posterior	  pharyngeal	  bulb.	  	  
(A)	  mCherry::CDC-­‐42	  is	  concentrated	  
around	  the	  convoluted	  tubular	  area,	  
with	  some	  elevated	  expression	  also	  
evident	  surrounding	  the	  nucleus	  
(arrowheads).	  	  
(B)	  	  EXC-­‐5::GFP	  is	  strongly	  
concentrated	  in	  the	  subapical	  region	  
surrounding	  the	  convoluted	  excretory	  
canal	  tubule	  and	  canaliculi.	  	  	  
(C)	  Merged	  micrographs.	  	  All	  
photographs	  false-­‐colored	  and	  contrast-­‐
enhanced	  to	  show	  areas	  of	  highest	  
expression.	  	  Bar,	  50	  µm.	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Accumulation	  of	  Early	  Endosomes	  Precedes	  Cyst	  Formation	  
	  
To	  test	  whether	  the	  accumulation	  of	  early	  endosomal	  material	  adjacent	  to	  cysts	  was	  the	  
cause	  or	  a	  result	  of	  cyst	  formation,	  we	  examined	  the	  expression	  of	  early	  endosomal	  marker	  
EEA-­‐1	  (Fig.	  6.10)	  and	  recycling	  endosomal	  marker	  RME-­‐1	  in	  rh232	  animals	  prior	  to	  and	  
during	  the	  formation	  of	  excretory	  canal	  cysts	  (data	  not	  shown).	  Other	  strains	  examined	  
included	  BK30,	  BK36,	  BK209,	  BK204,	  BK221,	  BK217,	  BK215,	  BK212,	  and	  BK231;	  looking	  at	  
CDC-­‐42,	  CHC-­‐1,	  RAB-­‐5,	  and	  RAB-­‐11	  expression	  over	  time	  (data	  not	  shown).	  	  Cysts	  initially	  
formed	  in	  the	  late	  stages	  of	  embryogenesis	  and	  early	  first	  larval	  stage.	  	  Cysts	  formed	  
suddenly	  and	  were	  initially	  small	  in	  size.	  	  In	  exc-­5	  mutants,	  these	  cysts	  formed	  at	  the	  end	  of	  
both	  anterior	  and	  posterior	  canals,	  but	  occasionally	  developed	  in	  additional	  isolated	  areas	  
along	  the	  length	  of	  the	  canal.	  
	  
The	  EEA-­‐1	  marker	  showed	  altered	  expression	  during	  the	  process	  of	  cyst	  formation.	  	  In	  
animals	  containing	  only	  the	  mCherry::eea-­1	  integrant,	  there	  was	  little	  visible	  EEA-­‐1	  
accumulation	  along	  the	  length	  of	  the	  canal	  even	  after	  the	  animal	  hatched.	  	  When	  expressed	  
in	  rh232	  animals,	  however,	  there	  appeared	  strong	  build-­‐ups	  of	  mCherry::EEA-­‐1	  during	  
embryogenesis	  in	  regions	  of	  the	  canal	  prior	  to	  cyst	  formation	  (Fig.	  6.10).	  	  Continuous	  
observation	  of	  these	  canals	  showed	  the	  rapid	  development	  of	  cysts	  at	  the	  locations	  where	  
EEA-­‐1::mCherry	  had	  accumulated.	  	  Since	  expression	  of	  EEA-­‐1	  precedes	  the	  appearance	  of	  
cysts,	  we	  conclude	  that	  the	  abnormal	  buildup	  of	  apical	  early	  endosomes	  in	  exc-­5	  mutants	  
causes	  weakening	  of	  the	  apical	  cytoskeleton	  that	  allows	  collapse	  of	  the	  tubule	  into	  fluid-­‐
filled	  cysts.	  	  We	  conclude	  that	  disruption	  of	  EXC-­‐5-­‐mediated	  endosome	  regulation	  precedes	  
and	  is	  likely	  the	  cause	  of	  failure	  of	  the	  apical	  surface	  leading	  to	  cyst	  formation.
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Figure	  6.10	  –	  Accumulation	  of	  EEA-­1	  Precedes	  Cyst	  Formation	  
	  
Alteration	  of	  subcellular	  marker	  expression	  precedes	  cyst	  formation	  in	  exc-­5	  (rh232)	  
animals.	  	  (A-­G)	  DIC	  and	  fluorescence	  micrographs	  of	  a	  single	  animal	  expressing	  
mCherry::eea-­1	  driven	  by	  the	  exc-­9	  promoter,	  beginning	  at	  the	  3-­‐fold	  stage	  of	  
embryogenesis.	  	  Expression	  is	  evident	  in	  many	  head	  neurons	  at	  this	  stage	  as	  well	  as	  in	  the	  
excretory	  canal	  cell.	  	  Images	  were	  taken	  at	  the	  times	  indicated,	  starting	  at	  the	  point	  at	  
which	  observation	  of	  the	  animal	  began.	  	  Wild-­‐type	  embryos	  hatch	  within	  2	  hours	  of	  the	  3-­‐
fold	  stage	  at	  20°C	  45.	  Cysts	  appear	  in	  DIC	  micrographs	  with	  DIC	  “shadow”	  to	  the	  upper	  left	  
of	  the	  cyst.	  	  Gut	  granules	  and	  other	  subcellular	  organelles	  show	  a	  DIC	  “shadow”	  to	  the	  
lower	  right	  of	  the	  object.	  	  Animal	  was	  moving	  inside	  the	  embryo;	  DIC	  and	  fluorescence	  
micrographs	  show	  similar	  positions,	  but	  cannot	  always	  be	  directly	  overlaid.	  	  Boxed	  areas	  
indicate	  the	  same	  areas	  of	  the	  animal,	  and	  are	  enlarged	  in	  panels	  to	  the	  right.	  	  An	  asterisk	  
designates	  the	  posterior	  pharyngeal	  bulb.	  	  Arrows	  in	  enlarged	  DIC	  micrographs	  show	  cysts.	  	  
(A)	  No	  cysts	  were	  evident	  in	  the	  canals,	  and	  eea-­1	  expression	  was	  barely	  detectable	  in	  the	  
left-­‐hand	  posterior	  canal.	  	  (B)	  Localized	  eea-­1	  accumulation	  is	  evident	  in	  the	  canal,	  while	  
no	  cysts	  have	  formed.	  	  (C)	  The	  area	  expressing	  eea-­1	  in	  panel	  B	  now	  shows	  small	  cysts	  
(right-­‐hand	  enlarged	  panels),	  while	  eea-­1	  expression	  is	  now	  evident	  in	  a	  new	  area	  near	  the	  
cell	  body	  (left-­‐hand	  enlarged	  panels).	  	  (D-­F)	  eea-­1	  expression	  persists	  throughout	  this	  area	  
of	  the	  posterior	  canal	  as	  cysts	  become	  evident.	  	  (G)	  By	  the	  time	  of	  hatching,	  eea-­1	  
expression	  has	  spread	  and	  intensified,	  many	  new	  cysts	  have	  formed,	  and	  cysts	  have	  greatly	  
enlarged.	  	  Brightness	  and	  contrast	  was	  enhanced	  in	  DIC	  micrographs	  only	  to	  show	  cysts	  
more	  clearly.	  	  Fluorescence	  micrographs	  were	  brightened	  and	  contrast	  increased	  to	  show	  
areas	  of	  greatest	  canal	  fluorescence.	  	  In	  enlarged	  panels,	  DIC	  micrographs	  only	  were	  
digitally	  sharpened.	  	  Bars,	  50	  µm.
	  
	   86	  
Discussion	  
EXC-­5	  mediates	  movement	  of	  material	  from	  apical	  early	  endosomes	  to	  recycling	  
endosomes	  
All	  cells	  must	  constantly	  recycle	  and	  move	  material	  in	  order	  to	  accommodate	  growth	  and	  
movement	  of	  the	  animal.	  	  For	  narrow	  single-­‐celled	  tubules,	  recycling	  is	  especially	  
important.	  	  Osmotic	  pressure	  constantly	  exerts	  force	  to	  expand	  the	  tubule.	  	  Nematodes	  
continuously	  bend	  back	  and	  forth,	  additionally	  stressing	  the	  narrow	  excretory	  canals.	  	  In	  
the	  excretory	  canals,	  loss	  of	  proteins	  at	  the	  basolateral	  surface	  causes	  misdirection	  and	  
shortening	  of	  tubule	  outgrowth,	  but	  does	  not	  affect	  lumen	  diameter	  67,117.	  Failure	  of	  the	  
apical	  surface	  allows	  osmotic	  pressure	  to	  form	  fluid-­‐filled	  cysts	  rapidly.	  	  EXC	  proteins	  thus	  
prevent	  loss	  or	  weakening	  of	  the	  apical	  canal	  surface	  48.	  As	  seen	  here	  and	  in	  previous	  work,	  
overexpression	  of	  EXC-­‐5,	  EXC-­‐9,	  or	  constitutively-­‐active	  CDC-­‐42	  proteins	  allows	  the	  tubule	  
to	  form	  and	  maintain	  a	  normal	  diameter,	  but	  prevents	  extension	  of	  the	  canals	  along	  the	  
basal	  surface,	  which	  results	  in	  a	  convoluted	  tubule	  51,57.	  Similar	  results	  have	  been	  seen	  in	  C.	  
elegans	  mosaic	  animals	  deficient	  in	  basolateral	  or	  basement	  membrane	  proteins	  (integrin,	  
laminin)	  66,67,	  as	  well	  as	  in	  the	  narrow	  single-­‐celled	  tubular	  termini	  of	  Drosophila	  trachea	  
deficient	  in	  talin	  or	  integrin	  6.	  We	  infer	  that	  EXC	  proteins	  that	  mediate	  intracellular	  
trafficking	  primarily	  exert	  their	  effects	  on	  movement	  of	  vesicles	  to	  or	  from	  the	  apical	  
surface,	  but	  that	  overexpression	  of	  these	  proteins	  can	  prevent	  normal	  basolateral	  
trafficking	  as	  well.	  
Expression	  of	  multiple	  labeled	  markers	  for	  subcellular	  compartments	  found	  that	  all	  of	  
these	  compartments	  are	  at	  greatest	  concentration	  near	  the	  excretory	  cell	  body,	  but	  are	  all	  
present	  throughout	  the	  length	  of	  the	  canals.	  	  These	  results	  confirm	  previous	  electron	  
micrographic	  studies	  that	  showed	  endoplasmic	  reticulum,	  Golgi,	  multivesicular	  bodies,	  
lysosomes,	  and	  a	  myriad	  of	  tubulovesicular	  structures	  throughout	  the	  excretory	  canals,	  
especially	  near	  the	  apical	  (luminal)	  surface	  48,107.	  
The	  results	  presented	  in	  this	  chapter	  show	  that	  EXC-­‐5	  plays	  a	  critical	  role	  in	  returning	  
material	  to	  the	  apical	  surface	  in	  the	  canals.	  	  When	  exc-­5	  is	  deleted,	  most	  of	  the	  mCherry-­‐
labeled	  markers	  retained	  the	  position	  and	  intensity	  observed	  in	  wild-­‐type	  animals,	  with	  the	  
exception	  of	  labeled	  EEA-­‐1	  and	  RME-­‐1.	  	  Without	  EXC-­‐5	  present,	  RME-­‐1/EHD,	  found	  on	  
labeled	  recycling	  endosomes	  31,112,118,	  appeared	  gradually	  depleted,	  while	  EEA-­‐1,	  a	  marker	  
for	  early	  endosomes,	  abnormally	  accumulated.	  	  EEA-­‐1	  formed	  large	  irregular	  accretions	  
especially	  surrounding	  cysts.	  	  Such	  enlarged	  endosomes	  are	  a	  hallmark	  of	  blocked	  recycling	  
119,120.	  Most	  strikingly,	  progressive	  studies	  showed	  that	  the	  accumulations	  of	  EEA-­‐1	  formed	  
at	  these	  locations	  prior	  to	  the	  formation	  of	  cysts,	  and	  could	  in	  fact	  be	  used	  to	  predict	  the	  
sites	  of	  cyst	  formation.	  	  We	  infer	  that	  EXC-­‐5	  is	  needed	  for	  the	  transport	  of	  material	  from	  
apical	  early	  endosomes	  to	  recycling	  endosomes.	  	  In	  this	  model	  (Fig.	  6.11),	  when	  EXC-­‐5	  is	  
missing,	  apical	  surface	  proteins	  that	  guide	  reformation	  and	  strengthening	  of	  the	  
cytoskeleton	  are	  taken	  up	  into	  endocytic	  vesicles,	  but	  cannot	  pass	  further	  into	  recycling	  
endosomes	  to	  be	  returned	  to	  the	  surface,	  so	  that	  the	  apical	  cytoskeleton	  is	  not	  maintained,	  
ultimately	  to	  collapse	  (Fig.	  6.11B).	  	  When	  exc-­5	  is	  overexpressed,	  the	  apical	  surface	  is	  
maintained	  or	  in	  severe	  cases	  constricted;	  we	  hypothesize	  that	  so	  much	  material	  is	  passed	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to	  the	  apical	  surface	  that	  traffic	  to	  the	  basal	  surface	  is	  slowed	  and	  eventually	  depleted,	  
leading	  to	  inability	  of	  the	  canal	  to	  extend	  properly,	  so	  that	  the	  cell	  forms	  convoluted	  
tubules	  of	  normal	  diameter	  inside	  an	  enlarged	  cell	  body	  (Fig.	  6.11C).	  	  Such	  a	  balance	  of	  
apical	  to	  basal	  endocytic	  trafficking	  mediated	  by	  Rho	  proteins	  such	  as	  Cdc42	  has	  been	  
found	  to	  be	  important	  for	  the	  maintenance	  of	  polarity	  in	  mammalian	  epithelial	  cells	  38,121.	  	  
The	  Excretory	  Canals	  Are	  a	  Sensitive	  Indicator	  of	  Endosomal	  Movement	  and	  
Structure	  
The	  labeled	  markers	  used	  here	  have	  previously	  been	  found	  to	  label	  distinct	  structures	  in	  
nematode	  intestinal	  cells	  and	  coelomocytes	  15,122,123.	  Although	  the	  distance	  from	  apical	  to	  
basal	  surface	  is	  much	  smaller	  in	  the	  canals	  vs.	  wide	  intestinal	  cells,	  the	  markers	  labeled	  
distinct	  locations	  within	  the	  canals.	  	  In	  addition,	  the	  great	  length	  of	  the	  canals	  (the	  longest	  
cell	  in	  the	  organism)	  provides	  a	  sensitive	  indicator	  of	  the	  effects	  of	  trafficking	  on	  cell	  
structure.	  	  The	  distance	  from	  nucleus	  to	  distal	  cell	  surfaces	  is	  magnified,	  so	  that	  differences	  
in	  endosome	  concentration	  along	  the	  length	  of	  the	  canals	  are	  easily	  apparent.	  	  As	  a	  result,	  
mild	  changes	  in	  the	  dose	  of	  EXC-­‐5	  produced	  rapid	  formation	  of	  easily	  detectable	  cysts,	  or	  of	  
convolutions	  in	  the	  path	  of	  the	  canals.	  
Expression	  of	  a	  few	  of	  the	  markers	  by	  themselves	  occasionally	  showed	  effects	  on	  canal	  
structure.	  	  In	  some	  cases,	  this	  expression	  caused	  the	  luminal	  surface	  of	  the	  canal	  cell	  to	  
dissociate	  from	  the	  basal	  surface,	  which	  resulted	  in	  formation	  of	  a	  narrow	  “tail”	  of	  
cytoplasm	  without	  a	  lumen	  (Fig.	  6.2D).	  This	  ‘tailing’	  effect	  was	  seen	  consistently	  in	  animals	  
overexpressing	  EXC-­‐5	  in	  conjunction	  with	  any	  of	  the	  subcellular	  markers.	  Expression	  of	  
marked	  RAB-­‐5	  or	  RAB-­‐11	  at	  low	  but	  significant	  penetrance	  (7-­‐9%,	  Table	  6.2)	  caused	  the	  
canals	  to	  exhibit	  the	  convoluted	  canal	  structure	  caused	  by	  overexpression	  of	  functional	  
EXC-­‐5	  or	  EXC-­‐9	  51,	  in	  which	  the	  apical	  tubule	  is	  maintained	  at	  its	  proper	  diameter	  and	  
length,	  but	  the	  basal	  surface	  fails	  to	  extend.	  	  One	  possible	  explanation	  is	  that	  
overexpression	  of	  any	  of	  these	  proteins	  increases	  the	  rate	  of	  turnover	  of	  material	  from	  the	  
apical	  surface,	  which	  then	  monopolizes	  the	  recycling	  pathways	  such	  that	  membrane	  
proteins	  from	  the	  basal	  surface	  are	  not	  efficiently	  recycled.	  	  Overexpression	  of	  RAB	  
proteins	  can	  alter	  the	  ratio	  of	  material	  passed	  through	  different	  pathways;	  e.g.	  in	  
mammalian	  cells,	  RAB-­‐11	  overexpression	  forced	  material	  away	  from	  movement	  into	  
lysosomes	  towards	  greater	  amounts	  of	  recycling	  124,125.	  Expression	  of	  constitutively	  
activated	  RAB-­‐5	  causes	  the	  formation	  of	  enlarged	  endosomes	  126,127,	  but	  that	  effect	  was	  not	  
seen	  here	  in	  canals	  with	  wild-­‐type	  levels	  of	  EXC-­‐5.	  	  In	  canals	  overexpressing	  EXC-­‐5,	  
surprisingly,	  expression	  of	  labeled	  EEA-­‐1	  did	  cause	  enlargement	  of	  endosomes.	  	  It	  will	  be	  
interesting	  to	  observe	  the	  effects	  on	  canal	  structure	  caused	  by	  manipulation	  of	  other	  
proteins	  that	  regulate	  trafficking.
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Figure	  6.11	  –	  A	  Model	  for	  EXC-­5	  Function	  in	  Membrane	  Trafficking	  
	  
Model	  for	  effects	  of	  EXC-­‐5	  on	  organelle	  
movement.	  	  (A)	  EXC-­‐5	  mediates	  the	  
passage	  of	  early	  endosomes	  to	  recycling	  
endosomes,	  presumably	  through	  
activation	  of	  CDC-­‐42	  as	  well	  as	  other	  
small	  GTPases.	  	  (B)	  Loss	  of	  EXC-­‐5	  through	  
mutation	  prevents	  movement	  of	  apical	  
early	  endosomes,	  marked	  by	  RAB-­‐5	  and	  
especially	  by	  EEA-­‐1,	  which	  then	  
accumulate.	  	  As	  less	  material	  is	  moved	  
into	  the	  recycling	  endosome,	  the	  
expression	  of	  the	  recycling	  endosome	  
marker	  RME-­‐1	  is	  depleted.	  	  Loss	  of	  
membrane-­‐bound	  proteins	  at	  the	  apical	  
surface	  cause	  weakening	  of	  this	  surface,	  
eventually	  to	  break	  under	  osmotic	  
pressure	  from	  the	  canal	  lumen,	  to	  form	  a	  
fluid-­‐filled	  cyst.	  	  	  
(C)	  Overexpression	  of	  EXC-­‐5	  enhances	  
apical	  recycling,	  so	  that	  the	  apical	  surface	  
is	  maintained	  and	  lumen	  diameter	  
remains	  narrow.	  	  The	  large	  amount	  of	  
apical	  material	  passing	  through	  the	  
recycling	  endosome	  prevents	  efficient	  
passage	  of	  material	  from	  the	  basal	  early	  
endosome,	  presumably	  including	  
membrane	  proteins	  such	  as	  integrins	  that	  
bind	  to	  the	  basement	  membrane.	  	  Slow	  
recycling	  of	  these	  proteins	  to	  the	  basal	  
surface	  allows	  delamination	  of	  these	  cells	  
to	  occur,	  as	  seen	  in	  animals	  
overexpressing	  exc-­5	  57,	  and	  extension	  of	  
the	  canals	  is	  halted. 
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EXC-­5	  as	  a	  Model	  for	  FGD	  Activity	  
EXC-­‐5	  is	  homologous	  to	  the	  FGD	  family	  of	  four	  mammalian	  guanine	  exchange	  factors	  56,57.	  
These	  genes	  include	  FGD1,	  which	  is	  defective	  in	  Aarskog-­‐Scott	  Syndrome,	  a	  developmental	  
syndrome	  in	  which	  the	  skeleton	  of	  the	  jaws	  and	  limbs	  are	  malformed	  58;	  and	  FGD4,	  the	  
locus	  of	  Charcot-­‐Marie-­‐Tooth	  Syndrome	  Type	  4H	  (CMT4H),	  a	  muscular	  dystrophy	  59.	  FGD1	  
has	  been	  shown	  in	  3T3	  cells	  to	  activate	  the	  Rho-­‐GTPase	  CDC42,	  but	  also	  had	  other	  effects	  
not	  mediated	  through	  CDC42	  77,78.	  We	  found	  similar	  effects	  here.	  	  Transient	  expression	  of	  
constitutively	  active	  CDC-­‐42,	  as	  well	  as	  stable	  expression	  of	  the	  small	  GBD-­‐WSP-­‐1	  (which	  
binds	  to	  activated	  CDC-­‐42	  106,	  both	  exerted	  effects	  on	  the	  canal	  similar	  to	  that	  of	  EXC-­‐5	  
overexpression.	  	  Both	  in	  wild-­‐type	  animals	  and	  mutants	  lacking	  EXC-­‐5	  function,	  expression	  
of	  WSP-­‐1	  GBD	  caused	  shortening	  of	  the	  canals	  and	  formation	  of	  convoluted	  tubules,	  similar	  
to	  the	  effects	  of	  EXC-­‐5	  overexpression	  (Table	  6.2).	  	  Transient	  expression	  of	  constitutively	  
active	  CDC-­‐42	  had	  the	  same	  effect	  in	  wild-­‐type	  animals.	  	  In	  addition,	  when	  the	  exc-­5	  gene	  
was	  overexpressed,	  expression	  of	  WSP-­‐1	  GBD	  had	  little	  further	  effect	  on	  canal	  morphology,	  
consistent	  with	  EXC-­‐5	  overexpression	  having	  already	  activated	  CDC-­‐42.	  	  Finally,	  transient	  
expression	  of	  dominant-­‐negative	  CDC-­‐42	  in	  wild-­‐type	  worms	  caused	  defects	  in	  canal	  
morphology	  similar	  to	  that	  caused	  through	  loss	  of	  EXC-­‐5	  activity.	  	  We	  infer	  that	  EXC-­‐5	  and	  
WSP-­‐1	  GBD	  may	  cause	  similar	  effects	  on	  CDC-­‐42	  by	  causing	  an	  increase	  in	  the	  amount	  of	  
this	  GTPase	  present	  in	  the	  activated,	  phosphorylated,	  form.	  
On	  the	  other	  hand,	  we	  saw	  no	  obvious	  differences	  in	  the	  location	  of	  labeled	  GBD-­‐WSP-­‐1	  in	  
the	  canals	  when	  EXC-­‐5	  was	  present	  or	  deleted.	  	  GBD-­‐WSP-­‐1	  labeled	  some	  puncta,	  but	  most	  
of	  the	  expression	  of	  both	  GBD-­‐WSP-­‐1	  and	  CDC-­‐42	  was	  cytoplasmic,	  so	  it	  is	  not	  clear	  if	  
activated	  CDC-­‐42	  would	  have	  been	  easily	  evident	  in	  these	  animals.	  	  While	  constitutively-­‐
active	  CDC-­‐42	  did	  not	  rescue	  the	  cystic	  phenotype	  in	  exc-­5	  mutants,	  it	  is	  worth	  noting	  that	  
overexpression	  of	  GBD-­‐WSP-­‐1	  had	  the	  strongest	  rescuing	  effects	  of	  any	  gene	  tested.	  As	  
mentioned	  above,	  expression	  of	  GBD-­‐WSP-­‐1	  in	  an	  rh232	  mutant	  shortened	  the	  canal	  length	  
but	  it	  also	  prevented	  cysts	  from	  forming	  in	  50%	  of	  the	  canals	  examined.	  Even	  those	  canals	  
that	  did	  develop	  cysts,	  showed	  a	  reduced	  number	  of	  them	  (Table	  6.2).	  This	  suggests	  that	  
the	  length	  of	  the	  canal	  and	  cyst	  formation	  are	  separable	  events,	  and	  that	  EXC-­‐5	  may	  
function	  through	  multiple	  pathways,	  not	  all	  of	  which	  are	  directly	  mediated	  by	  interaction	  
with	  CDC-­‐42.	  	  EXC-­‐5	  does	  exhibit	  some	  genetic	  interactions	  with	  MIG-­‐2,	  a	  Rac	  homologue	  57	  
(Chapter	  5),	  and	  with	  EXC-­‐9,	  a	  homologue	  of	  the	  mammalian	  LIM-­‐domain	  protein	  CRIP	  51.	  It	  
will	  be	  important	  to	  determine	  if	  these	  other	  proteins	  similarly	  affect	  endosome	  
morphology	  in	  the	  excretory	  canals	  and	  other	  cells	  where	  they	  are	  expressed.	  
In	  patients	  with	  CMT4H,	  the	  Schwann	  cells	  of	  the	  peripheral	  nervous	  system	  develop	  
properly	  to	  wrap	  around	  neurons	  to	  form	  single-­‐celled	  tubular	  insulation.	  	  Over	  the	  course	  
of	  years,	  however,	  tubules	  in	  CMT4H	  patients	  develop	  structural	  defects	  strikingly	  similar	  
in	  morphology	  to	  those	  of	  the	  excretory	  canals	  in	  exc-­5-­‐deficient	  mutants,	  with	  apparently	  
normal	  tubules	  juxtaposed	  next	  to	  myelin	  outfoldings	  that	  no	  longer	  insulate	  the	  nerves	  65.	  
While	  FGD1	  is	  associated	  with	  transport	  from	  the	  trans-­‐Golgi	  network	  99,	  FGD	  proteins	  all	  
contain	  a	  FYVE	  domain	  that	  associates	  with	  phosphatidylinositol	  3-­‐phosphate	  
characteristic	  of	  early	  endosomes	  63.	  Mammalian	  FGD1	  and	  FGD2	  as	  well	  as	  fungal	  FGD	  
have	  all	  been	  found	  associated	  with	  early	  endosomes	  or	  plasma	  membrane	  64,72,100.	  Based	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on	  the	  results	  presented	  here,	  we	  suggest	  that	  EXC-­‐5	  functions	  similarly	  to	  other	  FGD	  
proteins	  in	  the	  regulation	  of	  endosomes	  and	  membrane	  trafficking.	  The	  results	  also	  suggest	  
that	  the	  narrow	  single-­‐celled	  tubules	  of	  the	  mammalian	  Schwann	  cells,	  like	  those	  of	  the	  
nematode	  excretory	  canals,	  are	  a	  difficult	  cell	  structure	  to	  maintain,	  and	  that	  endosomal	  
traffic	  must	  be	  delicately	  balanced	  in	  order	  to	  accommodate	  the	  movement	  and	  growth	  of	  
these	  polarized	  cells	  over	  the	  lifespan	  of	  the	  individual.
	  
	   91	  




In	  order	  to	  take	  a	  more	  directed	  approach	  to	  finding	  conditional	  alleles	  of	  EXC-­‐5,	  we	  have	  
incorporated	  self-­‐excising	  sequences	  of	  amino	  acids,	  called	  inteins,	  into	  EXC-­‐9	  and	  EXC-­‐5.	  
The	  inteins	  used,	  208-­‐S18	  and	  103-­‐S36,	  are	  temperature-­‐sensitive	  variants	  whose	  excision	  
depends	  on	  their	  permissive	  temperatures.	  Incorporation	  of	  the	  208-­‐S18	  intein	  into	  EXC-­‐9	  
was	  able	  to	  rescue	  the	  Exc-­‐9	  mutant	  phenotype,	  but	  this	  activity	  has	  not	  shown	  a	  
temperature-­‐dependent	  effect.	  
Rationale	  
“When	  during	  development	  is	  EXC-­‐5	  required?”	  
Although	  we	  were	  unable	  to	  isolate	  a	  temperature-­‐sensitive	  (ts)	  allele	  of	  EXC-­‐5	  itself	  (see	  
Chapter	  2),	  we	  were	  still	  interested	  in	  creating	  a	  conditional	  version	  of	  the	  protein.	  
Creating	  a	  conditional	  form	  of	  EXC-­‐5	  would	  allow	  us	  to	  understand	  at	  what	  point	  in	  the	  
formation	  of	  the	  canal	  cell	  is	  EXC-­‐5	  activity	  required	  and	  at	  what	  point	  can	  EXC-­‐5	  activity	  
stop	  cyst	  formation.	  
Inteins	  are	  self-­‐excising	  sequences	  of	  amino	  acids	  that	  remove	  themselves	  post-­‐
translationally	  from	  the	  proteins	  in	  which	  they	  exist128.	  Once	  spliced	  out	  of	  the	  protein,	  the	  
inteins	  leave	  no	  residual	  amino	  acid	  sequence	  to	  interfere	  with	  the	  final	  protein	  product.	  
Mutations	  in	  yeast-­‐derived	  inteins	  have	  led	  to	  the	  development	  of	  a	  wide	  range	  of	  TS	  
variants,	  allowing	  conditional	  control	  of	  their	  splicing	  129,130.	  By	  engineering	  these	  TS	  
inteins	  into	  a	  particular	  gene,	  it	  is	  possible	  to	  create	  a	  TS	  allele	  of	  that	  gene.	  At	  permissive	  
temperatures,	  these	  inteins	  will	  splice	  themselves	  out,	  leading	  to	  a	  non-­‐mutant	  protein	  
sequence.	  At	  non-­‐permissive	  temperatures,	  the	  inteins	  will	  remain	  in	  the	  protein	  product	  
and	  disrupt	  the	  normal	  protein	  sequence,	  to	  yield	  a	  non-­‐functional	  protein.	  
We	  used	  two	  different	  TS	  intein:	  103-­‐S36,	  which	  is	  permissive	  at	  18°	  but	  mutant	  at	  higher	  
temperatures;	  208-­‐S18,	  which	  is	  permissive	  at	  22°	  but	  nonfunctional	  at	  higher	  
temperatures,	  and	  engineered	  them	  into	  exc-­9	  and	  exc-­5	  in	  order	  to	  create	  TS	  alleles	  of	  both	  
genes.	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Materials	  and	  Methods	  
Strains	  Used	  
exc-­5	  (rh232)	  and	  exc-­9	  (n2669)	  were	  used	  to	  test	  the	  ability	  of	  the	  intein	  transgenes	  to	  
rescue	  the	  mutant	  phenotypes.	  
DNA	  Constructs	  
An	  exc-­5	  cDNA	  was	  created	  from	  mRNA	  prepared	  from	  wild-­‐type	  (N2)	  animals	  with	  a	  
Magnetic	  mRNA	  Isolation	  kit	  and	  Phusion®RT-­‐PCR	  Kit	  (New	  England	  Biolabs).	  The	  
resultant	  2481	  bp	  exc-­5	  cDNA	  was	  amplified	  and	  sub-­‐cloned	  into	  a pENTR™/D-TOPO® 
vector (Invitrogen Corporation). The sequence of this cDNA encodes the shorter and more 
prevalent isoform of EXC-5 56	  
The	  208-­‐S18	  and	  108-­‐S36	  intein	  constructs	  were	  a	  generous	  gift	  from	  Change	  Tan.	  In	  order	  
to	  make	  a	  clean	  excision	  of	  the	  intein,	  the	  intein	  sequence	  must	  be	  placed	  just	  before	  a	  
naturally	  occurring	  cysteine	  in	  the	  protein	  of	  interest.	  For	  exc-­9,	  we	  chose	  an	  insertion	  site	  
roughly	  in	  the	  middle	  of	  the	  protein,	  in	  front	  of	  Cys-­‐36.	  For	  exc-­5	  the	  sequence	  was	  placed	  
in	  the	  last	  half	  of	  the	  DH	  domain,	  in	  front	  of	  Cys-­‐434.	  This	  was	  done	  to	  ensure	  that	  
unspliced	  intein	  sequence	  left	  in	  the	  protein	  would	  disrupt	  a	  major	  functional	  domain	  of	  
EXC-­‐5.	  Incorporation	  of	  the	  intein	  sequence	  into	  the	  genes	  was	  accomplished	  via	  a	  fusion	  
PCR	  method	  131.	  Two	  fragments	  of	  the	  gene	  to	  be	  used	  were	  amplified,	  one	  fragment	  
containing	  the	  sequence	  upstream	  of	  the	  cysteine	  and	  one	  fragment	  containing	  the	  cysteine	  
and	  all	  downstream	  sequence.	  For	  exc-­9,	  which	  was	  amplified	  from	  genomic	  DNA,	  the	  
upstream	  fragment	  was	  amplified	  using	  a	  forward	  primer	  in	  the	  5’	  UTR	  and	  a	  reverse	  
primer	  containing	  the	  21bp	  of	  sequence	  prior	  to	  the	  cysteine	  as	  well	  as	  the	  first	  21bp	  of	  the	  
intein	  sequence	  (for	  a	  total	  primer	  size	  of	  42bp).	  The	  downstream	  fragment	  was	  amplified	  
using	  a	  forward	  primer	  that	  contained	  21bp	  of	  intein	  sequence	  followed	  by	  21bp	  of	  exc-­9	  
sequence	  starting	  at	  the	  cysteine	  and	  a	  reverse	  primer	  in	  the	  3’UTR.	  DNA	  fragments	  of	  exc-­
5	  were	  amplified	  in	  a	  similar	  manner,	  but	  due	  to	  amplification	  from	  a	  cDNA	  in	  pENTR™	  
instead	  of	  a	  genomic	  copy,	  the	  M13F	  and	  M13R	  primers	  were	  used	  in	  place	  of	  the	  5’UTR	  
and	  3’UTR	  primers	  used	  for	  exc-­9.	  The	  intein	  sequences	  were	  re-­‐amplified	  as	  linear	  PCR	  
products	  with	  primers	  specific	  for	  the	  first	  and	  last	  21bp	  of	  the	  intein.	  These	  three	  
fragments:	  the	  upstream	  gene	  fragment,	  the	  intein	  fragment,	  and	  the	  downstream	  
fragment,	  were	  all	  placed	  in	  the	  same	  PCR	  reaction	  and	  amplified	  using	  primers	  specific	  to	  
the	  beginning	  and	  end	  of	  each	  gene.	  The	  resultant	  product	  was	  a	  fusion	  of	  all	  three	  
fragments	  and	  contained	  the	  intein	  sequence	  directly	  in	  front	  of	  the	  chosen	  cysteine.	  These	  
products	  were	  then	  sub-­‐cloned	  into	  a	  pENTR™	  vector	  and	  subsequently	  used	  in	  a	  
Gateway®	  reaction	  with	  an	  expression	  vector	  containing	  the	  1.4kb	  promoter	  of	  exc-­9	  
linked	  to	  mCherry.	  The	  resultant	  product	  was	  a	  construct	  that	  contained	  an	  N-­‐terminal	  
mCherry-­‐tagged	  exc-­9	  or	  exc-­5	  intein-­‐containing	  gene	  under	  the	  direction	  of	  the	  exc-­9	  
promoter.	  As	  a	  control,	  both	  the	  exc-­5	  cDNA	  and	  a	  genomic	  copy	  of	  exc-­9	  that	  did	  not	  
contain	  the	  intein	  sequence	  were	  placed	  into	  the	  mCherry	  expression	  vector	  and	  tested	  for	  
activity.	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Microinjection	  
Injection	  of	  the	  exc-­9	  control	  plasmid	  and	  the	  exc-­9	  intein	  construct	  was	  at	  100ng/µl	  into	  
exc-­9	  (n2669)	  animals.	  	  
Injection	  of	  the	  exc-­9	  construct	  containing	  the	  208-­‐S18	  (22°)	  intein	  at	  100ng/µl	  into	  exc-­9	  
(n2669)	  animals	  resulted	  in	  a	  worm	  line	  containing	  a	  stable	  array	  of	  the	  transgene.	  Animals	  
were	  placed	  at	  15°	  and	  25°	  and	  allowed	  to	  grow	  for	  three	  or	  more	  days	  and	  produce	  
progeny.	  Second	  generation	  animals	  were	  then	  examined	  to	  see	  if	  the	  canals	  were	  rescued	  
or	  mutant.	  At	  the	  same	  time,	  second	  generation	  animals	  were	  picked	  from	  each	  
temperature	  and	  placed	  at	  the	  opposite	  temperature.	  Animals	  were	  allowed	  to	  grow	  for	  
three	  or	  more	  days	  and	  produce	  progeny.	  Second	  generation	  animals	  were	  examined	  again	  
to	  see	  if	  the	  canals	  were	  rescued	  or	  mutant.	  Temperature	  was	  monitored	  in	  order	  to	  verify	  
that	  incubator	  temperatures	  had	  not	  exceeded	  the	  permissive	  temperatures.	  
Injection	  of	  the	  exc-­9	  construct	  containing	  the	  103-­‐S36	  (18°)	  intein	  at	  100ng/µl	  into	  exc-­9	  
(n2669)	  animals	  resulted	  in	  a	  worm	  line	  containing	  an	  unstable	  array	  of	  the	  transgene.	  
Animals	  were	  placed	  at	  15°	  or	  25°	  and	  allowed	  to	  grow	  for	  three	  days.	  Animals	  were	  then	  
examined	  for	  their	  canal	  phenotypes.	  	  
Results	  
EXC-­9	  Intein	  does	  not	  show	  Temperature-­Dependent	  Rescue	  
Injection	  of	  the	  exc-­9	  control	  plasmid	  (lacking	  an	  inserted	  intein)	  into	  exc-­9	  (n2669)	  
animals	  rescued	  the	  mutant	  phenotype	  and	  in	  some	  cases	  cause	  convoluted	  tubules.	  This	  
result	  indicates	  that	  the	  expression	  vector	  as	  well	  as	  the	  exc-­9	  sequence	  used	  in	  the	  
production	  of	  the	  intein-­‐containing	  version	  was	  functional	  and	  able	  to	  rescue	  the	  exc-­9	  
mutant	  animals.	  	  
Some	  animals	  expressing	  the	  EXC-­‐9::208-­‐S18	  intein	  did	  display	  almost	  complete	  rescue	  
(Fig.	  7.1).	  Unfortunately,	  this	  effect	  was	  infrequent	  and	  not	  temperature-­‐dependent.	  Only	  
5%	  of	  the	  canals	  at	  15°	  (n=82)	  showed	  a	  rescued	  or	  partially	  rescued	  phenotype.	  Similarly,	  
at	  25°	  only	  6.5%	  of	  canals	  (n=124)	  showed	  a	  rescued	  or	  partially	  rescued	  phenotype.	  These	  
results	  indicate	  that	  the	  EXC-­‐9::203-­‐S18	  intein	  is	  able	  to	  create	  enough	  EXC-­‐9	  activity	  to	  
restore	  the	  wild-­‐type	  phenotype	  at	  a	  low	  frequency,	  but	  this	  activity	  is	  independent	  of	  
temperature.	  These	  results	  indicate	  that	  intein	  splicing	  is	  occurring	  randomly	  and	  
inefficiently.	  
Interestingly,	  animals	  expressing	  the	  EXC-­‐9::103-­‐S36	  intein	  could	  not	  be	  rescued.	  At	  all	  
temperatures,	  all	  animals	  examined	  showed	  a	  mutant	  phenotype.	  
EXC-­5	  Intein	  does	  not	  Produce	  Transgenic	  Progeny	  
Injection	  of	  the	  exc-­5	  control	  plasmid	  into	  exc-­5	  (rh232)	  animals	  at	  50ng/µl	  and	  at	  10ng/µl	  
(for	  a	  total	  of	  120	  animals)	  produced	  almost	  no	  transgenic	  animals.	  
Injection	  of	  the	  exc-­5	  construct	  containing	  the	  103-­‐S36	  intein	  at	  50,	  15,	  and	  5ng/µl	  into	  exc-­
5	  (rh232)	  animals	  (for	  a	  total	  of	  95	  animals)	  resulted	  in	  no	  transgenic	  animals.	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Figure	  7.1	  –	  EXC-­9::208-­S118	  Functions	  Independently	  of	  Temperature	  	  
The	  EXC-­‐9::208-­‐S18	  protein	  fusion	  rescues	  the	  exc-­9	  (n2669)	  phenotype	  at	  low	  frequencies	  independent	  of	  
temperature.	  Fluorescent	  images	  of	  L4	  animals	  expressing	  the	  EXC-­‐9::208-­‐S18	  fusion	  protein.	  (A-­C)	  Animals	  
were	  grown	  at	  25°.	  (A)	  The	  majority	  of	  the	  animals	  had	  a	  mutant	  phenotype.	  (B)	  Infrequently	  (6.4%)	  the	  
animals	  showed	  either	  partial	  or	  (C)	  full	  rescue	  of	  the	  canal.	  Similarly	  to	  animals	  grown	  at	  25°,	  (D-­F)	  animals	  
grown	  at	  15°	  (D)	  were	  mostly	  mutant.	  (E)	  Animals	  showed	  either	  partial,	  or	  (F)	  full	  rescue	  at	  the	  same	  
frequency	  (5%)	  as	  animals	  grown	  at	  25°.	  Arrows	  indicate	  the	  cell	  body.	  C	  and	  F	  show	  only	  the	  ends	  of	  canals	  
that	  reached	  full	  length	  in	  the	  animal.
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Discussion	  
If	  the	  EXC-­‐9::208-­‐S18	  intein	  were	  working	  as	  expected,	  all	  or	  almost	  all	  of	  the	  animals	  kept	  
at	  15°	  should	  be	  rescued.	  The	  intein	  should	  excise	  itself	  from	  the	  EXC-­‐9	  protein	  and	  leave	  
behind	  a	  fully	  functional	  protein.	  At	  25°	  the	  ability	  of	  the	  inteins	  to	  remove	  themselves	  
should	  be	  destroyed,	  leaving	  only	  non-­‐functional	  EXC-­‐9	  protein	  being	  produced.	  Our	  data	  
did	  not	  show	  this.	  Instead,	  it	  appears	  that	  in	  the	  majority	  of	  the	  animals	  the	  intein	  is	  not	  
being	  excised,	  even	  in	  animals	  grown	  at	  15°.	  
The	  EXC-­‐9::103-­‐S36	  protein	  did	  even	  worse.	  None	  of	  the	  animals	  expressing	  this	  intein	  
construct	  showed	  any	  reduction	  of	  the	  mutant	  phenotype.	  It	  is	  worth	  noting	  that	  the	  103-­‐
S36	  intein	  had	  two	  silent	  mutations	  present	  in	  the	  constructs	  sent	  by	  Change	  Tan	  as	  
compared	  to	  the	  sequences	  we	  were	  provided.	  At	  basepair	  1190,	  there	  is	  a	  CA	  
transverion	  causing	  the	  codon	  to	  change	  from	  GTC	  to	  GTA,	  both	  of	  which	  code	  for	  valine.	  
The	  second	  mutation	  is	  at	  basepair	  1394	  and	  has	  a	  TC	  transition	  causing	  the	  codon	  to	  
change	  from	  CGT	  to	  CGC,	  both	  of	  which	  code	  for	  arginine.	  It	  is	  possible	  that	  these	  mutations	  
are	  affecting	  the	  ability	  of	  the	  intein	  to	  be	  excised	  although	  it	  is	  unclear	  how.	  In	  addition,	  
the	  phenotype	  of	  exc-­9	  (n2669)	  animals	  injected	  with	  the	  exc-­9::	  103-­S36	  construct	  appear	  
to	  be	  more	  mutant	  than	  those	  animals	  injected	  with	  exc-­9::208-­S18.	  Canals	  were	  
consistently	  shorter	  and	  more	  cystic	  than	  animals	  expressing	  EXC-­‐9::208-­‐S18	  (personal	  
observations).	  
Currently,	  the	  exc-­5	  intein-­‐containing	  construct	  uses	  the	  103-­‐S36	  intein.	  Although	  no	  
transgenic	  lines	  have	  been	  created	  using	  this	  construct,	  work	  on	  creating	  an	  EXC-­‐5::208-­‐
S18	  intein	  is	  underway	  as	  the	  results	  from	  using	  103-­‐S36	  in	  the	  exc-­9	  background	  were	  
unproductive.	  
To	  date,	  there	  has	  not	  been	  any	  significant	  transgenic	  progeny	  generated	  from	  the	  injection	  
of	  the	  exc-­5	  constructs.	  There	  are	  several	  reasons	  why	  these	  may	  be	  failing.	  The	  first	  is	  that	  
isolating	  transgenic	  progeny	  from	  exc-­5	  (rh232)	  animals	  can	  be	  difficult.	  The	  animals	  are	  
sensitive	  to	  osmotic	  stress	  and	  have	  lower	  survival	  rates	  from	  the	  injection	  process	  
(personal	  observations)	  than	  do	  N2	  animals.	  In	  addition,	  rh232	  animals	  produce	  less	  
progeny	  than	  do	  wild-­‐type	  animals	  and	  become	  egg-­‐laying-­‐defective	  as	  they	  become	  older.	  
Although	  injection	  of	  rh232	  animals	  can	  work,	  previous	  more	  successful	  methods	  of	  
permanently	  introducing	  transgenes	  into	  the	  rh232	  background	  have	  been	  accomplished	  
through	  use	  of	  genetic	  crossing	  from	  a	  worm	  strain	  that	  already	  contains	  the	  integrated	  
array.	  	  It	  may	  be	  easiest	  to	  inject	  these	  constructs	  into	  N2	  animals	  first,	  integrate	  the	  
resulting	  array,	  and	  then	  cross	  them	  into	  exc-­5	  (rh232)	  animals.	  
The	  second	  problem	  may	  be	  related	  to	  the	  construct	  itself.	  Previous	  work	  with	  
microinjecting	  exc-­5	  has	  shown	  the	  animals	  to	  be	  sensitive	  to	  the	  amount	  of	  EXC-­‐5	  being	  
expressed	  in	  the	  animal	  when	  exc-­5	  is	  being	  expressed	  under	  its	  native	  promoter	  (see	  
Chapter	  3	  and	  Chapter	  6).	  The	  1.4kb	  exc-­9	  promoter	  is	  significantly	  stronger	  than	  the	  exc-­5	  
promoter	  is,	  and	  expressing	  EXC-­‐5	  at	  higher	  levels	  may	  be	  lethal	  even	  when	  the	  injections	  
are	  done	  at	  low	  concentrations.	  This	  could	  be	  solved	  two	  ways.	  The	  first	  is	  injecting	  carrier	  
DNA	  with	  the	  Pexc-­9::mCherry::exc-­5	  cDNA	  constructs	  as	  was	  done	  with	  N2	  DNA	  and	  the	  exc-­
5::gfp	  construct	  when	  creating	  BK157	  in	  order	  to	  reduce	  the	  repetitive	  copy	  number	  of	  the	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transgene	  in	  the	  extra-­‐chromosomal	  arrays	  that	  are	  built	  in	  the	  animals.	  The	  second	  is	  to	  
change	  the	  promoter	  being	  used	  in	  the	  constructs	  to	  the	  native	  exc-­5	  promoter.	  Although	  
more	  technically	  involved,	  this	  method	  would	  ensure	  that	  EXC-­‐5	  is	  expressed	  in	  exactly	  the	  
right	  tissues,	  in	  exactly	  the	  right	  time,	  and	  at	  less	  deleterious	  levels	  than	  is	  expressed	  from	  
the	  exc-­9	  promoter.	  
The	  third	  problem	  may	  be	  the	  protein	  sequence	  on	  either	  side	  of	  the	  intein	  insertion	  site.	  
Previous	  studies	  have	  shown	  that	  excision	  efficiency	  of	  inteins	  either	  in	  vitro	  or	  in	  vivo	  can	  
be	  altered	  by	  the	  sequences	  upstream	  and	  downstream	  of	  the	  intein132.	  Although	  we	  are	  
limited	  on	  the	  possible	  insertion	  sites,	  it	  is	  possible	  that	  alternative	  insertion	  sites	  may	  be	  
more	  effective	  and	  have	  more	  temperature-­‐sensitive	  activity.	  
Even	  if	  the	  exc-­5	  constructs	  were	  successfully	  expressed,	  it	  is	  unclear	  whether	  intein	  
splicing	  is	  a	  viable	  strategy	  in	  C.	  elegans.	  To	  date,	  using	  temperature-­‐sensitive	  inteins	  have	  
been	  successful	  in	  bacteria,	  yeast,	  D.	  melanogaster,	  and	  zebrafish	  130(C.	  Tan,	  personal	  
communication).	  To	  our	  knowledge	  this	  is	  the	  first	  time	  that	  intein	  splicing	  has	  been	  
attempted	  in	  C.	  elegans.	  Although	  there	  is	  no	  specific	  aspect	  of	  C.	  elegans	  biology	  that	  would	  
lead	  us	  to	  believe	  that	  intein	  splicing	  would	  not	  work	  (the	  inteins	  are	  self-­‐excising),	  it	  is	  
possible	  that	  this	  type	  of	  approach	  is	  not	  effective	  in	  nematodes.
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Chapter	  8:	  Generating	  Antibodies	  to	  EXC-­5	  	  
	  
Abstract	  
We	  chose	  four	  different	  amino	  acid	  sequences	  from	  EXC-­‐5	  as	  antigens	  for	  the	  production	  of	  
EXC-­‐5	  antibodies.	  The	  antibodies	  did	  not	  show	  specific	  banding	  patterns	  for	  the	  expected	  
mass	  of	  the	  EXC-­‐5	  protein.	  Antibodies	  from	  animals	  656	  and	  658	  did	  label	  the	  excretory	  
canal	  but	  this	  labeling	  was	  also	  observed	  in	  rh232	  animals.	  In	  addition,	  GFP-­‐labeled	  EXC-­‐5	  
derived	  from	  worm	  protein	  lysates	  was	  not	  detectable	  using	  commercially	  produced	  GFP	  
antibodies.	  
Rationale	  
“How	  can	  we	  identify	  and	  manipulate	  EXC-­‐5?”	  
In	  order	  to	  perform	  a	  host	  of	  biochemical	  experiments,	  the	  most	  simple	  of	  which	  would	  be	  
to	  detect	  the	  presence	  or	  absence	  of	  EXC-­‐5	  protein	  in	  animals	  and	  more	  complex	  ones	  such	  
as	  co-­‐immunoprecipitations	  to	  identify	  EXC-­‐5	  binding	  partners,	  we	  required	  an	  antibody	  
that	  could	  bind	  and	  recognize	  EXC-­‐5.	  
We	  chose	  four	  amino	  acid	  sequences	  from	  different	  parts	  of	  the	  EXC-­‐5	  protein	  to	  be	  used	  as	  
antigenic	  peptides	  and	  then	  tested	  the	  resultant	  eight	  polyclonal	  antibodies	  for	  their	  
specificity	  to	  the	  EXC-­‐5	  protein	  by	  means	  of	  western	  blot	  and	  in	  situ	  labeling.	  	  
None	  of	  the	  antibodies	  showed	  strong	  specificity	  for	  the	  EXC-­‐5	  protein,	  so	  an	  alternate	  
strategy	  was	  used.	  Antibodies	  for	  GFP	  were	  used	  to	  try	  and	  isolate	  GFP-­‐labeled	  EXC-­‐5	  
protein	  for	  the	  purposes	  of	  using	  the	  EXC-­‐5::GFP	  protein	  in	  co-­‐immunoprecipitation	  
reactions.	  
	  
Material	  and	  Methods	  
Strains	  Used	  
N2	  and	  exc-­5	  (rh232)	  animals	  were	  used	  for	  protein	  lysates	  in	  testing	  the	  rabbit-­‐derived	  
antibodies	  to	  EXC-­‐5.	  exc-­5	  (rh232)	  animals	  were	  also	  used	  to	  prepare	  an	  acetone	  powder	  
for	  purifying	  the	  antibodies.	  N2,	  BK36,	  and	  BK157	  were	  used	  to	  generate	  protein	  lysates	  
for	  experiments	  using	  the	  GFP	  antibodies.	  BK157	  contains	  the	  exc-­5::gfp	  insertion	  and	  was	  
used	  to	  identify	  GFP-­‐labeled	  EXC-­‐5	  protein.	  BK36	  animals	  contain	  the	  Pvha-­1::gfp	  transgene,	  
which	  expresses	  GFP	  at	  a	  very	  high	  level	  in	  the	  excretory	  canals,	  and	  were	  used	  as	  a	  
positive	  control	  for	  the	  GFP	  antibody.	  N2	  animals	  have	  no	  GFP	  expression	  and	  were	  used	  as	  
a	  negative	  control.	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Antibody	  Production	  
Four	  peptides	  corresponding	  to	  different	  regions	  of	  the	  EXC-­‐5	  were	  chosen	  based	  on	  their	  
location	  within	  the	  domain	  structure	  of	  EXC-­‐5	  and	  their	  predicted	  antigenic	  properties.	  One	  
peptide	  was	  designed	  at	  aa’s	  107-­‐120	  in	  the	  N-­‐terminal	  region	  of	  EXC-­‐5	  
(ISGDIKGMKPIEFSN),	  two	  peptides	  were	  designed	  for	  the	  end	  of	  the	  first	  PH	  domain	  at	  aa’s	  
525-­‐539	  and	  598-­‐612	  (KTEERFIFLFNDLVI,	  QKEKNDWVDSIFSII),	  and	  a	  fourth	  peptide	  was	  
designed	  between	  the	  FYVE	  and	  last	  PH	  domain	  at	  aa’s	  695-­‐709	  (GIPRSFSTQSNMRRN).	  
Synthetic	  peptides	  were	  made	  and	  antibody	  production	  was	  done	  by	  Sigma-­‐Genosys	  (The	  
Woodlands,	  Texas).	  Two	  rabbits	  were	  used	  for	  each	  peptide,	  resulting	  in	  eight	  different	  
antibodies:	  653,	  654	  –	  (ISGDIKGMKPIEFSN);	  655,	  656	  –	  (KTEERFIFLFNDLVI);	  657,	  658	  –	  
(QKEKNDWVDSIFSII);	  659,	  660	  –	  (GIPRSFSTQSNMRRN).	  To	  reduce	  nonspecific	  
background,	  immune	  sera	  were	  treated	  with	  an	  acetone	  powder	  made	  from	  exc-­5	  (rh232)	  
animals	  to	  remove	  antibodies	  that	  bound	  to	  anything	  other	  than	  EXC-­‐5.	  
The	  antibodies	  used	  against	  GFP	  were	  commercially	  produced	  by	  Roche	  Applied	  Science™	  
(Mannheim,	  Germany)	  as	  ‘Anti-­‐GFP’	  and	  is	  a	  mixture	  of	  two	  monoclonal	  antibodies.	  
	  
Western	  Blotting	  	  
Whole	  animal	  protein	  lysates	  were	  made	  from	  both	  N2	  and	  exc-­5	  animals.	  Animals	  were	  
suspended	  in	  RIPA	  buffer	  containing	  both	  ‘cOmplete	  Mini’	  protease	  inhibitor	  tablets	  and	  
‘PhosSTOP’	  phosphatase	  inhibitor	  tablets	  (Roche	  Applied	  Science,	  Mannheim,	  Germany),	  
frozen	  in	  liquid	  nitrogen,	  and	  then	  ground	  into	  a	  powder.	  The	  powder	  was	  collected	  and	  
frozen	  at	  -­‐80°C.	  Protein	  samples	  were	  taken	  from	  these	  stocks	  and	  allowed	  to	  thaw.	  
Samples	  were	  prepared	  for	  loading	  by	  adding	  61.5µg	  of	  protien	  with	  sample	  buffer	  
containing	  1%	  SDS,	  10%	  glycerol,	  1%	  TRIS	  ph6.8,	  and	  bromophenol	  blue	  and	  then	  boiled	  
for	  10	  minutes.	  Samples	  were	  then	  run	  via	  SDS-­‐PAGE	  on	  10%	  polyacrylamide	  gels.	  The	  
separated	  proteins	  were	  then	  transferred	  to	  Immobilon™-­‐P	  transfer	  membrane	  (Millipore,	  
MA).	  Blots	  were	  blocked	  with	  5%	  milk/PBST.	  The	  blots	  were	  cut	  into	  strips	  and	  then	  
treated	  with	  either	  pre-­‐immune	  serum	  as	  a	  control	  or	  primary	  antibody	  from	  the	  immune	  
serum	  of	  one	  of	  the	  eight	  antibodies.	  Anti-­‐sera	  dilutions	  were	  1:250	  for	  the	  lower	  affinity	  
sera	  (653,	  654,	  655,	  and	  657)	  and	  1:500	  for	  the	  higher	  affinity	  sera	  (656	  and	  658).	  
Peroxidase-­‐labeled	  affinity-­‐purified	  antibodies	  to	  rabbit	  IgG	  were	  used	  as	  secondary	  
antibodies	  (Kirkegaard	  &	  Perry	  Laboratories,	  Inc.,	  Gaithersburg,	  Maryland)	  in	  a	  1:5000	  
dilution.	  Blots	  were	  developed	  by	  use	  of	  ECL	  ™	  Western	  Blotting	  Detection	  Reagents	  
(Amersham	  Biosciences,	  Buckinghamshire,	  England)	  and	  imaged	  on	  X-­‐ray	  film.	  	  
Blots	  labeled	  for	  GFP	  were	  done	  similarly	  using	  protein	  lysates	  for	  N2,	  BK36,	  and	  BK157	  
animals.	  Whole	  blots	  were	  blocked	  with	  5%	  milk/PBST;	  incubated	  with	  Anti-­‐GFP	  
antibodies	  at	  a	  1:1000	  dilution	  in	  1%	  BSA/PBST;	  then	  labeled	  using	  peroxidase-­‐conjugated	  
affinity-­‐purified	  antibodies	  to	  mouse	  IgG	  (Kirkegaard	  &	  Perry	  Laboratories,	  Inc.,	  
Gaithersburg,	  Maryland)	  at	  a	  dilution	  of	  1:2000	  in	  1%	  BSA/PBST.	  Blots	  were	  imaged	  using	  
a	  KODAK™	  4000R	  Image	  Station,	  the	  use	  time	  of	  which	  was	  generously	  provided	  by	  E.	  
Lundquist.	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In	  situ	  Labeling	  
Glass	  slides	  were	  prepared	  by	  adding	  one	  drop	  of	  N2	  animals	  and	  one	  drop	  of	  exc-­5	  (rh232)	  
animals	  on	  opposite	  ends.	  Cover	  slips	  were	  placed	  over	  the	  drops	  and	  then	  the	  slides	  were	  
submerged	  in	  liquid	  N2.	  The	  slides	  were	  then	  removed,	  the	  cover	  slips	  cracked	  off	  the	  
frozen	  worm	  samples,	  and	  then	  placed	  into	  ice-­‐cold	  methanol	  for	  two	  minutes.	  The	  slides	  
were	  then	  removed	  and	  placed	  in	  ice-­‐cold	  acetone	  for	  four	  minutes.	  Slides	  were	  then	  taken	  
out	  of	  the	  acetone	  and	  allowed	  to	  dry.	  Drops	  of	  primary	  antibody	  were	  applied	  to	  the	  N2	  
and	  exc-­5	  worm	  samples	  and	  allowed	  to	  incubate	  overnight.	  Slides	  were	  washed	  with	  PBS	  
and	  then	  treated	  with	  GFP-­‐labeled	  affinity-­‐purified	  secondary	  antibodies	  to	  rabbit	  IgG	  
(Kirkegaard	  &	  Perry	  Laboratories,	  Inc.,	  Gaithersburg,	  Maryland),	  and	  10µl	  of	  a	  1mg/ml	  
solution	  of	  p-­‐Phenylenediamine	  was	  added	  to	  preserve	  fluorescence.	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Results	  
EXC-­5	  Antibodies	  Do	  Not	  Show	  Expected	  EXC-­5-­Specific	  Binding	  on	  Blots	  or	  in	  Worms	  
The	  expected	  mass	  for	  EXC-­‐5	  is	  97	  kDa	  for	  the	  longer	  isoform	  and	  95	  kDa	  for	  the	  shorter	  
isoform.	  Preliminary	  tests	  with	  all	  the	  antibodies	  on	  both	  N2	  and	  rh232	  lysates	  showed	  no	  
single	  band	  at	  this	  size	  that	  was	  both	  present	  in	  the	  N2	  animals	  and	  absent	  in	  the	  rh232	  
animals	  (Fig.	  8.1).	  	  Immune	  serum	  from	  animal	  656	  showed	  an	  extreme	  amount	  of	  
background	  sensitivity	  as	  did	  serum	  from	  animal	  658.	  In	  addition	  to	  adjusting	  antibody	  
concentrations	  and	  exposure	  times,	  the	  antibodies	  were	  then	  cleared	  with	  an	  acetone	  
powder	  made	  from	  crushed	  exc-­5	  (rh232)	  animals.	  This	  was	  done	  to	  eliminate	  any	  
antibodies	  that	  would	  bind	  to	  proteins	  other	  than	  EXC-­‐5.	  Since	  rh232	  animals	  should	  have	  
no	  EXC-­‐5	  protein,	  antibodies	  binding	  to	  any	  background	  protein	  present	  in	  the	  animals	  
should	  adhere	  to	  the	  acetone	  powder	  and	  be	  removed	  from	  the	  solution,	  presumably	  
leaving	  only	  the	  antibodies	  that	  can’t	  bind	  to	  the	  proteins	  in	  an	  exc-­5	  mutant	  animal.	  After	  
these	  adjustments,	  background	  signal	  from	  the	  antibodies	  was	  greatly	  reduced	  (Fig.	  8.2).	  
Unfortunately,	  these	  changes	  did	  not	  show	  a	  band	  corresponding	  to	  the	  expected	  ~100	  kDa	  
EXC-­‐5	  protein	  in	  N2	  lysates,	  but	  missing	  in	  the	  rh232	  lysates.	  On	  the	  contrary,	  antibodies	  
654,	  655,	  657,	  659	  and	  660	  all	  showed	  a	  strong	  bands	  at	  ~50	  kDa	  in	  the	  rh232	  lysate	  and	  
not	  in	  the	  N2	  lysate.	  This	  is	  counter-­‐intuitive	  to	  what	  we	  were	  expecting,	  especially	  
considering	  the	  rh232-­‐acetone-­‐powder-­‐treated	  antibodies,	  which	  should	  have	  removed	  or	  
reduced	  all	  binding	  of	  the	  antibody	  with	  the	  exc-­5	  lysate.	  The	  exc-­5	  (rh232)	  strain	  was	  
checked	  to	  make	  sure	  that	  the	  animals	  being	  used	  contained	  the	  rh232	  deletion,	  and	  it	  was	  
confirmed	  that	  the	  strain	  was	  missing	  the	  exc-­5	  coding	  region	  (see	  Chapter	  2	  for	  methods).	  	  
In	  parallel	  to	  the	  blots,	  we	  also	  examined	  the	  staining	  of	  worms	  with	  these	  antibodies	  after	  
treatment	  with	  the	  rh232	  acetone	  powder.	  Based	  on	  the	  expression	  pattern	  of	  GFP-­‐labeled	  
EXC-­‐5,	  we	  would	  expect	  to	  see	  the	  excretory	  canal,	  pharynx,	  and	  some	  other	  neurons	  being	  
labeled	  by	  an	  antibody	  specific	  to	  EXC-­‐5.	  Similarly	  to	  the	  blots,	  this	  labeling	  should	  be	  
present	  in	  N2	  animals	  and	  not	  in	  the	  exc-­5-­‐null	  strain	  rh232.	  Antibodies	  656	  and	  658	  both	  
labeled	  the	  canal	  as	  well	  as	  the	  pharynx.	  In	  addition,	  658	  appeared	  also	  to	  label	  the	  duct	  
cell	  (Fig.	  8.3).	  Labeling	  of	  the	  canal	  between	  N2	  and	  exc-­5	  worms	  was	  inconsistent	  and	  had	  
a	  high	  amount	  of	  background	  fluorescence,	  commonly	  seen	  for	  antibody	  staining	  of	  worms.	  	  
Labeling	  of	  the	  canal	  was	  seen	  in	  both	  backgrounds	  with	  both	  antibodies,	  although	  the	  
canal	  was	  labeled	  more	  prevalently	  in	  N2	  animals	  (data	  not	  shown).
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Figure	  8.1	  –	  Immune	  Sera	  do	  not	  Show	  EXC-­5	  Specificity	  
	  
Images	  of	  Western	  blots	  
exposed	  to	  X-­‐ray	  film	  for	  
1	  minute.	  Immune	  serum	  
from	  eight	  rabbits	  (653-­‐
660),	  each	  inoculated	  
with	  one	  of	  four	  different	  
antigenic	  peptides,	  were	  
tested	  against	  N2	  and	  exc-­
5	  (rh232)	  protein	  lysates.	  
None	  of	  the	  sera	  
identified	  a	  ~100kDa	  
band	  (the	  expected	  size	  of	  
EXC-­‐5)	  in	  the	  N2	  lysate	  
and	  not	  in	  the	  exc-­5	  
(rh232)	  lysate.	  	  
(A)	  Sera	  from	  animals	  
653-­‐656.	  656	  showed	  
extremely	  high	  reactivity	  
with	  worm	  proteins.	  	  
(B)	  Sera	  from	  animals	  
657-­‐660.	  658	  also	  shows	  
high	  reactivity	  with	  worm	  
proteins.	  Although	  there	  
are	  bands	  present	  at	  
~100kDa,	  these	  bands	  
are	  not	  specific	  to	  the	  N2	  
lysate.
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Figure	  8.2	  –	  Preadsorbed	  Sera	  do	  not	  Show	  EXC-­5	  Specificity	  	  
	  
Images	  of	  Western	  blots	  exposed	  to	  X-­‐ray	  film.	  Immune	  sera	  were	  treated	  with	  an	  acetone	  
powder	  composed	  of	  exc-­5	  (rh232)	  animals	  and	  tested	  against	  protein	  lysates	  from	  both	  N2	  
and	  exc-­5	  (rh232)	  animals	  along	  with	  the	  pre-­‐immune	  sera	  (PRE)	  controls.	  No	  ~100kDa	  
bands	  were	  seen	  that	  were	  specific	  to	  the	  N2	  lysate.	  (A)	  653,	  654.	  (B)	  655,	  656.	  (C)	  657,	  
658.	  (D)	  659,	  660.	  656	  and	  658	  still	  have	  high	  reactivity	  to	  both	  the	  N2	  and	  exc-­5	  (rh232)	  
protein	  lysate.	  Interestingly,	  the	  banding	  pattern	  between	  the	  exc-­5	  (rh232)	  and	  N2	  protein	  
lysate	  differ.	  Frequently	  the	  immune	  sera	  identified	  a	  ~50kDa	  band(arrow)(654,	  655,	  657,	  
in	  both	  the	  pre-­‐immune	  and	  immune	  serum	  from	  660)	  that	  was	  not	  present	  in	  N2	  animals.	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Figure	  8.3	  –	  In	  situ	  labeling	  of	  C.	  elegans	  using	  656	  and	  658	  	  
Fluorescent	  micrographs	  of	  animals	  labeled	  with	  either	  immune	  serum	  from	  656	  or	  658.	  
Arrows	  indicated	  the	  labeled	  excretory	  canal.	  Asterisks	  indicate	  the	  posterior	  bulb	  of	  the	  
pharynx.	  (A)	  656	  brightly	  labels	  the	  excretory	  canal	  as	  well	  as	  the	  pharynx	  of	  N2	  animals.	  
(B)	  656	  also	  brightly	  labels	  the	  excretory	  canal	  and	  pharynx	  of	  exc-­5	  (rh232)	  animals.	  (C)	  
658	  brightly	  labels	  the	  excretory	  canal	  as	  well	  as	  the	  duct	  cell	  (solid	  arrowhead)	  and	  the	  
mouth	  of	  the	  animal	  (open	  arrowhead).	  The	  pharynx	  is	  also	  faintly	  labeled.	  This	  labeling	  
was	  seen	  in	  both	  N2	  and	  exc-­5	  (rh232)	  animals.	  Magnifications	  are	  as	  indicated.
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EXC-­5::GFP	  Protein	  is	  Undetectable	  in	  BK157	  Animals	  
The	  molecular	  mass	  of	  GFP	  is	  roughly	  30	  kDa.	  The	  predicted	  mass	  of	  EXC-­‐5	  fused	  to	  GFP	  is	  
approximately	  126	  kDa	  (121	  kDa	  for	  the	  shorter	  isoform).	  Blots	  using	  N2,	  BK36,	  and	  
BK157	  protein	  lysates	  showed	  a	  clear	  band	  in	  the	  BK36	  animals	  at	  about	  30	  kDa,	  
corresponding	  to	  the	  GFP	  protein	  (Fig.	  8.4).	  In	  addition,	  there	  was	  no	  GFP	  detected	  in	  the	  
N2	  protein	  lysates,	  as	  we	  expected.	  Although	  both	  controls	  for	  the	  detection	  of	  GFP	  worked,	  
we	  did	  not	  observe	  the	  ~120	  kDa	  band	  size	  for	  EXC-­‐5::	  GFP	  (or	  any	  other	  band)	  in	  the	  
BK157	  lysate.	  
	  
	  Figure	  8.4	  –	  Identifying	  GFP-­labeled	  EXC-­5	  Protein	  
Image	  of	  a	  western	  blot	  labeled	  with	  Anti-­‐GFP	  antibodies.	  Three	  different	  protein	  lysates	  
were	  used.	  GFP	  has	  a	  molecular	  mass	  of	  ~30	  kDa.	  N2	  animals	  do	  not	  express	  GFP	  and	  were	  
used	  as	  a	  negative	  control.	  BK36	  animals	  contain	  the	  qpIs11	  insertion	  and	  express	  GFP	  at	  
high	  levels	  in	  the	  canal	  (Fig.	  1.10A,	  6.1A)	  and	  were	  used	  as	  a	  positive	  control.	  BK157	  
animals	  contain	  the	  qpIs78	  insertion	  and	  express	  EXC-­‐5::GFP.	  Expression	  of	  GFP	  was	  easily	  
detected	  in	  BK36	  animals	  but	  not	  in	  BK157.	  BK157	  lanes	  have	  increasing	  amounts	  of	  
protein.	  The	  last	  lane	  contains	  as	  much	  undiluted	  protein	  lysate	  as	  possible	  in	  the	  well.
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Discussion	  
It	  is	  unclear	  what	  the	  antibodies	  designed	  for	  EXC-­‐5	  are	  binding	  to,	  but	  it	  is	  very	  unlikely	  to	  
include	  the	  EXC-­‐5	  protein.	  After	  confirming	  the	  deletion	  in	  the	  rh232	  strain	  used	  for	  the	  
experiments,	  only	  sequence	  in	  the	  genome	  for	  antibody	  binding	  sites	  659	  and	  660	  still	  
exist.	  Clearing	  the	  antibodies	  with	  an	  acetone	  powder	  was	  ultimately	  ineffective,	  although	  
it	  did	  alter	  the	  banding	  patterns	  for	  both	  N2	  and	  exc-­5	  animals.	  It	  should	  be	  noted	  that	  the	  
banding	  pattern	  between	  N2	  and	  exc-­5	  animals	  are	  different,	  which	  indicates	  that	  the	  
population	  of	  proteins	  within	  each	  preparation	  differ	  significantly.	  This	  result	  may	  be	  due	  
to	  some	  sort	  of	  contamination,	  although	  the	  strains	  were	  grown	  and	  prepared	  in	  parallel	  to	  
minimize	  the	  amount	  of	  discrepancy	  between	  the	  two	  preparations.	  In	  addition,	  this	  effect	  
persisted	  using	  a	  second	  preparation	  of	  a	  protein	  lysate	  from	  exc-­5	  animals.	  Alternatively,	  
the	  exc-­5	  mutation	  may	  be	  having	  a	  tremendous	  effect	  on	  the	  protein	  expression	  pattern	  of	  
the	  animals.	  As	  we	  know	  now,	  EXC-­‐5	  controls	  recycling	  and	  transport	  in	  the	  canal	  cell.	  If	  
these	  defects	  are	  occurring	  in	  the	  pharynx	  and	  other	  nerves	  that	  exc-­5	  is	  expressed	  in,	  the	  
effects	  on	  the	  animal	  could	  be	  large.	  The	  physiology	  of	  exc-­5(rh232)	  animals	  is	  clearly	  
altered	  from	  that	  of	  N2	  animals.	  exc-­5	  animals	  must	  compensate	  for	  not	  only	  the	  
morphological	  defects	  caused	  by	  large	  cyst	  formation	  interfering	  with	  normal	  organ	  
architecture/placement	  within	  the	  animal,	  but	  also	  less	  efficient	  growth.	  exc-­5	  mutants	  are	  
noticeably	  less	  healthy	  than	  are	  N2	  animals	  (slower	  growth,	  lower	  number	  of	  progeny,	  and	  
often	  egg-­‐laying-­‐defective	  as	  young	  adults).	  What	  the	  strong	  50	  kDa	  protein	  is	  that	  several	  
antibodies	  are	  recognizing	  in	  the	  exc-­5	  lysate	  but	  not	  in	  the	  N2	  lysate	  is	  unclear.	  
Interestingly,	  antibody	  staining	  within	  the	  animals	  did	  show	  canal	  labeling	  for	  antibodies	  
656	  and	  658,	  though	  this	  labeling	  was	  seen	  in	  both	  N2	  and	  exc-­5	  animals.	  These	  two	  
antibodies	  also	  show	  the	  highest	  background	  staining	  and	  therefore	  may	  be	  more	  reactive	  
to	  worm	  proteins	  overall	  rather	  than	  to	  EXC-­‐5	  specifically.	  It	  is	  possible	  that	  the	  rabbits	  
being	  used	  for	  the	  generation	  of	  these	  antibodies	  had	  nematode	  infections	  either	  actively	  
or	  at	  one	  point	  in	  their	  lives.	  This	  would	  explain	  why	  they	  had	  such	  broad-­‐spectrum	  
reactivity	  on	  the	  western	  blots,	  and	  labeled	  tissues	  that	  are	  directly	  exposed	  to	  the	  external	  
environment	  in	  the	  animals	  (Fig.	  8.2).	  	  
In	  retrospect,	  the	  immune	  sera	  received	  from	  Sigma-­‐Genosys	  could	  have	  been	  handled	  
much	  better.	  The	  sera	  were	  never	  specifically	  purified	  for	  IgG	  polyclonal	  antibodies	  and	  
purification	  with	  a	  Protein	  A	  column	  would	  have	  been	  relatively	  simple.	  An	  even	  more	  
effective	  way	  to	  prepare	  the	  sera	  (but	  more	  complex)	  would	  have	  been	  by	  immunoaffinity	  
purification.	  By	  linking	  either	  the	  peptides	  or	  the	  EXC-­‐5	  protein	  to	  activated	  beads,	  the	  
polyclonal	  serum	  could	  be	  purified	  specifically	  for	  antibodies	  that	  recognize	  EXC-­‐5	  or	  a	  
peptide	  of	  EXC-­‐5	  sequence	  by	  use	  of	  an	  antigen-­‐linked	  column.	  Relatively	  large	  quantities	  
of	  sera	  still	  exist	  and	  have	  been	  kept	  frozen	  for	  six	  years.	  Future	  work	  would	  require	  
testing	  these	  sera	  to	  see	  if	  they	  still	  retain	  activity	  using	  a	  more	  rigorous	  purification	  step,	  
as	  mentioned	  above,	  before	  they	  could	  be	  used	  for	  other	  biochemical	  experiments.	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The	  antibodies	  designed	  to	  GFP	  worked	  quite	  well.	  Unfortunately,	  we	  were	  not	  able	  to	  
detect	  EXC-­‐5::GFP	  protein	  in	  the	  BK157	  strain.	  This	  is	  likely	  due	  to	  the	  less	  detectable	  
nature	  of	  GFP	  in	  the	  BK157	  strain	  despite	  efforts	  to	  concentrate	  the	  amount	  of	  protein	  
present	  in	  the	  samples	  as	  much	  as	  possible.	  The	  difference	  in	  relative	  levels	  of	  GFP	  between	  
these	  two	  strains	  can	  easily	  be	  seen	  in	  the	  microscope	  (Fig.	  6.1).	  In	  comparison	  to	  BK36,	  
BK157	  has	  extremely	  low	  fluorescence	  levels.	  To	  create	  enough	  GFP-­‐labeled	  EXC-­‐5	  protein	  
to	  use	  for	  other	  experiments,	  we	  would	  need	  to	  switch	  from	  native	  expression	  in	  C.	  elegans	  
to	  a	  bacterial-­‐based	  expression	  system.	  GFP	  would	  no	  longer	  be	  needed,	  and	  a	  more	  
purification-­‐friendly	  tag	  such	  as	  GST	  could	  be	  added	  instead	  to	  facilitate	  purification.	  
Future	  plans	  do	  include	  the	  production	  of	  such	  a	  GST-­‐labeled	  EXC-­‐5	  protein	  as	  well	  as	  
other	  proteins	  to	  be	  used	  for	  co-­‐immunoprecipitation	  experiments	  as	  well	  as	  for	  
identifying	  direct	  binding	  partners.
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Chapter	  9:	  Conclusions	  
	  
The	  primary	  purpose	  of	  this	  thesis	  is	  to	  describe	  how	  EXC-­‐5	  functions	  in	  order	  to	  maintain	  
tubular	  structures.	  Very	  little	  was	  known	  about	  the	  role	  of	  EXC-­‐5	  before	  this	  work	  was	  
done.	  The	  mutant	  phenotypes	  of	  exc-­5	  had	  been	  characterized,	  the	  tissues	  in	  which	  EXC-­‐5	  is	  
expressed	  had	  been	  identified,	  and	  the	  gene	  had	  been	  mapped	  and	  identified	  as	  a	  
homologue	  of	  FGD1	  48,56,57.	  Our	  simplistic	  starting	  model	  supposed	  that	  EXC-­‐5	  worked	  with	  
CDC-­‐42	  at	  the	  apical	  surface	  to	  maintain	  the	  structural	  integrity	  of	  the	  lumen	  (Fig.	  9.1).	  
Through	  my	  investigations	  we	  have	  affirmed	  the	  basics	  of	  our	  starting	  model	  but	  more	  
importantly	  we	  have	  significantly	  increased	  our	  understanding	  of	  how	  EXC-­‐5	  works	  within	  
the	  excretory	  canal	  and	  the	  cellular	  processes	  involved	  in	  tubule	  formation	  and	  
maintenance	  (Fig	  9.2).	  
The	  first	  approach	  was	  to	  determine	  when	  during	  cyst	  formation	  and	  excretory	  canal	  cell	  
growth	  EXC-­‐5	  is	  required.	  In	  Chapter	  One	  I	  describe	  the	  general	  characteristics	  of	  the	  canal	  
and	  its	  formation,	  as	  well	  as	  provide	  a	  detailed	  description	  of	  EXC-­‐5	  and	  its	  mutant	  
phenotypes.	  We	  know	  that	  EXC-­‐5	  is	  not	  necessary	  for	  the	  birth,	  differentiation,	  
polarization,	  or	  even	  formation	  of	  the	  excretory	  canal.	  In	  the	  rh232	  null	  allele,	  all	  these	  
processes	  are	  unaffected.	  Based	  on	  our	  observations	  on	  the	  development	  of	  cysts,	  EXC-­‐5	  is	  
required	  only	  at	  certain	  points	  along	  the	  canal,	  most	  importantly	  at	  the	  terminus	  of	  the	  
canal	  where	  outgrowth	  occurs.	  If	  EXC-­‐5	  were	  required	  along	  the	  entire	  length	  of	  the	  canal	  
to	  maintain	  tubule	  diameter,	  the	  entire	  canal	  would	  be	  affected,	  and	  uniformly	  disrupted.	  
This	  is	  not	  what	  is	  observed	  in	  rh232	  animals.	  In	  exc-­5	  null	  mutants,	  cysts	  are	  confined	  to	  
distinct	  points	  along	  the	  canal	  and	  are	  bounded	  by	  lengths	  of	  canal	  that	  retain	  their	  wild-­‐
type	  diameter	  (Figs.	  1.10,	  6.5,	  6.6).	  In	  addition,	  the	  canals	  do	  not	  extend	  past	  the	  vulva,	  and	  
maintain	  this	  relative	  length	  as	  the	  animals	  grows	  larger.	  The	  canal	  must	  be	  growing	  in	  
length	  to	  maintain	  this	  proportional	  body	  length.	  EXC-­‐5	  must	  not	  be	  absolutely	  required	  for	  
the	  lengthening	  of	  pre-­‐existing	  tubules	  as	  rh232	  mutants	  have	  canals	  that	  still	  reach	  the	  
vulva.	  EXC-­‐5	  activity	  is,	  however,	  important	  	  in	  this	  process	  as	  cysts	  do	  form	  in	  these	  areas	  
and	  become	  progressively	  larger.	  This	  again	  indicates	  that	  EXC-­‐5	  function	  is	  required	  at	  
certain	  points	  to	  maintain	  the	  tubule	  diameter	  as	  the	  canal	  grows	  and	  the	  animal	  ages.
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Figure	  9.1	  –	  Starting	  Model	  of	  EXC	  Proteins	  in	  the	  Canal	  
	  
A	  previous	  model	  of	  how	  EXC	  proteins	  function	  to	  maintain	  the	  canal	  included	  EXC-­‐1	  acting	  
upstream	  of	  EXC-­‐5	  to	  promote	  apical	  structure	  formation	  and	  inhibit	  the	  growth	  of	  the	  
basal	  surface	  through	  CDC-­‐42.	  EXC-­‐9	  was	  hypothesized	  to	  work	  downstream	  of	  EXC-­‐5	  at	  
the	  apical	  surface.	  EXC-­‐4	  is	  a	  CLIC	  family	  member	  of	  chloride	  ion	  channels	  that	  is	  required	  
for	  normal	  canal	  morphology	  49.	  EXC-­‐7	  is	  an	  ELAV	  homologue	  and	  RNA	  transport	  protein	  
that	  binds	  to	  sma-­1	  mRNA	  50	  and	  may	  help	  to	  transport	  it	  out	  of	  the	  nucleus	  at	  the	  cell	  body	  
to	  be	  translated	  closer	  to	  its	  product’s,	  βH-­‐spectrin,	  destination	  at	  the	  apical	  surface	  of	  the	  
canal.	  VHA	  is	  a	  vacuolar	  ATPase	  proton	  pump	  that	  lines	  the	  apical	  surface	  of	  the	  canal.	  The	  
promoter	  for	  one	  of	  its	  subunits,	  VHA-­‐1,	  is	  expressed	  only	  in	  the	  canal	  and	  head	  
mesodermal	  cell.	  Image	  courtesy	  of	  M.	  Buechner.
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Figure	  9.2	  	  –	  Current	  Model	  of	  EXC-­5	  Function	  in	  the	  Canal	  
(A)	  EXC-­‐9	  recognizes	  or	  is	  recruited	  to	  points	  of	  growth	  or	  damage	  along	  the	  canal.	  It	  then	  
recruits	  EXC-­‐1,	  which	  in	  turn	  promotes	  EXC-­‐5	  activity	  at	  the	  apical	  surface.	  EXC-­‐5	  indirectly	  
activates	  Rac	  on	  the	  early	  endosome.	  This	  activation	  may	  promote	  actin	  filament	  formation	  
and	  the	  movement	  of	  cargo	  from	  early	  endosomes	  to	  recycling	  endosomes.	  EXC-­‐5	  directly	  
activates	  CDC-­‐42	  to	  promote	  recycling	  of	  material	  back	  to	  the	  apical	  surface,	  including	  
activated	  Rac	  and	  other	  membrane	  associated	  proteins	  like	  spectrin,	  where	  they	  can	  
reinforce	  the	  apical	  surface	  through	  actin	  filament	  formation	  and	  anchoring	  to	  the	  plasma	  
membrane.	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Figure	  9.2	  B	  	  –	  Current	  Model	  of	  EXC-­5	  Function	  in	  the	  Canal	  
	  
(B)	  When	  EXC-­‐5	  is	  not	  present	  in	  the	  cell,	  material	  builds	  up	  in	  the	  early	  endosome	  and	  is	  
unable	  to	  be	  recycled	  back	  to	  the	  apical	  surface.	  RME-­‐1-­‐labeled	  recycling	  endosomes	  are	  
depleted,	  and	  the	  apical	  surface	  of	  the	  canal	  is	  weakened.	  This	  weakening	  allows	  pressure	  
from	  the	  fluids	  being	  transported	  through	  the	  lumen	  to	  exert	  more	  pressure	  on	  the	  canal	  
cell.	  In	  response,	  the	  canal	  cell	  forms	  cysts	  that	  continue	  to	  grow	  in	  size	  as	  the	  animal	  ages.	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Figure	  9.2	  C	  	  –	  Current	  Model	  of	  EXC-­5	  Function	  in	  the	  Canal	  
	  
(C)	  When	  EXC-­‐5	  is	  overexpressed,	  recycling	  to	  the	  apical	  surface	  is	  enhanced	  at	  the	  
expense	  of	  sorting	  to	  the	  basal	  surface.	  The	  abundance	  of	  activated	  CDC-­‐42	  and	  Rac	  may	  
indirectly	  inhibit	  sorting	  to	  the	  basal	  surface	  and	  prevent	  integral	  membrane	  proteins	  such	  
as	  integrin	  from	  being	  incorporated	  into	  the	  membrane.	  As	  a	  result,	  the	  basal	  surface	  is	  
unable	  to	  maintain	  its	  connection	  to	  the	  basement	  membrane	  and	  is	  unable	  to	  grow	  and	  
extend	  normally,	  causing	  a	  convoluted	  tubule	  phenotype.	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In	  order	  to	  be	  able	  to	  control	  EXC-­‐5	  activity	  during	  the	  growth	  of	  the	  canal	  and	  therefore	  
learn	  more	  about	  the	  developmental	  time	  requirements	  of	  EXC-­‐5,	  I	  attempted	  to	  create	  
conditional	  alleles	  of	  the	  gene	  (as	  described	  in	  Chapters	  Two	  and	  Seven).	  While	  several	  
new	  alleles	  were	  isolated	  and	  provided	  us	  with	  new	  insight	  into	  the	  protein,	  these	  attempts	  
were	  ultimately	  unsuccessful	  in	  generating	  the	  type	  of	  conditional	  allele	  that	  would	  have	  
been	  useful	  in	  developmental	  time-­‐course	  studies.	  As	  such,	  large	  questions	  still	  remain	  
about	  the	  timing	  and	  specific	  requirements	  of	  EXC-­‐5	  activity	  in	  the	  excretory	  canal.	  Is	  
supplying	  EXC-­‐5	  activity	  only	  in	  the	  early	  stages	  of	  cyst	  formation	  enough	  to	  prevent	  cysts	  
from	  forming	  later	  in	  the	  animal’s	  life?	  My	  prediction	  is	  that	  the	  answer	  is	  no.	  In	  my	  model	  
for	  EXC-­‐5	  function,	  its	  activity	  is	  continuously	  required	  to	  maintain	  the	  apical	  surface	  and	  
prevent	  the	  cysts	  from	  forming.	  What	  if	  you	  supplied	  EXC-­‐5	  activity	  after	  cysts	  have	  
formed?	  Would	  delayed	  activity	  reduce	  or	  repair	  cyst	  formation?	  It	  is	  unlikely	  that	  
supplying	  EXC-­‐5	  activity	  after	  a	  cyst	  has	  formed	  will	  cause	  the	  canal	  to	  return	  to	  normal.	  In	  
my	  model,	  cyst	  formation	  occurs	  because	  of	  a	  failure	  in	  the	  apical	  surface.	  This	  failure	  then	  
becomes	  progressively	  worse	  as	  the	  canal	  compensates	  for	  the	  continued	  osmotic	  pressure	  
against	  the	  cell	  by	  growing	  in	  size.	  There	  is	  no	  evidence	  that	  cyst	  formation	  is	  a	  reversible	  
process	  and	  it	  is	  unlikely	  that	  adding	  EXC-­‐5	  activity	  after	  they	  have	  formed	  would	  return	  
the	  canal	  back	  to	  a	  normal	  diameter.	  It	  is	  more	  likely	  that	  supplying	  EXC-­‐5	  activity	  after	  
cysts	  have	  already	  formed	  will	  prevent	  them	  from	  becoming	  more	  severe	  and	  prevent	  new	  
cysts	  from	  forming.	  Adding	  back	  EXC-­‐5	  activity	  may	  allow	  the	  cell	  to	  repair	  the	  apical	  
surface	  and	  prevent	  further	  damage	  or	  expansion.	  Future	  work	  will	  require	  alternative	  
methods	  to	  generate	  the	  kind	  of	  conditional	  expression	  of	  EXC-­‐5	  that	  is	  required	  to	  
investigate	  these	  hypotheses.	  
The	  second	  approach	  to	  identify	  how	  EXC-­‐5	  functions	  to	  maintain	  the	  excretory	  canal	  was	  
to	  identify	  other	  genes	  or	  proteins	  that	  interact	  with	  EXC-­‐5.	  By	  identifying	  interacting	  
genes	  or	  proteins,	  we	  can	  implicate	  EXC-­‐5	  in	  the	  same	  pathways	  that	  those	  genes	  or	  
proteins	  are	  involved.	  In	  Chapters	  Two	  and	  Three,	  I	  discuss	  the	  isolation	  of	  three	  different	  
mutations	  that	  affect	  the	  EXC-­‐5	  phenotype.	  One	  of	  these	  mutations,	  qp49,	  showed	  subtle	  
temperature-­‐sensitive	  suppression	  effects.	  The	  other	  mutations	  contained	  in	  strains	  BK188	  
and	  BK190	  act	  as	  genetic	  enhancers	  of	  EXC-­‐5.	  These	  results	  show	  that	  it	  is	  relatively	  easy	  to	  
isolate	  extragenic	  interactions	  with	  exc-­5.	  In	  order	  for	  these	  mutations	  to	  be	  informative	  on	  
the	  role	  EXC-­‐5	  plays	  in	  the	  excretory	  canal	  cell,	  these	  mutations	  need	  to	  be	  mapped	  and	  
identified.	  Future	  studies	  could	  accomplish	  this	  by	  continuing	  to	  use	  traditional	  mapping,	  
which	  is	  laborious	  and	  time	  consuming,	  or	  through	  the	  relatively	  new	  approach	  of	  whole-­‐
genome	  sequencing,	  which	  was	  not	  available	  when	  these	  alleles	  were	  isolated	  and	  has	  its	  
own	  limitations	  on	  sensitivity.	  	  
In	  Chapter	  Four,	  I	  discuss	  methods	  that	  were	  used	  to	  try	  to	  create	  a	  canal-­‐specific	  RNAi	  
strain.	  The	  creation	  of	  such	  a	  strain	  would	  allow	  us	  to	  selectively	  knock	  down	  genes	  in	  the	  
canal	  that	  would	  otherwise	  be	  deleterious	  to	  the	  worm.	  We	  could	  then	  manipulate	  these	  
genes	  in	  exc-­5	  (or	  other)	  mutants	  through	  RNAi	  and	  observe	  the	  effects	  on	  the	  phenotype.	  
Currently	  such	  a	  canal-­‐specific	  RNAi	  screen	  is	  being	  set	  up	  based	  on	  the	  effects	  of	  cell-­‐
specific	  expression	  of	  sid-­1.	  Although	  I	  was	  unsuccessful	  in	  creating	  a	  functional	  canal-­‐
specific	  RNAi	  strain,	  we	  did	  discover	  that	  RDE-­‐1	  has	  significant	  effects	  on	  the	  canal	  and	  
that,	  like	  neurons,	  the	  canal	  is	  resistant	  to	  RNAi.	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In	  Chapter	  Five,	  I	  discuss	  the	  effects	  of	  several	  genes	  on	  the	  EXC-­‐5	  phenotype	  and	  show	  
that	  CDC-­‐42	  and	  MIG-­‐2	  both	  interact	  with	  EXC-­‐5.	  Although	  the	  exact	  nature	  of	  this	  
interaction	  is	  unclear,	  it	  is	  likely	  that	  EXC-­‐5	  acts	  primarily	  as	  a	  GEF	  for	  CDC-­‐42	  and	  that	  
EXC-­‐5’s	  interactions	  with	  the	  Rac	  family	  member	  MIG-­‐2	  may	  be	  indirect.	  	  In	  addition,	  EXC-­‐9	  
and	  EXC-­‐1	  both	  show	  genetic	  interactions	  with	  EXC-­‐5,	  and	  these	  interactions	  place	  EXC-­‐5	  
downstream	  of	  both	  proteins.	  The	  specific	  functions	  of	  both	  EXC-­‐1	  and	  EXC-­‐9	  are	  unknown	  
and	  it	  will	  be	  interesting	  to	  find	  out	  how	  they	  work	  with	  EXC-­‐5	  in	  order	  to	  prevent	  cysts	  
from	  forming	  in	  the	  excretory	  canal.	  	  
In	  Chapter	  Six,	  the	  GBD	  of	  WSP-­‐1	  shows	  the	  most	  efficient	  rescue	  of	  rh232	  of	  all	  the	  
constructs	  tested.	  WSP-­‐1	  is	  the	  sole	  homologue	  of	  	  N-­‐WASP	  in	  C.	  elegans	  133.	  It	  is	  a	  
downstream	  target	  of	  both	  CDC-­‐42	  and	  Rac,	  and	  interacts	  with	  the	  Arp2/3	  complex	  to	  
stimulate	  actin	  filament	  formation	  134,135.	  Although	  it	  is	  unclear	  how	  only	  the	  GBD	  of	  WSP-­‐1	  
can	  cause	  this	  effect	  in	  the	  canal	  cell,	  it	  is	  consistent	  with	  the	  	  model	  that	  EXC-­‐5	  acts	  in	  the	  
same	  pathway	  as	  both	  CDC-­‐42	  and	  Rac,	  and	  that	  activation	  of	  these	  proteins	  is	  crucial	  to	  
maintain	  the	  apical	  surface.	  
Investigations	  into	  the	  interactions	  of	  EXC-­‐5	  with	  other	  proteins	  is	  ongoing.	  Current	  studies	  
include	  yeast	  two-­‐hybrid	  assays	  to	  test	  direct	  interactions	  between	  EXC-­‐5	  and	  other	  
candidate	  proteins	  such	  as	  EXC-­‐1	  and	  CDC-­‐42.	  In	  addition,	  the	  generation	  of	  a	  GST-­‐labeled	  
EXC-­‐5	  protein	  for	  use	  in	  pulldown	  assays	  is	  being	  undertaken	  to	  identify	  more	  EXC-­‐5	  
binding	  partners.	  
The	  third	  approach	  was	  to	  investigate	  how	  EXC-­‐5	  functioned	  in	  the	  canal	  cell.	  In	  
combination	  with	  our	  observations	  and	  previous	  work,	  we	  hypothesized	  that	  EXC-­‐5	  was	  
involved	  in	  directing	  material	  to	  the	  apical	  surface	  of	  the	  canal.	  In	  Chapter	  Six,	  we	  examined	  
a	  set	  of	  ten	  markers	  labeling	  various	  subcellular	  compartments	  and	  EXC-­‐5-­‐related	  proteins	  
in	  both	  exc-­5	  (rh232)	  mutants	  and	  animals	  mildly	  overexpressing	  EXC-­‐5::GFP.	  We	  show	  
that	  in	  both	  rh232	  mutants	  and	  EXC-­‐5	  overexpressors,	  the	  distribution	  of	  EEA-­‐1	  and	  RME-­‐1	  
is	  disrupted.	  	  These	  results	  indicate	  that	  EXC-­‐5	  function	  is	  essential	  in	  the	  movement	  of	  
material	  from	  early	  endosomes	  to	  recycling	  endosomes	  and	  then	  back	  to	  the	  plasma	  
membrane.	  In	  addition,	  mild-­‐overexpression	  of	  the	  markers	  CDC-­‐42,	  RAB-­‐5,	  RAB-­‐11,	  and	  
GBD:WSP-­‐1	  all	  caused	  mild	  convoluted	  and	  cystic	  phenotypes	  in	  a	  low	  percentage	  of	  canals	  
(Table	  6.2).	  This	  is	  consistent	  with	  the	  model	  that	  disruption	  of	  intracellular	  trafficking	  
leads	  to	  convolution	  and	  cyst	  formation	  in	  the	  canal.	  Although	  we	  believe	  that	  EXC-­‐5	  is	  
interrupting	  intracellular	  transport,	  it	  is	  difficult	  to	  delineate	  where	  cell	  polarization	  and	  
intracellular	  membrane	  trafficking	  diverge.	  To	  help	  elucidate	  this	  distinction,	  it	  would	  be	  
helpful	  to	  view	  the	  movement	  of	  cargo	  through	  the	  excretory	  canal	  in	  real	  time.	  The	  
creation	  of	  labeled	  cargoes	  that	  are	  recycled	  to	  either	  the	  apical	  or	  basal	  surface	  would	  
allow	  us	  to	  see	  accumulation	  of	  material	  in	  certain	  compartments	  or	  if	  they	  were	  being	  
missorted	  due	  to	  local	  disruption	  of	  cell	  polarity.	  	  
In	  addition,	  the	  actin	  network	  has	  been	  understudied	  in	  the	  canal.	  Based	  on	  our	  model,	  
EXC-­‐5	  is	  exerting	  its	  effects	  (indirectly)	  through	  modulation	  of	  the	  actin	  cytoskeleton.	  
Interestingly,	  recent	  studies	  have	  shown	  that	  the	  formation	  of	  actin	  filaments	  is	  essential	  
for	  the	  proper	  sorting	  of	  material	  out	  of	  endosomes	  136.	  Although	  not	  described	  in	  detail	  in	  
this	  thesis,	  the	  creation	  of	  a	  GFP-­‐labeled	  amino	  acid	  sequence	  that	  labels	  F-­‐actin,	  termed	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Lifeact	  137,	  and	  expressed	  only	  in	  the	  canal	  has	  not	  shown	  a	  distinct	  actin	  filament	  network	  
within	  the	  canal	  (Fig.	  9.3).	  The	  excretory	  canal	  is	  sensitive	  to	  expression	  of	  Lifeact,	  and	  
overexpression	  of	  Lifeact	  causes	  defects	  including	  shortening	  of	  the	  length	  of	  the	  canal,	  
widening	  of	  the	  lumen,	  occasional	  cysts,	  small	  cytoplasmic	  ‘tails’,	  and	  accumulations	  of	  
material	  at	  the	  canal	  termini.	  Regardless	  of	  the	  morphological	  defects,	  actin	  appears	  
enriched	  on	  the	  luminal	  surface	  and	  in	  accumulations	  where	  the	  canals	  prematurely	  end.	  It	  
is	  interesting	  to	  note	  that	  both	  CDC-­‐42	  and	  EXC-­‐5	  are	  enriched	  on	  the	  luminal	  surface	  as	  
well.	  Unfortunately,	  the	  small	  size	  of	  the	  excretory	  canal	  makes	  resolution	  of	  the	  observed	  
structures	  and	  distinct	  locations	  of	  the	  all	  of	  these	  proteins	  difficult	  using	  standard	  
differential	  interference	  contrast	  light	  microscopy.	  In	  the	  future,	  it	  may	  be	  useful	  to	  turn	  to	  
more	  elaborate	  light	  microscopy	  techniques	  such	  as	  3D	  structured	  illumination	  microscopy	  
(3D-­‐SIM)138	  or	  more	  traditional	  electron	  microscopy.	  
The	  central	  question	  of	  this	  dissertation	  is	  	  ‘How	  does	  EXC-­‐5	  function	  in	  order	  to	  maintain	  
tubular	  structure?’	  Taken	  together,	  my	  investigations	  support	  a	  new	  model	  of	  tubular	  
maintenance	  that	  includes	  membrane	  trafficking	  within	  the	  canal	  cell	  (compare	  Figs.	  9.1,	  
9.2).	  These	  observations	  show	  that	  EXC-­‐5	  functions	  with	  CDC-­‐42	  and	  Rac	  to	  direct	  
recycling	  of	  proteins	  to	  the	  apical	  surface	  of	  the	  canal.	  This	  direction	  of	  material	  to	  the	  
apical	  surface	  is	  not	  required	  universally	  along	  the	  canal	  tubule;	  it	  is	  required	  only	  at	  
certain	  points	  along	  the	  canal.	  Presumably,	  these	  points	  are	  where	  the	  canal	  is	  undergoing	  
significant	  restructuring	  because	  of	  growth	  or	  physical	  damage.	  The	  activity	  of	  EXC-­‐5	  is	  
related	  to	  but	  downstream	  of	  both	  EXC-­‐1	  and	  EXC-­‐9.	  Although	  it	  is	  unclear	  how	  EXC-­‐1	  and	  
EXC-­‐9	  interact	  with	  EXC-­‐5,	  it	  is	  possible	  that	  they	  help	  recruit	  and	  direct	  the	  remodeling	  
machinery	  necessary	  to	  maintain	  the	  apical	  structure	  at	  the	  points	  of	  growth	  or	  damage	  
where	  the	  cysts	  form.	  EXC-­‐5	  is	  part	  of	  this	  machinery	  and	  may	  indirectly	  activate	  Rac	  on	  
the	  early	  endosomes.	  The	  activation	  of	  Rac	  may	  help	  to	  remodel	  the	  actin	  cytoskeleton	  and	  
form	  the	  actin	  filaments	  necessary	  for	  the	  sorting	  of	  early	  endosomal	  material	  into	  
recycling	  endosomes.	  EXC-­‐5	  then	  directly	  activates	  CDC-­‐42	  to	  transport	  materials	  such	  as	  
activated	  Rac	  and	  spectrin	  back	  to	  the	  apical	  surface.	  These	  proteins,	  in	  addition	  to	  
activated	  CDC-­‐42,	  can	  reinforce	  the	  apical	  surface	  through	  actin	  filament	  formation	  and	  
anchoring	  to	  the	  plasma	  membrane.	  When	  exc-­5	  is	  mutant,	  materials	  are	  not	  efficiently	  
sorted	  to	  the	  apical	  surface	  and	  the	  actin	  cytoskeleton	  is	  not	  remodeled	  or	  reinforced	  to	  
maintain	  the	  structure	  of	  the	  lumen.	  The	  weakening	  of	  the	  apical	  matrix	  causes	  failure	  of	  
the	  lumen	  under	  the	  osmotic	  pressure	  from	  fluid	  within	  the	  excretory	  canal.	  This	  increased	  
pressure	  causes	  the	  canal	  cell	  to	  respond	  by	  growing	  and	  forming	  a	  cyst.	  As	  the	  animal	  
ages,	  the	  constant	  pressure	  causes	  the	  cysts	  to	  continue	  to	  increase	  in	  size.	  When	  EXC-­‐5	  is	  
overexpressed,	  sorting	  to	  the	  apical	  surface	  is	  enhanced.	  This	  increased	  rate	  of	  transport	  to	  
the	  apical	  surface	  is	  at	  the	  expense	  of	  sorting	  to	  the	  basal	  surface.	  The	  abundance	  of	  
activated	  CDC-­‐42	  and	  Rac	  due	  to	  the	  enhanced	  EXC-­‐5	  activity	  may	  indirectly	  inhibit	  sorting	  
to	  the	  basal	  surface	  and	  prevent	  integral	  membrane	  proteins	  such	  as	  integrin	  from	  being	  
incorporated	  into	  the	  membrane.	  This	  leads	  to	  an	  inability	  of	  the	  basal	  surface	  to	  adhere	  to	  
the	  extracellular	  matrix	  of	  the	  basement	  membrane	  and	  consequently	  its	  inability	  to	  extend	  
along	  the	  length	  of	  the	  animal,	  causing	  a	  convoluted	  tubule	  phenotype.
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  Figure	  9.3	  –	  Actin	  is	  Enriched	  on	  the	  Apical	  Surface	  of	  the	  Canal	  
	  
F-­‐actin-­‐binding	  peptide	  Lifeact	  fused	  to	  GFP	  and	  expressed	  under	  the	  vha-­1	  promoter	  in	  wild-­‐type	  
(N2)	  animals.	  Arrows	  indicate	  the	  excretory	  cell	  body.	  Solid	  arrowheads	  indicate	  the	  basal	  surface	  
of	  the	  canal.	  Open	  arrowheads	  indicate	  the	  apical	  surface	  of	  the	  canal.	  Asterisks	  indicate	  the	  
posterior	  bulb	  of	  the	  pharynx.	  All	  images	  are	  of	  L4	  animals	  taken	  at	  630x	  magnification.	  (A)	  Actin	  is	  
enriched	  on	  the	  luminal	  surface	  of	  the	  canal.	  (B)	  Expression	  of	  Lifeact	  causes	  defects	  in	  canal	  
structure.	  The	  canals	  are	  short	  and	  have	  a	  defective	  lumen.	  This	  animal	  has	  a	  mass	  at	  the	  end	  of	  the	  
canal	  filled	  with	  small	  vesicles.	  (C)	  Fluorescence	  micrograph	  of	  the	  same	  animal	  shown	  in	  panel	  B	  
shows	  that	  Lifeact	  accumulates	  at	  the	  ends	  of	  these	  short	  canals	  where	  actin	  filament	  formation	  
may	  be	  most	  active.	  Lifeact	  may	  be	  over-­‐stabilizing	  these	  dynamic	  actin	  filaments	  and	  disrupting	  
normal	  morphology.	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Many	  questions	  still	  remain	  about	  how	  this	  process	  works.	  What	  activities	  do	  EXC-­‐9	  and	  
EXC-­‐1	  have	  in	  this	  pathway?	  They	  both	  seem	  to	  be	  working	  upstream	  of	  EXC-­‐5.	  Are	  they	  
regulating	  growth	  or	  repair?	  How	  does	  EXC-­‐5’s	  interaction	  with	  CDC-­‐42	  cause	  sorting	  to	  
the	  apical	  surface?	  Is	  it	  directly	  related	  to	  actin	  cytoskeleton	  remodeling?	  How	  does	  the	  
cycling	  of	  CDC-­‐42	  between	  its	  active	  and	  inactive	  state	  control	  trafficking?	  Our	  work	  with	  
DN	  and	  CA	  forms	  of	  the	  protein	  indicate	  that	  the	  ability	  of	  CDC-­‐42	  to	  switch	  between	  the	  
two	  states	  is	  essential	  in	  wild-­‐type	  activity.	  What	  role	  does	  Rac	  play	  in	  these	  processes	  
either	  directly	  or	  indirectly?	  How	  does	  the	  function	  of	  EXC-­‐5	  compare	  with	  that	  of	  the	  other	  
FGD	  proteins?	  Does	  the	  family	  of	  FGD	  proteins	  work	  to	  control	  membrane	  trafficking	  in	  all	  
cells	  and	  their	  specific	  effects	  are	  dependent	  on	  the	  cells	  they	  are	  expressed?	  	  
These	  questions	  and	  many	  more	  like	  them	  are	  the	  driving	  force	  of	  scientific	  discovery.	  If	  
they	  are	  to	  be	  answered,	  we	  must	  encourage	  and	  foster	  the	  innate	  curiosity	  we	  have	  as	  
humans	  about	  the	  world	  we	  live	  in.	  We	  must	  share	  our	  enthusiasm	  and	  appreciation	  of	  
science	  with	  the	  people	  around	  us.	  We	  must	  educate	  and	  inform	  others	  on	  the	  value	  of	  
continuous	  learning,	  the	  desire	  to	  know	  more,	  and	  of	  the	  scientific	  process.	  Education	  and	  
scientific	  research	  must	  remain	  a	  priority	  in	  our	  national	  identity	  if	  we	  are	  to	  continue	  to	  
be	  a	  successful	  country.	  We	  must	  continue	  to	  support	  our	  scientific	  institutions	  and	  our	  
research	  funding	  agencies.	  In	  this	  dissertation,	  I	  have	  only	  touched	  on	  a	  small	  fragment	  of	  
the	  knowledge	  we	  have	  accumulated	  due	  to	  our	  continued	  support	  of	  the	  sciences.	  For	  us	  
to	  continue	  to	  improve	  our	  quality	  of	  life	  and	  to	  be	  able	  to	  understand	  the	  world	  in	  which	  
we	  live,	  it	  is	  imperative	  that	  we	  do	  not	  forget	  some	  of	  the	  naïve	  wonder	  we	  have	  all	  felt	  at	  
one	  point	  in	  our	  lives	  and	  use	  that	  to	  fuel	  our	  curiosity	  to	  discover	  more	  about	  the	  world	  
around,	  and	  in	  the	  case	  of	  this	  dissertation,	  the	  world	  flowing	  through	  us.
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